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Abstract 
Lucas Frank McCormick, Ph.D. 
Department of Chemistry, May 2013 
University of Kansas 
 
Of major interest to modern synthetic organic chemistry is the use of transition metal 
catalysis to achieve carbon-carbon bond formation.  Over the past 40 years many of these 
versatile and simple methodologies have been developed including the Heck reaction, Stille 
coupling, Suzuki coupling, Sonogashira coupling, Buckwald-Hartwig reaction, Tsuji-Trost 
reaction, Negishi coupling and olefin metathesis.  One application of these methods is in the 
formation of nitrogen-containing heterocycles, an omnipresent feature of many biologically 
active alkaloids and synthetic drugs.  The goal of this dissertation is to expand the known 
applications of sequential transition metal catalysis to the synthesis of highly substituted bridged 
N-heterocycles and their subsequent diversification.  Our future goal is to have the 
methodologies described herein applied to combinatorial library synthesis. 
 The first project outlines a successful development of a new sequential transistion metal-
catalyzed methodology utilizing a copper-catalyzed three-component coupling followed by a 
palladium-catalyzed Heck cascade to form an aryl-fused isoquinuclidine (2-
azabicyclo[2.2.2]octane) core.  Diversification of the bridged core is then explored including 
palladium-catalyzed allylic functionalization and ruthenium-catalyzed cross-metathesis. 
 The second project described herein involves a sequential copper-catalyzed three-
component coupling followed by a radical initiated intramolecular cyclization.  By this process, 
diversification of the isoquinuclidine (2-azabicyclo[2.2.2]octane) core is achieved in the initial 
Cu-catalyzed reaction. 
 iv 
 The third project describes our preliminary efforts at developing a sequential transition 
metal-catalyzed method for the preparation of a bicyclobenzazepine (1-azabicyclo[3.2.2]nonane) 
scaffold and the challenges faced there in. 
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 Carbon-carbon bond forming reactions are an important area of modern synthetic organic 
chemistry. Classic reactions, including the Grignard reaction, Diels-Alder cycloadditon and 
many more, are widely applied in the synthesis of organic compounds.  However, over the past 
40 years a new approach to carbon-carbon bond formation has emerged.  Transition metal 
catalysis is a powerful method of facilitating multiple transformations with high chemo-, regio-, 
and stereoselectivity, typically under mild conditions.  Additionally, sequencing these methods 
together has allowed researchers to rapidly access organic compounds of ever increasing 
molecular complexity.  Major advantages to sequential transition metal catalysis include 
avoidance of protection/deprotection chemistry and broad substituent tolerance, making these 
methods well suited for application to combinatorial library synthesis. 
Our interest lies in the sequencing of these reactions in such a way to achieve the 
formation and subsequent diversification of bridged N-heterocycles.  Ubiquitous in nature, 
nitrogen-containing compounds, and synthetic methods for accessing them, have become one of 
the central themes in modern synthetic organic chemistry.  The goal of this dissertation is to 
expand our understanding of not only transition metal catalysis, but also the challenge of 
synthesizing and diversifying complex, structurally rigid, bridged scaffolds.   
What follows is a brief description of the layout and content of this dissertation.  Part I of 
chapter two outlines the biological activity and formation of two specific bridged N-heterocyclic 
scaffolds, including both naturally occurring alkaloids and synthetic priviledged structures.  Part 
II of chapter two discusses all the synthetic methods employed throughout the completion of this 
research project.  
The next three chapters describe all of the experimental work conducted during this 
graduate project. Chapter three discusses our construction of the aryl-fused Isoquinuclidine (2-
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azabicyclo[2.2.2]octane) ring system, using an intramolecular Heck cascade reaction.  This is 
followed by an in-depth discussion of our efforts to diversify that core structure and our eventual 
success in attaching a second priviledged structure via a flexible linker. 
Chapter four explores the possibility of forming an analogous Isoquinuclidine (2-
azabicyclo[2.2.2]octane) ring system, via an intramolecular radical cascade method.  Proof of 
concept results have been acquired. 
Chapter five outlines our initial attempts at obtaining an alternative bicyclobenzazepine 
(1-azabicyclo[3.2.X]octane) ring system via a reversed reaction order of Ru-catalyzed RCM 
followed by Pd-Catalyzed Heck (as compared to project 1) 
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2.1 Isoquinuclidines 
 Bridged N-heterocycles can be found as the core structure in many naturally occurring 
alkaloids and synthetic priviledged structures.  For this reason, extensive research has gone into 
isolation and characterization of these alkaloids, development of total synthesis strategies, 
preparation of synthetic analogs, and exploration of their potential biological activity. 
2.1.1 Naturally Occurring Alkaloids 
The isoquinuclidine (2-azabicyclo[2.2.2]octane) ring system, containing a non-
bridgehead nitrogen, is a rigid scaffold present in a diverse range of biologically active alkaloids 
and synthetic priviledged structures (Figure 2.1). 
 
Figure 2.1 2-azabicyclo[2.2.2]octane ring system 
Of these naturally occurring compounds, the Iboga family of alkaloids, primarily isolated 
for the Tabernanthe or Tabernaemontana species of plants, is by far the most studied (Figure 
2.2).1  Ibogaine was the first member of this vast family isolated and identified and has since 
been found active in the treatment of addiction including reduction of drug cravings and 
withdrawal symptoms.2  However, ibogaine also possesses adverse tremorigenic, hallucinogenic, 
neurotoxic, and cardiovascular side effects leading investigators to search for safer and more 
effective structural derivatives.3  One promising analogue is 18-methoxycoronaridine, which has 
been shown to retain the anti-addiction properties, without expressing the negative side effects, 
presumably due to an increased selectivity (Figure 2.2).3-4  18-methoxycoronaridine and its 
congeners have also shown promising reactivity in treatment of morphine, cocaine, alcohol, 
methamphetamine and nicotine addiction in rats.5  In addition, iboga-type indole alkaloids have 
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demonstrated promising pharmacology including anti-diarrheal activity,6 antifungal, anti-HIV, 
anti-cholinesterasic and leishmanicide activities.1a 
 
Figure 2.2 Representative iboga alkaloids 
What follows is a brief summary of the structures and activities of other alkaloids (Figure 
2.3).  Dioscorine is a toxic central nervous system depressant and modulator of the nicotinic 
acetylcholine receptor.7  Mearsine8 and grandisine B9 are two rare isoquinuclidinone alkaloids 
containing the unusual azabicyclo[2.2.2]oct-2-en-5-one core.  Grandisine B, a structurally novel 
indolizidine alkaloid, from the Australian rainforest tree Elaeocarpus grandis, has demonstrated 
binding affinity for the human -opioid receptor.9  Lannotinidines A, a member of the 
Lycopodium family of alkaloids, was recently isolated and shown to enhance mRNA expression 
for nerve growth factor.10  Koumine, an alkaloid of Gelsemium elegans (Benth.), has shown 
analgesic effects in rodents for inflammatory and neuropathic pain.11  Lirofoline A, another 
alkaloid isolated from the genus Tabernaemontana, has shown major activity in reversing 
multidrug resistance in vincristine-resistant KB cells.12  Securinega alkaloids (including securinol 
A), isolated from the plant family Euphorbiaceae, has an intriguing bridged tetracyclic structure 
and wide ranging biological activity.  In addition to use in traditional Chinese medicine, 
securinega alkaloids have been investigated for their cytotoxicity in the treatment of Bell’s palsy, 
ALS symptoms, aplastic anemia, malaria, bacterial infection and leukemia.13  Keramaphidin B, a 
member of the manzamine family of alkaloids and believed to be a plausible biogenetic 
precursor of ircinal A (not shown), has shown anticancer activity in the treatment of leukemia 
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and human epidermoid carcinoma.14  Paraherquamide A is a secondary metabolite, with potent 
antiparasitic and antinematodal activity. 
Figure 2.3 Alkaloids containing an isoquinuclidine core 
 Bisindole alkaloids are a class of molecules consisting of two indole moieties joined by a 
flexible alkyl linker.  One prominent example of a naturally occurring bisindole alkaloid, 
containing the isoquinuclidine ring system, is the vobasinyl-iboga family of alkaloids (Figure 
2.4, voacamine shown).  Vobasinyl-iboga bisindole alkaloids have demonstrated activity in the 
treatment of Alzheimer’s disease,15 plasmodia,16 leukemia and lung cancer tumors,17 other forms 
of cancer18 and more.19 
 
Figure 2.4 Bisindole alkaloid voacamine 
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 Due to the previously mentioned biological activity of naturally occurring alkaloids, 
containing the isoquinuclidine core, there has been extensive interest in developing efficient total 
synthesis strategies.1a, 13, 20  
Observing the previously summarized alkaloids it should be noted that aryl-fused 
isoquinuclidines have, thus far, not been found in nature.  Similar scaffolds, containing an aryl-
fused N-heterocycle as part of a different core structure, include roelactamine21 (active against 
Parkinson’s and Alzheimer’s disease) and morphine22 (opiate analgesic) (Figure 2.5). 
 
Figure 2.5 Alkaloids containing a similar bridged N-heterocyclic core 
2.1.2 Synthetic Analogues 
In addition to the previously mentioned naturally occurring alkaloids, a vast array of 
isoquinuclidine containing priviledged structures have been prepared over the years and tested 
for their potential biological activity.  What follows is a summary of the diverse pharmacological 
effects of these synthetic agents, including several dimeric scaffolds which have been tethered 
together to explore new avenues of biological activity.23   
A common feature in many of the biologically active substances outlined below is the use 
of an isoquinuclidine ring system to establish a “conformationally rigid” framework.  Analogues 
of flexible compounds which have demonstrated potent biological activity are synthesized 
containing the rigid bridge skeleton, thereby forcing them into a more reactive conformation.  An 
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analogous scenario is in the Diels-Alder cycloaddition reaction, where dienes that are forced into 
the s-cis conformation are more reactive than flexible dienes. 
Effects on the conformational reactivity of a previously identified biologically active 
compound were explored in a recent publication by Borne et al. who synthesized a series of 
isoquinuclidine analogs of chloroquine (Figure 2.6).24  Chloroquine is a widely used antimalarial 
agent which has unfortunately become less effective due to drug resistance.25  All six analogues 
showed in-vitro antimalarial and antileishmanial activity, with compound 2.1 being the most 
potent in both cases (two times more than chloroquine). Although the specific mode of activity is 
still not known, the semirigid nature of these molecules is believed to be a contributing factor. 
 
Figure 2.6 Chloroquine and isoquinuclidine containing analogues 
This relationship between rigidity and activity was also demonstrated by Iriepa et al. who 
synthesized several isoquinuclidine containing analogues of procaine to investigate their 
anesthetic activity.26  A range of activity was revealed including ester linkages being more 
reactive than amides and anti stereoisomers more reactive than syn.  Compound 2.2 proved to be 
the most potent with a threefold improvement in activity and duration of action when compared 
to local anesthetic procaine. 
11 
 
 
Figure 2.7 Procaine and isoquinuclidine containing analogues 
An important subclass of pharmaceutical isoquinuclidines is central nervous system 
active agents (Figure 2.8).  Iriepa et al. synthesized a family of compounds possessing an 
isoquinuclidine tethered to 4-amino-5-chloro-2-methoxybenzoate and identified promising 
reactivity from analogue 2.3 for the treatment of nausea and vomiting (5-HT3 antagonists).26  A 
common feature, characteristic of nearly all potent 5-HT3 antagonists, is an aromatic ring at a 
specified distance from a carbonyl and a basic site.26-27  Additional examples include 
antipsychotic 2.4,28 psychotomimetic agent 2.5,29 sedative 2.629 and analgesic 2.7;30 as well as 
others active against Alzheimer’s disease related learning and memory issues (2.8)31 and 
dementia related memory loss (2.9).32  
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Figure 2.8 Isoquinuclidine containing priviledged structures with central nervous system activity 
In addition to central nervous system active agents, priviledged structures containing the 
isoquinuclidine scaffold has shown promising biological activity including: hormone suppression 
(2.10),33 lowering blood sugar (2.11),29 cholesterol biosynthesis suppression (2.12),29 increased 
bronchial secretion (2.13),34 treatment of obesity, diabetes and sexual dysfunction (2.14),35 
autoimmune and inflammatory disease treatment (2.15)36 and suppression of abnormal heart 
rhythms (2.16)37 (Figure 2.9). 
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Figure 2.9 Biologically active priviledged structures with an isoquinuclidine core 
Looking at the previously described synthetic agents, we once again see a lack of aryl-
fused analogues.  However, an exhaustive search of the literature did reveal a limited number of 
examples.38  Isoquinuclidine containing analogues of pentazocine, a synthetic opioid analgesic, 
were prepared (2.17-2.19) and tested for possible analgesic and central nervous system activity 
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(Figure 2.10).39  Altough all three analogues failed to express analgesic activity at the doses 
tested, lactam analogues 2.17 and 2.18 did show promising central nervous system activity.  
 
Figure 2.10 Pentazocine and isoquinuclidine containing analogues 
 Karachine, an unusual protoberberine alkaloid, was isolated and fully characterized in the 
early 1980’s, revealing that the compound was not a natural product but rather the result of 
berberine and two molecucles of acetone reacting during isolation (Figure 2.11).40  Although 
karachine itself has not yet been screened for potential biological activity, other protoberberine 
alkaloids have demonstrated antimicrobial, anti-inflammatory and antimalarial activity (among 
others).41  Analogous isoquinuclidine containing scaffold 2.20 has also been prepared and shown 
to be a potent noncompetitive N-methyl-D-aspartate antagonist (anesthetic).42 
 
Figure 2.11 Protoberberine alkaloids and an isoquinuclidine containing synthetic analogue 
One final example of an aryl-fused isoquinuclidine compound, which has recently been 
published, is oxazatricycle 2.21 (Figure 2.12).43  Although biological activity screening was not 
conducted, analogues of the oxazatricycle structure did demonstrate interesting molecular 
switching properties. 
14 
 
 
Figure 2.12 Isoquinuclidine containing oxazatricycle  
 The observed lack of biological activity studies and preparation strategies pertaining to 
isoquinuclidine containing alkaloids and synthetic agents represents a significant gap in the 
literature, towards which I have focused the majority of my graduate research.   
Analogous aryl-fused N-heterocycles, possessing a different core structure, have been 
synthesized by Martin et al.  Using sequential transition-metal catalysis, they have been able to 
synthesize a series of natural product analogues including benzomorphans 2.22 and 2.23 (similar 
to morphine) and bicyclobenzazepine 2.24a (similar to roelactamine).44  Biological screening is 
currently in progress; however preliminary studies indicate promising activity in the treatment of 
Alzheimer’s disease and cancer.45  
 
Figure 2.13 Aryl-fused bridge N-heterocyclic analogues of morphine and roelactamine  
Bridged N-heterocyclic scaffold 2.25 has recently been constructed by Kim et al. using a 
Heck cascade type reaction, however biological screening is yet to be undertaken (Figure 2.14). 
15 
 
 
Figure 2.14 Aryl-fused bridge N-heterocycle 
Preparation of Synthetic Analogues 
Due to the demonstrated vast abundance of biologically active alkaloids and priviledged 
structures which contain the isoquinuclidine core, a wide range of methods have been applied to 
the construction of this unique structural motif.29  Of these methods, the Diels-Alder reaction, 
including asymmetric synthesis, is by far the most commonly employed.46  Use of a Diels-Alder 
cycloaddition reaction was recently demonstrated via cyclization of 1,2-dihydropyridine with N-
phenyl maleimide to form bridged product 2.26 in an 87% yield as a single diastereomer 
(Scheme 2.1).47  A similar asymmetric hetero Diels-Alder reaction was implemented by Evans et 
al. in their total synthesis of (-)-epibatidine (not shown); affording bridged product 2.27 (Scheme 
2.2).48  A 79% yield of the exo diastereomer was obtained.     
Scheme 2.1 
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Scheme 2.2 
 
A third example, implemented by Borne et al., employs a benzyne Diels-Alder to obtain 
aryl-fused bridged lactam 2.17, in an unfortunately low 7% yield (Scheme 2.3).39, 49  Subsequent 
catalytic hydrogenation and reduction yielded 2.18 and 2.19 respectively, both in good yields.  In 
spite of the low 7% yield, this method represents one of only a limited number of methods 
capable of forming the aryl-fused isoquinuclidine core.38  The Diels-Alder method is also limited 
due to the sensitive electronic requirements of the aryl component. 
Scheme 2.3 
 
 To date, there has only been one combinatorial library synthesis method of constructing 
the isoquinuclidine core published.  Yang et al. developed a cycloaddition protocol for forming 
17 
 
oxazatricycles via parallel solution-phase synthesis.  Nine analogues were synthesized in yields 
ranging from 62 to 93%, including oxazatricycle 2.21 at 82% (Scheme 2.4).43 This method, in 
addition to the benzyne Diels-Alder reaction, constitutes the only strategy identified thus far for 
obtaining the aryl-fused isoquinuclidine core. 
Scheme 2.4 
 
 Efficient one-pot synthesis of an isoquinuclidine scaffold was accomplished via a novel 
cascade presumed to involve an aldol-type condensation, Michael addition, addition to a nitrile 
group and finally an annulation to afford azabicyclooctane 2.28 in a 67% yield (Scheme 2.6).50 
Scheme 2.5 
 
 Another recent method, employed by Shin and et al., utilized a gold-catalyzed redox-
pinacol-Mannich-Michael cascade reaction to construct the isoquinuclidine core (2.29) in a 75% 
yield (Scheme 2.6).51   
Scheme 2.6 
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Other strategies recently employed include intramolecular condensation to afford imine 
2.30 (Scheme 2.7),30 domino 1,5-hydride shift formation of amide 2.31 (Scheme 2.8),52 
intramolecular nitrone-olefin [3+2]-cycloaddition synthesis of bridged scaffold 2.32 (Scheme 
2.9)53 and a Mannich-aza-Michael cyclization to afford 16 compounds with amine 2.33 as a 
common core (Scheme 2.10).54 
Scheme 2.7 
 
Scheme 2.8 
 
Scheme 2.9 
 
Scheme 2.10 
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2.2 Bicycloazepines 
 The bicyclobenzazepine and bicycloazepine (1-azabicyclo[3.2.x]octane) ring systems 
(with nitrogen at the bridgehead) are common rigid structural motifs found in various 
biologically active alkaloids and synthetic priviledged structures (Figure 2.15).  Whereas aryl-
fused analogues of the isoquinuclidine core are rare, bicyclobenzazepines are relatively more 
common.   
 
Figure 2.15 1-azabicyclo[3.2.X]octane) ring system (X = 1-2) 
2.2.1 Naturally Occurring Alkaloids 
 Naturally occurring agents containing a bicycleazepine scaffold include communesins,55 
lyconadins,56 stemofolines,57 daphnanes and crinine (Figure 2.16).  Communesins (communesin 
A shown) are a class of polycyclic indole alkaloids isolated from various species of marine 
fungus which exhibit antileukemic and insecticidal activities.55  Lyconadins (lyconadine A 
shown) are a subclass of the lycopodium family of alkaloids which contains as many as 201 
members.  Lyconadin A was first isolated in 2001 and has since shown activity against 
lymphoma and human epidermoid carcinoma cells.56  Stemofoline, from the stemona alkaloids, 
is a potent insecticide and acetylcholinesterase inhibitor (treats glaucoma, Alzheimer’s disease 
and more).57  The daphniphyllum alkaloids (including methyl homodaphniphyllate) are a vast 
collection of naturally occurring molecules with unusual and diverse ring systems.  However, 
although select members exhibit mild cytotoxicity against lymphoma, adequate pharmacological 
activity studies have thus far not been undertaken.58  Haemanthamine, from the pancratium 
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alkaloid family, possesses antioxidant and anticonvulsant activity.59  Due to the complexity 
found in these unusual ring systems there has been great interest in total synthesis and 
biosynthetic studies of these challenging targets.55-57, 60 
 
Figure 2.16 Alkaloids with a bicycloazepine core 
2.2.2 Synthetic Analogues 
In addition to alkaloid total synthesis there has been an interest in formation and 
biological testing of synthetic targets (priviledged structures) containing the bicycloazepine ring 
system.  Chemists at the Eli Lilly & Co. pharmaceutical company have developed a method of 
synthesizing a series of pyridine fused polycyclic amines in order to investigate their selective 
activation or inhibition of biological receptors (Scheme 2.11).61  Bicycloazepine 2.34 was 
constructed in two steps via sequential ring-closing metathesis followed by radical cyclization; 
however screening for possible biological activity has not yet been undertaken. 
Scheme 2.11 
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 Another company, Aventis Pharma, published a novel protocol for the formation of 
bridged -lactams analogues of -lactam antibiotics (Scheme 2.12).62  Bicycloazepine formation 
was accomplished via a rhodium-catalyzed carbenoid cyclization reaction affording bridged N-
heterocycle 2.35 in a modest 40% yield.  Unfortunately, this product proved highly unstable 
resulting in degradation during silica gel chromatography; however, via protection/deprotection 
they, were then able to obtain stable carboxylic acid derivative 2.36.  The carboxylic acid variant 
exhibited weak antibiotic activity, while the ester form showed none at the doses tested. 
Scheme 2.12 
 
 The instability observed for bridged -lactam 2.35 highlights a common challenge in 
bicycloazepine synthesis.  Bridged bicyclic lactams (bicycle caprolactams) which contain the 
amide nitrogen in the bridgehead position are known as twisted amides due to their inability to 
achieve resonance stabilization.  This reduction in resonance conjugation is the result of partial 
or complete disconnection of the nitrogen lone pair and the carbonyl, causing the amide to 
behave more like an amino ketone (Scheme 2.13).63   
Scheme 2.13 
 
In spite of this challenging instability, a limited number of aryl-fused twisted lactams 
(bicyclocaprolactams) have been successfully synthesized.  Brown et al. obtained twisted amide 
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2.37, via a condensation reaction, in a 58% yield (Scheme 2.14).64  A second example is the 
MnO2 oxidation of haemanthidine to afford oxohaemanthidine (Scheme 2.15).65 
Scheme 2.14 
 
Scheme 2.15 
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2.3 Pd-Catalyzed Heck Reaction 
 The Heck reaction, first described by Richard F. Heck, is one of the most powerful and 
versatile synthetic strategies used by organic chemists today.  This reaction is a Palladium-
mediated cross-coupling between an aryl (vinyl) halide and an alkene under basic conditions 
(Scheme 2.16).  The mechanism begins with the Pd precatalyst (commonly Pd(OAc)2)) being 
reduced in-situ to form a reactive Pd(0) species, which then enters the catalytic cycle.  Oxidative 
addition of the aryl halide to the Pd(0) complex is followed by syn addition to an olefin via 
carbopalladation.  Next, the complex undergoes an internal C-C bond rotation to place a sp3-
bonded -hydrogen in a syn alignment with the palladium atom.  The complex then goes through 
a reversible -hydride elimination to generate the desired substituted olefin.  The final step is 
reductive elimination of the hydridopalladium(II) halide to regenerate the active Pd(0) complex, 
which helps to shift the equilibrium toward product.66  
Scheme 2.16 
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 The Heck reaction, which has been broadly applied in modern synthetic organic 
chemistry, possesses a seemingly endless combination of reaction conditions.66 For the purposes 
of this text, important variables to consider include substrate, solvent, temperature, catalyst, 
ligand/ligandless, base and additive.   
 Considering substrate dependence, the Heck reaction typically requires an aryl, benzyl or 
vinyl halide (Br, Cl) although triflates are also frequently employed.  Common catalysts include 
palladium(II) acetate, tetrakis(triphenylphosphine)palladium(0) and palladium chloride.  A wide 
variety of ancillary ligands can be used in the Heck reaction to stabilize the catalyst with the 
most common being Ph3P.  In addition to phosphine ligands, the Heck reaction can be improved 
(or hindered) by the presence of other chelating agents including bases, anions, olefins and the 
solvent.  The base has four roles including: stabilization of the Pd(0) complex, reducing the rate 
of oxidative addition, speeding up the carbopalladation step and recycling the Pd(0) complex 
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thereby causing the -hydride elimination equilibrium to favor products.  Typical bases include 
Et3N and (n-Bu)3N for nonpolar solvents and inorganic bases (acetates, carbonates, bicarbonates, 
phosphates and fluorides) for polar solvents.  An example of a Heck reaction where an additive 
is used would be those developed by Jeffery et al. employing a quaternary ammonium salt (i.e. 
TBAC or TBAB.67  Quaternary ammonium salts are useful in reactions where the addition of 
supporting ligands would crowd the palladium coordination sphere.  A coordination sphere may 
become crowded when fragments of the substrate itself, including heteroaromatic rings, 
aminoacrylates and olefins, are capable of coordinating to the palladium catalyst.  Use of Jeffery 
conditions also allows for lower reaction temperatures.  The Heck reaction can generally be 
achieved in any solvent; however the majority of Heck reactions favor an aprotic, polar solvent, 
including Lewis basic organic solvents (DMF, DMA, or DMSO), aqueous solvents or ionic 
liquids.  Ligand accelerated Heck reactions favor solvents of lower polarity such as toluene, 
dioxane and THF. 
Intramolecular Heck/Carbocycle Formation 
 An intramolecular Heck cyclization can be defined as coupling of a vinyl/aryl halide with 
a tethered alkene.68  The intramolecular Heck reaction is capable of forming a wide range of ring 
sizes, ranging from 3 to over 14, with medium sized (5-7) ring formation being the most 
common.  Furthermore, cyclization may occur through either an exo or endo fashion based on 
ring size as described by Baldwin rules.69  Baldwin’s rules are a qualitative set of generalizations 
establishing the probability (kinetic feasibility) of ring closure.  When two inequivalent 
cyclization pathways exist, one is commonly favored (low energy, fast) and the other disfavored 
(high energy, slow).  With Heck cyclizations this implies that carbopalladation will proceed 
through a trigonal system in either an exo or endo fashion.  A favored cyclization is one that 
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allows the C-Pd to achieve a trajectory of approach to the olefin through low energy natural bond 
angles.  Alternatively, a disfavored cyclization would require severe, high energy bond angles 
and/or distorted bond lengths.  Select Baldwin’s rules include: 3- to 7-exo-trig cyclizations 
favored, 3- to 5-endo-trig disfavored, and 6- to 7-endo-trig favored.69 
For the purpose of this text, our primary interest is in the preference for a 5-endo-trig vs. 
a 6-exo-trig cyclization.  Baldwin rules (and literature precedent)68 suggest a 6-exo-trig 
cyclization should be favored over a 5-endo-trig, however it is important to realize that these are 
only general rules.  Although rare, 5-endo-trig type products have been synthesized, however, 
their formation is typically explained via an alternative mechanism than direct cylization and 
they are seldom competing against a possible 6-exo-trig pathway.70  The first known example of 
a 5-endo-trig path being favored, in the presence of a competing 6-exo-trig cyclization, was 
recently published by Tanner et al. in 2006 (Scheme 2.17).71  Aryl triflate 2.38, cyclizing 
exclusively through a 5-endo-trig mechanism, afforded tricycle 2.39 in a 94% yield.  The 
rationale for this unexpected outcome states that the steric bulk of the adjacent quaternary carbon 
is forcing the mono-substituted olefin into a close proximity with the aryl-palladium, forcing the 
5-endo-trig cyclization event.71 
Scheme 2.17 
 
Formation of Regioisomers 
 One major challenge of the Heck reaction is the potential for alkene isomerization, 
typically arising due to competing - and ’-hydride elimination pathways (Scheme 2.18).72  
28 
 
This problem can sometimes be avoided using alkenes with unsymmetric steric and electronic 
properties (CH2=CHCO2R); however, the reversibility of -hydride elimination can still be an 
issue.  -Hydride elimination reversal (readdition of the palladium hydride to the alkene) can be 
followed by an undesired alternative ’-hydride elimination. 
Scheme 2.18 
 
 An example of this regioisomer formation issue was outlined in 1984 by Grigg et al. 
(Scheme 2.19).72c  Heck cyclization of vinyl bromide 2.40 proceeded in a 6-exo-trig fashion, to 
afford s-cis diene 2.41a.  However, subsequent readdition of the palladium catalyst, followed by 
’-hydride elimination, generated s-trans diene 2.41b.  The two inseparable regioisiomers were 
obtained in a 4:1 ratio, in a combined yield of 86%. 
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Scheme 2.19 
 
 Principle methods for suppression of regioisomer formation include variation of the Pd-H 
scavenger (base),66b, 73 and addition of silver salts.74  If in situ suppression of isomer formation 
proves impossible, an alternative approach is catalytic isomerization of the exo (less substituted) 
product into the endo (more substituted) produce via a subsequent reaction process,75 or vice 
versa.76  Another possibility is selective reduction of the olefin isomer mixture into a single 
diastereomer using Crabtree’s iridium catalyst or palladium on carbon.77 Crabtree’s iridium 
catalyst is particularly useful because of its ability to achieve stereoselective reduction though 
chelation and its high reactivity which allows it to reduce tri- and tetrasubstituted olefins.77 
Intramolecular Heck Cascade 
 Cascade reactions, also known as domino reactions, are an important area of modern 
organic synthesis because they allow for a rapid increase in molecular complexity in a single 
step, from a relatively simple substrate.78  In a cascade process two or more bond-forming 
reactions take place, under identical conditions, with the first transformation resulting in 
functionalities that allow the second transformation to proceed.  Domino reactions are therefore 
an elegant, environmentally friendly method of combining multiple steps into a single 
transformation, effectively preserving resources and reducing waste production.  Due to their 
cost effective ability to form complex structural motifs from relatively simple substrates, cascade 
reactions are well suited for both pharmaceutical and industrial settings.  A Heck cascade 
reaction is a palladium-catalyzed process where two or more bond forming reactions occur in a 
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single step.  This occurs when, following the first cyclization, -hydride elimination is not 
possible, allowing the alkyl palladium species to participate in a second cyclization event.  With 
two different regiochemical pathways available it is important to establish/identify differences 
between them, so that sequential carbopalladation occurs in a specific order.  The most common 
method of differentiating between two or more competing cyclization pathways is ring size.  
Generally accepted rules include: intramolecular Heck cyclization being favored over 
intermolecular and medium-sized (n = 5-6) ring formation being favored over small- (n < 5) or 
large-sized rings (n > 6).   
 For the purposes of this text we will focus primarily on two- step Heck cascade methods 
of forming 5- and 6-membered ring polycycles, from diene and enyne precursors.  Beginning 
with formation of fused-, spiro- and (most importantly) bridged hydrocarbon polycycles, I’ll then 
move into an in-depth examination of nitrogen containing polycycle formation and finally, 
synthesis of aryl-fused bridged N-heterocycles. 
The Heck cascade reaction has been extensively applied toward the construction of 
hydrocarbon polycycles.  Overman et al. have achieved efficient synthesis of tricyclic aryl-fused 
polycyclic hydrocarbons (2.43a-c) via a Heck cascade transformation (Scheme 2.20).79  Using 
various acyclic dienyl aryl iodide starting materials (2.42a-c) they were able to obtain the 
corresponding fused polycyclic products in goods yields as mixtures of stereoisomers.  They 
were also pleased to observe complete suppression of endo olefin stereoisomer formation when a 
silver carbonate base was employed. 
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Scheme 2.20 
 
 Intramolecular Heck cyclization of an alternative acyclic aryl iodide starting material 
(2.44a-c) afforded 5- and 6-membered ring spirocycles 2.45a-c in good yields (Scheme 2.21).79  
Similar spirocycle 2.47 was obtained in a modest 57% yield, via Heck cyclization of benzyl 
chloride 2.46.80  Thirdly, an analogous Heck cascade process was applied to unsaturated enol 
triflate derivatives 2.48a-d in order to synthesize a range of medium sized ring spiro polycycles 
(2.49a-d) in good to moderate yields (Scheme 2.22).79b, 81  Interestingly, although a silver salt 
wasn’t employed in the formation of spirocycles 2.47 and 2.49a-d, olefin regioisomer formation 
wasn’t observed. 
Scheme 2.21 
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Scheme 2.22 
 
Scheme 2.23 
 
Overman et al. have also employed the Heck cascade method to access bridged 
polycyclic hydrocarbons 2.50a and 2.50b (Scheme 2.24).79  A scaled up version of this 
methodology was later utilized in the total synthesis of (±)-scopadulcic acid B82 and A.83 
Scheme 2.24 
  
Palladium-catalyzed domino Heck reactions have also been shown to be effective in the 
cyclization of enyne precursors.  Using dienyne 2.51, the de Meijere group has constructed 
various polycyclic scaffolds by variation of the base or R substituent (Scheme 2.25).84  When a 
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monosubstituted terminal olefin (2.51, R = H) was used, along with Ag2CO3, Heck cyclization 
afforded bicycle 2.52 in a 52% yield.  However, when the silver salt was exchanged for K2CO3, 
the product went through an additional isomerization step to form fused tricycle 2.53.  Finally, 
when a 1,1-disubstituted olefinic substrate was used (R = Me), with a Ag2CO3 base, a three-fold 
cyclization pathway led to tetracycle 2.54.  This diversity of products clearly demonstrates the 
substrate and reagent dependence of the intramolecular Heck cyclization process. 
Scheme 2.25 
 
Heck cyclization of enyne precursors has also been demonstrated by Negishi et al.85  
Vinyl iodide 2.55 cyclized in a “zipper”-mode86 two-fold cyclization to afford fused bicycle 2.56 
in a 76% yield (Scheme 2.26).  Polycycle 2.58 was also obtained in a 63% yield, via Heck 
cascade cyclization of enyne precursor 2.57.85 
Scheme 2.26 
 
34 
 
Scheme 2.27 
 
Of particular interest to my research is the less common application of Heck cascade 
chemistry to nitrogen containing heterocycle formation.  Grigg et al. accomplished Heck 
cyclization of amide 2.59, using Jeffery’s ligandless Heck conditions (analogous to my work), to 
construct lactam 2.60 in a high 92% yield (Scheme 2.28).87  Interestingly, contrary to the results 
observed in my research, isomerization of the exo olefin was avoided under these conditions.  
They were also able to obtain polycycle 2.62, via a threefold cyclization of enyne precursor 2.61 
(Scheme 2.29.88  
Scheme 2.28 
 
Scheme 2.29 
 
 The Heck cascade reaction has also been employed as a key step in natural product total 
synthesis.  Examples include use by the Keay group for the total synthesis of (+)-xestoquinone.89  
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Two-fold Heck cyclization of aryl triflate 2.63 afforded (+)-xestoquinone precursor 2.64 in an 
82% yield, with a new quaternary center (Scheme 2.30).  Shibasaki et al. later improved on the 
method’s stereoselectivity by employing an alternative chiral ligand.90 
 Heck cascade chemistry was also employed by Ishibashi et al. in their total synthesis of 
haouamine A (Scheme 2.31).91  Cyclization of highly substituted amide 2.65 afforded lactam 
2.66, as a mixture of stereoisomers, in a nearly quantitative yield. 
Scheme 2.30 
 
Scheme 2.31 
 
 Finally, the only example published thus far of bridged N-heterocycle formation, via a 
Pd-Heck cascade, is from the Kim group.92  Using Jeffrey’s ligandless Heck conditions,67 they 
were able to synthesize novel pentacyclic benzoazepino[2,1,3]isoindole 2.25 from enamide 
precursor 2.67 (R = H, Ph) (Scheme 2.32).  However, as expected, when a -hydrogen was 
present following the first cyclization (2.67, R = Et), rapid -hydride elimination terminated the 
Heck cascade to afford lactam 2.68 (Scheme 2.32). 
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Scheme 2.32 
 
Trapping of Organopalladium Intermediates 
 In most of the previously described Heck reactions, cascade cyclization is followed by a 
-hydride elimination event; however, an attractive alternative involves trapping the alkyl 
palladium intermediate prior to elimination, via an anion capture process.  Possible anion capture 
agents include formate ion,93 zinc,87 tin,94 and boron95 derivatives, CO96 and more.97  However, 
in all of these cases the substrate is designed so that -hydride elimination is not possible, 
because elimination is typically kinetically favored over anion capture.  Novel palladium-
catalyzed cyclization of vinyl bromide 2.69, terminated via Suzuki coupling, proceeded with 
suppression of -hydride elimination to form pyrrolidine 2.70 (Scheme 2.33).98  This unusual 
precedent is explained by neighboring group stabilization of the alkylpalladium intermediate via 
a tosyl oxygen, thereby suppressing -hydride elimination and giving a 92% yield of pyrrolidine 
2.70 (R = Ts).  In order to test this working hypothesis, Heck cyclization was performed on an 
analogous benzyl protected substrate, affording a much lower 30% yield of Suzuki coupled 
product 2.70 (R = Bn). 
37 
 
Scheme 2.33 
 
2.4 Radical Cascade Reaction 
 Intramolecular free radical cyclization has emerged as a powerful tool for heterocycle 
synthesis.99  Major advantages to the radical process include functional-group tolerance, pH 
neutral conditions and their ability to be easily extended to a cascade process (without having to 
consider -hydride elimination).78, 99-100  What follows is a discussion of select radical cascade 
reactions, on diene and enyne substrates, to form fused and bridged polycyclic molecular 
scaffolds.  This review of radical cascade chemistry is also limited to traditional AIBN/tin 
hydride protocols. 
A seminal work in the radical cascade cyclization of diene precursors, published by 
Parker and Fokas, outlines their recent total synthesis of (-)-morphine (Scheme 2.34).22  Aryl 
bromide intermediate 2.71 was treated with tributyltin hydride and AIBN at reflux in benzene to 
afford tetracyclic morphine precursor 2.72 in a 30% yield, with two new rings and all carbon 
quaternary centers set. 
Scheme 2.34 
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Radical cyclization of diene substrates has also been employed as a key step in the total 
synthesis of (-)-estafiatin101 and isogymnomitrene (Figure 2.17).102 
 
Figure 2.17 Natural products obtained via a radical cascade reaction. 
While attempting the total synthesis of (-)-estafiatin, Lee et al. obtained bridged O-
heterocycle 2.74 via an unusual 8-endo-trig, 5-exo-trig cyclization pathway, affording diene 2.73 
in an 80% yield (Scheme 2.35).103  Interestingly the initial competing 5-exo-trig was not 
observed. 
Scheme 2.35 
 
In spite of their relatively wide spread use in modern organic synthesis, radical cascade 
transformations have experienced only limited application in the formation of bridged N-
heterocycles.  As previously discussed, Kim et al. obtained a novel aryl-fused azabicyclooctane 
scaffold 2.68 via Heck cascade cyclization of Baylis-Hillman adduct 2.67 (R = H) (Scheme 
2.32).92  However, when that same substrate (2.67) was reacted under radical cyclization 
conditions they observed formation of unexpected fused polycycle 2.75 in a modest 56% yield 
(Scheme 2.36).104  Together these two methods nicely highlight the synthetic potential of 
diversity oriented synthesis.105 
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Scheme 2.36 
 
 
Of particular interest to the context of this document are radical cascade cyclizations of 
enyne precursors and the formation of bridged N-heterocycles.  Radical cyclization of an enyne 
substrate has been employed in the formation of various interesting scaffolds including polycycle 
2.76 at a 75%,106 2.77 at 70%107 and 2.78 at 48%108 (Scheme 2.37).  However, in each of these 
cases, cyclization proceeded through a less pertinent mechanism (through the alkene, then the 
alkyne). 
Scheme 2.37  
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More applicable to my research, are radical cascade reactions which proceed via 
cyclization with the alkene first, then the alkyne.  This reaction pathway was employed in the 
radical cascade cyclization of enyne 2.79, concluding the total synthesis of hirsutene in a 64% 
yield (Scheme 2.38).109   
Scheme 2.38 
 
 Synthesis of a bridged N-heterocycle scaffold, via radical cascade cyclization of an enyne 
precursor has recently been accomplished by Porco et al. (Scheme 2.39).38c  Radical cyclization 
of enyne 2.80 proceeded with high regioselectivity through first a 6-endo-trig then 5-exo-dig 
cyclization to afford azabicyclooctane 2.81 in a 76% yield. 
Scheme 2.39 
 
As can be seen from the previous review, radical cascade chemistry has experienced only 
limited application in the construction of bridged N-heterocycles.  Seeing this as a significant gap 
in the literature our group has endeavored to develop our own radical cascade method.  
2.5 Cu-Catalyzed Three-Component Coupling Reaction 
 A multicomponent reaction is a convergent process in which three or more starting 
materials combine to create a new, significantly more complex, product.44, 110  The power of 
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multicomponent reactions lies in their ability to achieve rapid and efficient synthesis of libraries 
of compounds, known as diversity oriented synthesis, simply by changing the starting 
materials.45, 111  Transition metal-catalyzed multicomponent chemistry has emerged as an elegant 
and efficient method for forming complex and highly diverse structures in a one-pot fashion.110a  
Thus, multicomponent synthesis is considered a modern green chemical process.  In addition, 
subsequent transformations are frequently employed to further enhance molecular complexity.  
Herein we review the development and application of copper-catalyzed three-component 
coupling reactions between imines, acid chlorides and an organometallic agent to form highly 
substituted amide products (2.82) (Scheme 2.40).   
Scheme 2.40 
 
Recently, there has been a sharp increase in the popularity of imines in multicomponent 
chemistry due to their substrate-dependent reactivity and the vast array of commercially 
available aldehydes and amines, allowing access to innumerable imines and thereby diverse 
molecular scaffolds.112  The lone-pair electrons on the imine nitrogen possess sufficient 
nucleophilic character such that, an electron rich imine will nucleophilically add into an electron 
deficient electrophile (acid chloride) affording N-acyliminium chloride intermediate 2.83 
(Scheme 2.41). 
Scheme 2.41 
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 Taking advantage of this unique N-acyliminium chloride forming process, Arndtsen et al. 
have developed a series of novel amide forming three-component coupling reactions, using 
various organometallic agents.110a, 112  The first of these reactions to be published utilized vinyl-, 
alkyl-, aryl- and heteroaryl-substituted organostannane reagents to achieve rapid synthesis of 
various amide products (2.84) (Scheme 2.42).113   
Scheme 2.42 
 
Mechanistically, the reaction begins with nucleophilic addition of the imine lone-pair into 
the acid chloride to form N-acyl iminium chloride intermediate 2.83 (Scheme 2.43).  
Concurrently, the organostannane transmetalates with the copper(I) catalyst to form an 
organocuprate.  Finally, nucleophilic addition of the organocuprate into the N-acyl iminium 
chloride yields amide product 2.82. 
Scheme 2.43 
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Similar approaches have been employed by Arndtsen et al. to couple other nucleophilic 
agents to the acyl iminium intermediate.  One such example is the three-component coupling of 
an imine, alkyne and acid chloride to form highly substituted propargylamides (2.82a), using a 
CuI catalyst (Scheme 2.44).114  A third variation is the use of organoindium nucleophiles to form 
-substituted amides (2.82b) and carbamates (Scheme 2.45).115  Recently, Arndtsen et al. have 
developed a new strategy for the nucleophilic addition of organoboranes as a straightforward 
approach to -substituted amides (2.82c), without the need for activated imines (Scheme 
2.46).116 
Scheme 2.44 
 
Scheme 2.45 
 
Scheme 2.46 
 
Since being developed by Arndtsen, this copper-catalyzed three-component coupling 
methodology has been expanded and applied as a key step in the synthesis of various complex 
heterocycles. Helena Malinakova et al. have developed new methodologies for forming 
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indenoisoquinolines (Scheme 2.47)117 and hexahydro-1H-isoindolones (Scheme 2.48)118 both of 
which were subsequently applied to combinatorial library synthesis.111   
Scheme 2.47 
 
Scheme 2.48 
 
Arndtsen’s three-component method has also been recently employed in the synthesis of 
tetrahydro-1H-isoindolones, analogous to the Malinakova publication, by Huang et al. (Scheme 
2.49).119 
Scheme 2.49 
 
2.6 Ru-Catalyzed Olefin Metathesis 
 Olefin metathesis is an organometallic reaction where two double bonds come together 
and undergo a formal exchange of substituents (Scheme 2.50).120  In recent years olefin 
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metathesis has experienced a tremendous increase in use due to the development of ruthenium-
based catalysts. 
Scheme 2.50 
 
 Grubbs et al. began investigating olefin methathesis in 1972 and by the early 1990’s had 
demonstrated ruthenium(II) carbene complexes to be highly effective catalysts with both high 
reactivity and functional group tolerance.121  Grubbs I catalyst,122 introduced in 1995, was largely 
supplanted by the second generation Grubb II catalyst123 in 1999.  While both catalysts are used 
for the same function in organic synthesis, the second generation catalyst possesses a higher 
activity (Table 2.1).123 
Table 2.1 
 
Substrate Product Time Yield (%) with Grubbs I 
Yield (%) 
with Grubbs II 
  
10 min 100 100 
 
 
10 min 20 100 
 
 
90 min NR 90 
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24 h NR 31 
 
The generally accepted mechanism for both cyclic and acyclic olefin cross metathesis 
proceeded through an alternating series of metallacyclobutanes and metal-carbene intermediates, 
with removal of ethelene being a major driving force (Scheme 2.51).  
Scheme 2.51 
 
Ring-Closing Metathesis 
 Ring-closing metathesis (RCM) is the intramolecular olefin metathesis of two tethered 
unsaturated fragments (alkene or alkyne) as shown in Scheme 2.51.  This versatile cyclization 
process is capable of rapid, facile formation of almost any ring size (5 or greater), including 
previously challenging 7-8 membered rings and macrocycles.  However, the RCM reaction is 
limited by sensitivity to the use of electron-deficient alkenes and the substitution pattern of the 
substrate, especially when using Grubbs I catalyst.  For this reason RCM of ,-unsaturated 
amides has been poorly investigated.  A limited number of reports found in the literature indicate 
that ,-unsaturated amides can be successfully cyclized with primary olefins, utilizing either 
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Grubbs I or II, the choice of which is highly substrate dependent.124  RCM of acrylate adduct 
2.84 proceeds rapidly using Grubbs I to generate a 93% yield of ,-unsaturated -lactam 2.85 
(Scheme 2.52).124e  When methacrylate 2.86 was subjected to RCM conditions, the Grubbs I 
catalyst remained functional, however the reaction required the addition of a Ti(OiPr)4 Lewis 
acidic additive to afford a 90-92% yield of -lactam 2.87 (Scheme 2.53).124c  Conversely, 
cyclization of N-acryloyl-allylic amine 2.88 in order to form -lactam 2.89, while unsuccessful 
using Grubbs I, proceeded to an 82% yield using Grubbs II, without the need for an additive 
(Scheme 2.54).124d 
Scheme 2.52 
 
Scheme 2.53 
 
Scheme 2.54 
 
Cross Metathesis 
 Olefin cross metathesis125 (CM), in relation to other branches of olefin methathesis, is a 
relatively understudied synthetic method, due to low yields and unpredictable product regio- and 
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stereoselectivity.  In addition, the CM of two different olefins is inevitably plagued by competing 
homodimerization reactions (Scheme 2.55).   
Scheme 2.55 
 
An investigation into CM of various olefin types led Grubbs et al. to form a general 
model for predicting homodimerization potential.126  Olefins are ranked into four different types 
based on their affinity for homodimerization (Table 2.2).  It is important to observe that these 
olefin type definitions require adjustment between different catalysts; however, in all cases steric 
bulk and electronic deficiency will deactivate the reaction.126 
Table 2.2 
 
 One method for improving the selectivity in CM is to couple two different types of 
olefins.  This is particularly true when coupling a Type I and Type III olefin.  Grubbs 
demonstrated this selectivity by coupling a functionalized 1,1-disubstituted olefin with a 
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monosubstituted terminal, to afford CM product 2.90 in a 81% yield (Scheme 2.56).127  This 
good yield was achieved with a low stoichiometric ratio of the two olefins and quantitative 
recovery of the unreacted disubstituted olefin starting material. 
Scheme 2.56 
 
 Selective CM has also been realized by Raju and Howell between methyleneoxetanone  
2.91 and various terminal olefins to form alkylideneoxetanones (2.92) in good yields with high 
Z:E stereoselectivity (Table 2.3).128  The surprising high yields, with only 1.5 equivalents of the 
CM partner, nicely demonstrate the heterodimerization selectivity of Type I –Type III CM.  The 
unexpected high Z-stereoselectivity observed is hypothesized to arise due to the steric effects of 
the CHPh2 substituent directing the catalyst to the opposite face of the lactone and the alkyl 
olefin substituent toward the carbonyl. 
Table 2.3 
 
Entry R Yield (%) Z:E 
1 (CH2)2OAc 84 >20:1 
2 (CH2)3OAc 90 >20:1 
3 (CH2)4OAc 85 14:1 
4 (CH2)8OAc 84 >20:1 
5 Ph 55 >20:1 
6 (CH2)2CH3 94 11:1 
7 (CH2)2Br 93 >20:1 
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Sequential RCM/Heck cyclization 
Separately, ruthenium catalysted ring-closing metathesis and palladium-catalyzed Heck 
cyclization have proven to be robust methods capable of forming a vast array of ring systems.  
Therefore, the natural conclusion over the past several years has been to combine these two 
methods in a sequential or one-pot fashion, in order to achieve rapid construction of highly 
substituted N-heterocyclic scaffolds.129  Outlined below are recent applications of sequential 
RCM/Heck catalysis in the preparation of novel bridged scaffolds and natural product synthesis. 
 One of the early pioneers, Grigg et al., has described a sequential olefin metathesis – 
intramolecular Heck reaction for forming aryl-fused bridged N-heterocycles including 2.93 in a 
78% yield (Scheme 2.57).130  This methodology was later adapted into a one-pot reaction using a 
polymer-bound palladium catalyst.131 Evans et al. then utilized this method to access analogous 
aza-bridged compounds.132 
Scheme 2.57 
 
 Sequential RCM/Heck reactions have also been extensively applied by Martin et al. in 
their formation of diverse bridged N-heterocyclic scaffolds (2.22-2.24) (Scheme 2.58).44, 110b  An 
important element of Martin’s work is the presence of reactive functionalities on the bridged core 
that can be further diversified into a collection of biologically active pharmaceutical agents.  This 
methodology has recently been applied to combinatorial library synthesis, affording 124 
analogues of bridged N-heterocyclic 2.24, several of which expressed promising biological 
activity (Scheme 2.58).45   
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Scheme 2.58 
 
 A similar RCM/Heck sequence was used by Judd et al. in their construction of novel 
bicyclic lactam scaffold 2.94 (Scheme 2.59).133   
Scheme 2.59
 
In addition to methodology development and library synthesis an RCM/Heck sequence 
has been employed as a key step in the total synthesis of various naturally occurring alkaloids 
including ervitsine,134 cleavamine,135 apparicine136 and cripowellins A (Figure 2.18).137  
Figure 2.18 
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2.7 Functionalization of Allylic C-H Bonds 
 Allylic functionalization (allylic C-H activation) has recently emerged as a powerful and 
popular synthetic tool for installing reactive functionalities in the allylic position of an 
unactivated olefin.  An sp3 C-H, adjacent to an olefin, is described as allylic because the unpaired 
electron(s) formed in the reaction intermediate are delocalized, thereby lowering the energy of 
that intermediate and making the initial C-H bond weaker than ordinary sp3 C-H bonds (Scheme 
2.60).  When transition metal catalysis is employed, this intermediate forms a highly 
stabilized-allyl intermediate. 
Scheme 2.60 
 
Acetoxylation 
 Allylic acetates are an important intermediate in organic synthesis due to their ability to 
undergo metal-catalyzed replacement of the acetate with various nucleophiles.  For this reason 
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there has been extensive interest in developing broadly applicable methods of installing an 
acetate substituent in the allylic position of an unactivated olefin (Scheme 2.70).138  Described 
herein are relevant palladium-catalyzed methods of allylic acetoxylation. 
One of the challenges faced when developing a catalytic acetoxylation reaction is the 
formation of an undesired Wacker oxidation product (Scheme 2.61).139  The Wacker oxidation is 
a palladium (II)-catalyzed reaction which proceeds via Markovnikov oxypalladation/-hydride 
elimination to afford a vinyl acetate and/or ketone product (Scheme 2.61).  Alternatively, 
acetoxylation is thought to be achieved through nucleophilic addition to a -allyl palladium 
intermediate to give an allyl acetate product.  Due to the similarly between these two reactions, 
achieving selective acetoxylation can be difficult. 
Scheme 2.61 
 
Intramolecular catalytic acetoxylation, to form unsaturated lactone 2.95 was 
demonstrated by Larock and Hightower in 1993 using Pd(OAc)2 in DMSO and molecular 
oxygen as an oxidant (Scheme 2.62).140  Under these conditions they were able to synthesize 5- 
and 6-membered lactones, with a preference for -bond formation at the internal olefinic carbon 
center.  This versatile method was capable of forming monocyclic, fused, spiro and bicyclic 
lactones in generally high yields (Scheme 2.62).  Since that time many more analogous reaction 
conditions have been developed that are capable of medium-size ring lactonization.141 
Scheme 2.62 
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 Intermolecular acetoxylation of alkenes is also of great interest to the synthetic 
community.  Heumann and Akermark have demonstrated the use of Pd(OAc)2 and benzoquinone 
(BQ) in AcOH, with MnO2 as a stoichiometric oxidant, to access acetoxylated cycloalkenes 
2.96a-d (Scheme 2.63).142  Akermark et al. later expanded their method to include the use of 
alternative oxidants including H2O2 and TBHP.141a  A large scale variant of the Pd(OAc)2-BQ-
H2O2 acetoxylation system was published one year later.143  Other methods including a PdCl2-
AgOAc-TeO2-TBHP catalytic system,144 nitro-complexes of palladium(II)145 and Pd(OCOCF3)2 
with stoichiometric BQ146 have also been successfully employed.  
Scheme 2.63 
 
 The mechanism for allylic acetoxylation of cyclohexane has been elucidated by Bäckvall 
and Akermark, revealing four major steps (Scheme 2.64).145e, 147  First, the olefin is activated by 
coordination of the palladium(II) acetate.  Secondly, an allylic hydrogen is removed, followed by 
BQ coordination to afford an -allyl palladium BQ complex.  Reductive elimination then 
produces the allylic acetate and Pd(0).  The final step in the catalyst cycle is regeneration of the 
Pd(II) catalyst with acetic acid.  The BQ is also regenerated, via the stoichiometric oxidant. 
Scheme 2.64 
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Christina White et al. have conducted an extensive investigation into the acetoxylation of 
terminal olefins.  Using Pd(OAc)2, BQ, a novel bissulfoxide ligand and dimethyl sulfoxide 
(DMSO) the White group was able to block the formation of the Wacker oxidation product and 
achieve selective formation of either the linear or branched acetoxylation product (Scheme 
2.65).139, 148  Under standard conditions (Pd(OAc)2, benzoquinone (BQ) and AcOH) they 
obtained the Wacker oxidation product; however addition of DMSO afforded the linear (E)-
allylic acetate with high regio- and stereoselectivity.139  Their working hypothesis, that this result 
was due to the sulfoxide ligation of palladium, was further supported when they demonstrated 
that a bis-sulfoxide Pd(II) acetate complex (in DCM) would also achieve allylic C-H oxidation.  
Although, in this case they observed nearly exclusive formation of the branched product, with 
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<1% of the Wacker oxidation product.139  Mechanistic studies revealed an analogous reaction 
pathway to that previously discussed.149 
Scheme 2.65 
 
In addition to the bissulfoxide ligand utilized by White, other research groups have 
successfully demonstrated the use of ligands such as bipyrimidine,150 4,5-diazafluorenone151 and 
thioethers.152  In 2010 Stahl and coworkers obtained modest yields of linear acetoxylated 
products, including 2.97 using a 4,5-diazafluorenone ligand and 1 atm of oxygen as the oxidant 
(Scheme 2.66).151  Mechanistic studies revealed that the new ligand facilitated reductive 
elimination, thereby eliminating the need for benzoquinone.  Successful acetoxylation of internal 
olefins was recently achieved using sodium perborate153 or iodonium salts154 as oxidants. 
Scheme 2.66 
 
 The intermolecular acetoxylation method has recently been extended to the formation of 
more complex allylic esters, including 2.98, by White,155 and Jean Le Bras,156 independently 
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(Scheme 2.67).  These reactions allowed the coupling of a wide range of aryl and alkyl 
carboxylic acids to a terminal olefin yielding linear (E)-allylic esters in high yields. 
Scheme 2.67 
 
 As demonstrated, acetoxylation is a powerful method for installing a leaving group at the 
allylic position of an unactivated olefin.  Furthermore, through careful selection of reaction 
conditions high regio- and stereoselectivity can be achieved.  However, thus far the method has 
only been applied to relatively simple substrates.  Notable exceptions include acetoxylation of 
naturally occurring terpenes,157 and a total synthesis of 6-deoxyerythronolide B.158  Future efforts 
should take advantage of this gap in the literature by attempting the acetoxylation of complex N-
heterocyclic scaffolds. 
Tsuji-Trost reaction 
 The palladium-catalyzed Tsuji-Trost reaction is a versatile tool widely used in modern 
organic synthesis (Scheme 2.68).159  Tsuji et al. first reported the reaction in 1965 and Trost et 
al. later began expanding the method, incorporating phosphine ligands, various nucleophiles and 
leaving groups and later asymmetric synthesis.160 
Scheme 2.68 
 
58 
 
 One of the major advantages to the Tsuji-Trost reaction is that it typically occurs under 
mild conditions, with high and predictable stereo-, regio- and chemoselectivity.161  As stated 
before, allyl acetates (among others) are commonly employed substrates.  Additionally, the 
method tolerates a wide variety of hard and soft nucleophiles (i.e. malonates).  The catalytic 
cycle begins with coordination of Pd(0) with the olefin of the allylic substrate, forming an η2 
complex (Scheme 2.69).  Oxidative addition then expels the leaving group (ionization) and forms 
an π-allyl complex.  Finally, nucleophilic attack, followed by dissociation of the Pd(0) affords 
the product.  If the π-allyl complex is unsymmetric, substitution will typically occur at the less 
hindered allylic position. 
Scheme 2.69 
 
 Allyl acetates are also useful as substrates in copper(I)-catalyzed cross coupling reactions 
with a Gridnard reagent (Scheme 2.70).162  Regioselectivity of carbon-carbon bond formation is 
an important aspect of this catalytic process, with various factors controlling formation of either 
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the  or  product.162b-d  This reaction is also highly stereoselective, with the nucleophile adding 
exclusively to the opposite side, with respect to the leaving group.162b 
Scheme 2.70 
 
Other Allylic Functionalization Methods 
Other methods of functionalizing the allylic position of an olefin include selenium 
dioxide oxidation, radical allylic bromination and Ireland-Claisen rearrangement.  Selenium 
dioxide allylic oxidation is a classic method for insertion of oxygen into an allylic C-H bond via 
a pericyclic process (Scheme 2.71).163  In spite of this reactions classic roots and undesired by-
products it is still widely used in natural product synthesis.164 
Scheme 2.71 
 
Allylic bromination (Wohl-Ziegler reaction) is yet another commonly used method of 
allylic functionalization, this time with even earlier origins (Scheme 2.72).165  Standard 
conditions use N-bromosuccinimide as a bromine source, AIBN or benzoyl peroxide as a radical 
source and anhydrous CCl4 as a solvent, at reflux.  Once radical initiation has occurred the allylic 
hydrogen is removed forming a resonance stabilized radical intermediate.  Termination with a 
bromine radical then gives the allylically substituted product.  If more than one allylic position is 
available, bromination will occur at the more substituted position, because of the stabilization 
incurred on the corresponding radical intermediate.  One major drawback is the need for CCl4, a 
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major environmental pollutant.  However, just as with the other methods, allylic bromination 
continues to be a powerful tool in natural product synthesis.166 
Scheme 2.72 
 
 The final allylic functionalization method to be discussed herein is the Ireland-Claisen 
rearrangement (Scheme 2.73).167  The Ireland-Claisen rearrangement is a recent variation 
(introduced in 1972) of the classic Claisen rearrangement.  This method has two major 
advantages including easily prepared allylic esters and high stereoselectivity (including chirality 
transfer).167-168  The reaction begins with base-catalyzed enolate formation, followed by a 
concerted Claisen-like rearrangement and finally hydrolysis to afford the carboxylic acid 
product.  McIntosh, a leading expert on the Ireland-Claisen rearrangement, has recently began 
successfully applying this method as a key step in natural product synthesis.169 
Scheme 2.73 
 
2.8 Hydroboration Reaction 
 The hydroboration-oxidation reaction is a classic method of coverting alkenes into 
alcohols (Scheme 2.74).  This two-step process begins with syn addition of BH3 in an anti-
Markovnikov fashion.  Addition of hydrogen peroxide then produces the alcohol product.  
Hydroboration is a powerful tool widely used in organic synthesis as demonstrated by Makabe et 
al. in their total synthesis of (-)-cassine (Scheme 2.75).170 
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Scheme 2.74 
 
Scheme 2.75 
 
2.9 Nucleophilic Substitution Reaction 
 The nucleophilic substitution reaction, one of the cornerstones of organic synthesis, is a 
process where a nucleophile attacks an electron deficient center, forming a new bond and 
displacing a leaving group (Scheme 2.76).  This can occur via either an SN2 mechanism, with 
bond making and bond breaking occurring at the same time or an SN1 mechanism with two steps 
and a planar carbenium ion intermediate.   
Scheme 2.76 
 
Addition of biologically relevant nucleophiles to an alkyl halide tether would allow for 
the introduction of a reactive functionality to an existing scaffold.  Two such nucleophiles are 
morpholine and sulfonamides.171  Addition of various morpholine analogues, including 
morpholine itself, to alkyl bromide substrates has been demonstrated by Berardi et al. (Scheme 
2.77).172  Sulfonamide addition has also been employed as demonstrated by Fukuyama et al. 
(Scheme 2.78).173   
Scheme 2.77 
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Scheme 2.78 
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Chapter Three 
Synthesis and Diversification of Aryl-Fused Azabicyclo[2.2.2]octanes via Cu/Pd/Ru Sequential 
Catalysis 
 
  
64 
 
Diversity-oriented synthesis has emerged as an important aspect of modern organic 
chemistry.174  In the Malinakova group we are interested in the sequencing of multicomponent 
reactions and subsequent annulation reactions in order to efficiently construct collections of 
functionally diverse molecular scaffolds (Scheme 3.1).  More specifically, we wish to employ 
modified Arndtsen three-component coupling chemistry to synthesize carefully selected acyclic 
amide precursors which can then be cyclized into aryl-fused bridged N-heterocycles.  For my 
first project I focused on the application of Heck cascade chemistry to polycyclic bridge 
formation in a single step. 
Scheme 3.1 
 
The proposed Heck reaction would begin with oxidative addition of palladium across the 
aryl halide bond, followed by selective syn addition to one olefin and then the other.  -hydride 
elimination would then give a bridged product (Scheme 3.2).  For the reaction to succeed and to 
achieve stereoselective syn addition it was important to carefully design the amide precursor.  
Once we had constructed the bridged scaffold we were then interested in exploring interesting 
avenues of diversification around that core structure.  Although many diversification points were 
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explored, our primary focus was on allylic functionalization of the bridgehead olefin.  This step 
proved to be the most challenging and therefore the most synthetically interesting.   
Scheme 3.2 
 
This project attracted our attention for two reasons; first, although Arndtsen extensively 
explored the three-component process, very little has been done to develop the synthetic 
applications of his three-component coupling process.  Secondly, our group hopes to expand on 
the observed lack of synthetic strategies for the formation of aryl-fused bicycloisoquinolines.  
We were also interested in expanding the current understanding of sequential organometallic 
diversity oriented synthesis.174  The following chapter will outline our accomplishments thus far. 
3.1 Cu-Catalyzed Three-Component Coupling 
 In order to explore a possible Heck cyclization we first needed to synthesize the desired 
amide precursor.  We envisioned amide synthesis via a copper-catalyzed three-component 
coupling reaction between an imine, acid chloride and vinyl tin (Scheme 3.2).  This process has 
been previously employed in our lab in the formation of indenoisoquinolines117 and hexahydro-
1H-isoindolones.118   
3.1.1 Optimization of Conditions 
Although the three-component coupling reaction has been previously optimized,113 a 
number of modifications employed in my work have contributed to an improved yield of my 
specific amides.  Modifications explored include addition of molecular sieves and changes in 
solvent ratio.  In all cases CuCl, imine and acid chloride were pre-mixed in ACN for 20-30 
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minutes (at ambient temperature) to allow time for acyl iminium formation.  A solution of vinyl 
tin in DCM was then added dropwise and the resulting solution was warmed to 45 oC and 
allowed to stir under argon for six hours.  The mixture was then cooled to room temperature, 
quenched with aqueous KF, and stirred overnight.  The crude product was then purified by 
column chromatography.  It is important to note that the acyl iminium intermediate is highly 
susceptible to water hydrolysis.175  For this reason all glassware was oven dried for at least six 
hours and only dry solvents were used.  We also theorized that the addition of molecular sieves 
would suppress hydrolysis and thereby improve overall yield.  This hypothesis stems from an 
earlier observation in our group where the addition of molecular sieves in the 3CC step had a 
positive effect on the yield.111a  However, as can be seen when comparing entries 1 and 2 (Table 
3.1), the addition of molecular sieves in my case greatly diminished the yield.  We believe this 
problem arises due to the molecular sieves catalyzing a polymerization of the methacryloyl 
chloride.176  We were also pleased to observe an increase in the yield when the polarity of the 
solvent system was decreased by increasing the proportion of DCM (entry 3, Table 3.1).  Finally, 
comparable yields were observed when the reaction was run with imine loading ranging from 
335 mg to 1.0 g indicating the reaction could be easily scaled up (entry 3 and 4, Table 3.1). 
Table 3.1 
 
Entry ACN : DCM Amide 3.2a (%)a 
1b 1.3 : 1.0 28 
2 1.3 : 1.0 50 
3 1.0 : 2.0 83c 
4 1.0 : 2.0 80d 
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aIsolated yield of a single compound. b4Ǻ  
molecular sieved added. c335 mg of imine used.  
d1.0 g of imine used 
 
3.1.2 Variation of Aryl Imine 
 After the three-component coupling conditions were sufficiently optimized we then set 
out to synthesize a series of amide analogues.  The first point of variation we chose to investigate 
was substitution in the aryl ring of the imine.  As previously stated, there is a dearth of studies in 
the literature pertaining to structure-activity relationship of aryl-fused 2-
azabicyclo[2.2.2]octanes.  For this reason we felt that variation of the aryl-fused component 
would constitute a valuable synthetic contribution.  As can be seen in Table 3.2, our improved 
protocol allowed for a successful installment of electronically diverse substituents to the 
aromatic ring, providing amides 3.2a-l in good to moderate yields (Table 3.2).  Significant signal 
broadening, arising due to hindered rotation about the amide C-N bond, was observed in 1H and 
13C NMR spectra of the amides.  Temperature dependent 1H NMR spectra was collected for 
amide 3.2a (Entry 1, Table 3.2) indicating that higher temperatures could reduce the occurrence 
of signal broadening. 
Table 3.2 
 
Entry Imine 3.1 Amide 3.2 Amide 3.2 (%)a 
3 
 
 
3.2a (83) 
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2 
 
 
3.2b (73) 
3 
 
 
3.2c (97) 
4 
 
 
3.2d (63) 
5 
 
 
3.2e (74) 
6 
 
 
3.2f (60) 
7 
 
 
3.2g (72) 
8 
 
 
3.2h (50) 
9 
 
 
3.2i (77) 
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10 
 
 
3.2j (57) 
11 
 
 
3.2k (62) 
12 
 
 
3.2l (50) 
aIsolated yield of a single compound. 
3.1.3 Variation of Vinyl Tin 
 In addition to diversification of the aryl imine component, we also explored variations in 
the structure of the vinyl tin and acid chloride.  For the vinyl tin component we sought to 
determine the reactivity of both 1,2- and 1,1-disubstituted vinyl stannanes (Scheme 3.3).  Three-
component coupling was achieved using the previously optimized conditions using either 
commercially available tri-N-butyl(1-propenyl)stannane or ethyl 2-(tributylstannyl)acrylate, 
formed in a single step from commercially available ethyl propiolate and tributyltin hydride 
under previously established conditions.117  The corresponding amides 3.2m and 3.2n were 
obtained in good yields, 75% and 72% respectively. 
Scheme 3.3 
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Scheme 3.4 
 
3.1.4 Variation of Acid Chloride 
 The third variable we attempted to investigate was substitution in the C-2 position of the 
acroyl chloride.  The first challenge of this process was to synthesize the C-2 substituted acroyl 
chloride.  Nick Ruhs, a former undergraduate research student in our lab, took on this project to 
develop a method for synthesizing phenylacryloyl chloride 3.3 (Scheme 3.5).  During his time in 
our lab Nick developed a three-step process including organocuprate addition, oxidation and 
chlorination to give the desired C-2 substituted acroyl chloride.  Unfortunately, he was unable to 
improve the second step (14 % yield max) before his time with us ended and we were forced to 
abandon this project. 
Scheme 3.5 
 
3.2 Pd-Catalyzed Heck Cascade 
As outlined in the previous chapter, the Heck reaction, specifically the intramolecular 
domino Heck cascade, has emerged as a power tool in modern synthetic organic chemistry for 
constructing complex heterocyclic scaffolds with novel carbon frameworks.  Our proposal 
includes a two-fold Heck cascade process that would go through a 6-exo-trig cyclization 
followed by another 6-exo-trig cyclization to form bridged lactam 3.4 (Scheme 3.6).  For this 
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transformation to be successful, the cyclization must proceed with a high regio- and 
stereoselectivity. 
Scheme 3.6 
 
3.2.1 Stereo- and Regioselectivity, Mechanism 
 Due to the presence of two olefins in the amide precursor, it is important to carefully 
consider which olefin will undergo carbopalladation first (Scheme 3.7).  Once the palladium has 
inserted into the aryl bromide bond, carbopalladation may proceed through a 5-endo-trig or 6-
exo-trig cyclization.  According to Baldwin’s rules69 a 6-exo-trig cyclization should be preferred 
over 5-endo-trig.  However, as demonstrated by Tanner et al. in 2006, under certain conditions 
the 5-endo-trig pathway may be favored.71  In spite of this precedent we still predicted a 6-exo-
trig cyclization to be the lower energy pathway because our substrate lacks unusual 
conformational restrictions.  Presence of the methyl substituent in the acrylamide functionality is 
critical for preventing a premature termination of our cascade via -hydride elimination.177  Once 
the first 6-exo-trig cyclization has occurred, we then predict a second 6-exo-trig cyclization.  
However, for this to be possible, it is necessary for the palladium and mono-substituted olefin to 
be on the same face of the newly formed lactam ring.  To determine if the palladium is expected 
to be on the same or opposite face we needed to consider the stereoselectivity of the cyclization. 
Scheme 3.7 
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 Once the palladium has undergone oxidative addition to the aryl halide, an equilibrium 
would exist between two conformations of the pre-cyclization amide intermediate (I and II), 
both having the mono-substituted olefin and N-benzyl protecting group in a low energy anti 
configuration (Scheme 3.8). The aryl palladium can then approach the 1,1-disubstituted olefin 
from one of two possible diastereotopic faces.  Approach from the re face would lead to high 
energy intermediate IV with the palladium on the same face as the N-benzyl protection group.  
This would also result in the palladium being on the opposite face from the mono-substituted 
olefin thereby disallowing the second cyclization event.  Alternatively, approach from the si face 
would produce intermediate III with the palladium and N-benzyl on opposite faces, thereby 
minimizing steric hinderance.  In this case, the palladium would also be on the same face as the 
mono-substituted olefin allowing for the second cyclization to proceed.  Thus, via the 
equilibrium between conformations I and II, all the substrate would be converted to desired 
intermediate III. 
Scheme 3.8 
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 The following catalytic cycle can be proposed for the assembly of the aryl-fused 
azabicyclo[2.2.2]octane core (Scheme 3.9).  Oxidative addition would be followed by a two-fold 
6-exo-trig cyclization, and finally -hydride elimination to give the bridged N-heterocyclic 
product.  Reductive elimination, driven by the base, would then regenerate the palladium (0) 
catalyst.  This strategy is superior to the benzyne Diels-Alder method of forming aryl-fused 
azabicyclo[2.2.2] octanes39 because it allows for a wider variety of substituents to be attached to 
the aryl ring (Diels-Alder hindered by electronic requirements). 
Scheme 3.9 
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3.2.2 Proof of Concept 
 As a proof of concept for our proposed palladium-catalyzed Heck cascade, the reaction 
outlined in Scheme 3.10 was carried out.  For our purposes we selected Jeffery’s ligand less 
Heck conditions,67 hypothesizing that cyclization would be improved by the olefins behaving as 
ligands for the palladium.  A solution of amide 3.2a (1.0 equiv.) in DMF (0.12 M) was injected 
into a vessel already containing the dry reagents including sodium carbonate (1.0 equiv.), 
tetrabutylammonium chloride (1.0 equiv.) and palladium acetate (10 mol%).  The resulting 
yellow solution was stirred overnight at 80 oC then purified by column chromatography to give a 
90% yield of the bridged product as a mixture of two isomers (3.4a and 3.4a’) (Scheme 3.10).  
Although the yield was pleasingly high we were disappointed to observe that the two isomers 
were inseperable by column chromatography.  The desired product was isolated as a mixture of 
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exo and endo isomers in a 1.5 : 1.0 ratio respectively (established by 1H NMR), with a combined 
yield of 90%. 
Scheme 3.10 
 
Fortunately, I was able to fully characterize the mixture using 1H NMR, establishing that 
we had isolated both the exo (3.4b) and endo (3.4b’) form of the product.  Also, by comparing 
the intergrations of the two signals at about 6.5 ppm, assigned to one of the protons on the 
substituted aromatic ring, I was able to determine the ratio of the exo and endo isomers at 1.5 : 
1.0 repectively (Figure 3.1).  
 
 
Figure 3.1 1H NMR of azabicyclooctane mixture of 3.4b and 3.4b’ 
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3.2.3 Formation of Regioisomers 
 We propose that the formation of double bond isomer is due to readdition of the H-
Pd(II)-(L)2Br species to the exo olefin, followed by an alternative -hydride elimination to give 
the endo product (Scheme 3.11).  Initial efforts to avoid isomer formation by variation of the 
base, with the intent of speeding up reductive elimination, resulted in only a slight change in the 
isomer ratio.  Clearly a mixture of products was not desired; however as will be discussed 
shortly, we envisioned a novel methodology for transforming the isomer mixture into a single 
product via an additional scaffold diversification process.  We have also eliminated the 
possibility to affect the ratio of the isomers via acid-catalyzed isomerization vide infra. 
Scheme 3.11 
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 To further explore the formation of double bond isomers, I endeavored to perform the 
Heck cyclization on amide 3.2m (Scheme 3.12).   For this substrate (3.2m), we thought that the 
readdition of the H-Pd(II)-X to the more substituted Heck product 3.4m’ might be strongly 
disfavored, and thus 3.4m’ might become the only product.  However, formation of 
stereoisomers of 3.4m and 3.4m” must be considered.  Unfortunately, we produced an even 
more complex mixture of products.  Bridged lactam 3.4m was isolated as a single diastereomer 
in a 22% yield; while regioisomers 3.4m’ and 3.4m” were collected as a complex inseparable 
mixture at a combined yield of 45%.  Although these results provided interesting insight into the 
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isomer formation issue, the lack of selectivity was undesirable and so this transformation was not 
further explored. 
Scheme 3.12 
 
3.2.4 Synthesis of Analogues 
As will be discussed in the next section, formation of an isomeric mixture was not 
foreseen to be a problem.  For this reason, my next goal was to synthesize a library of these 
bridged N-heterocycles by varying the three-component coupling reagents.  The first variable to 
explore was the aryl imine because it was evident from our review of the literature that the lack 
of aryl-fused azabicyclooctane analogues represented a significant gap in the literature.  Using 
the previously synthesized amides (3.2a-l), I performed Heck cyclization with Pd(OAc)2, TBAC 
and Na2CO3 in DMF at 80 oC (Table 3.3).  Heck cyclization of electron rich aryl amides 3.2a-d 
produced an isomeric mixture of bridged products 3.4a-d and 3.4a-d’ in good to excellent yields 
(Entries 1-4, Table 3.3).  By comparison of entry 1 and 2 we were also able to observe a shift in 
isomer ratio when using a different regioisomer.  Neutral aliphatic analogues 3.4e-g and 3.4e-g’ 
were also obtained via Heck cyclization, which may prove significant for medicinal studies 
because they demonstrate variation in shape of the hydrophobic region (Entry 5-7, Table 3.3).  
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Heck cyclization of electron deficient aryl halides was also successful, affording regioisomer 
mixtures 3.4h-j and 3.4h-j’ (Entry 8-10, Table 3.3).  Finally we explored the use of heteroaryl 
amides.  Unfortunately, using electron deficient pyridine 3.2k, we did not observe formation of 
azabicyclooctane 3.4k (Entry 11, Table 3.3) and electron rich thiophene 3.2l afforded a low 12% 
yield of azabicyclooctane 3.4l, as  a single regioisomer.  Our hypothesis is that the heteroaryl 
analogues hinder the success of the reaction through chelation with the palladium catalyst 
(Figure 3.2). 
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Figure 3.2. Possible chelation in heteroaryl cyclization intermediates. 
Interstingly, cyclization of bulky naphthyl amide 3.2f, substituted at the 3 position, 
afforded the greatest product ratio, with a significant excess of the exo isomer (Entry 6, Table 
3.3).  Conversely, amides 3.2c and 3.2i, both substituted at the 6 position, afforded the 
azabicyclo octane product with an excess of the endo isomer (Entry 3 and 9, Table 3.3).  
Additional analogues would need to be synthesized to fully understand this interesting 
observation.  Another intesting observation is the fluorinated bicyclooctanes 3.4i and 3.4i’ were 
seperable by column chromatography (Entry 9, Table 3.3).  With these results, we can conclude 
that the electronic properties of substituents on the aryl functionality have no significant effect on 
the success of the Heck cyclization, however steric- and electronic properties both appear to 
affect the isomer ratio. 
Table 3.3 
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Entry Amide  3.2 Bicyclooctanes 3.4 
Bicyclooctanes 
3.4 (%)a 
3.4 : 3.4’b 
(%) 
1 3.2a 
 
3.4a : 3.4a’ 
(68) 57 : 43 
2 3.2b 
 
3.4b : 3.4b’ 
(90) 60 : 40 
3 3.2c 
 
3.4c : 3.4c’ 
(80) 33 : 67 
4 3.2d 
 
3.4d : 3.4d’ 
(65) 57 : 43 
5 3.2e 
 
3.4e : 3.4e’ 
(77) 1.1 : 1.0 
6 3.2f 
 
3.4f : 3.4f’ 
(65) 52 : 48 
7 3.2g 
N
O
Bn
N
O
Bn  
3.4g : 3.4g’ 
(89) 50 : 50 
8 3.2h 
 
3.4h : 3.4h’ 
(66) 55 : 45 
9 3.2i 
 
3.4i : 3.4i’ 
(93)c 42 : 58 
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10 3.2j 
 
3.4j : 3.4j’ 
(80) 52 : 48 
11 3.2k 
N
N
O
Bn
N
N
O
Bn  
3.4k : 3.4k’ 
(0) - 
12 3.2l 
 
3.4l : 3.4l’ 
(12)d 100 : 0 
aCombined isolated yield of an inseparable mixture of two regioisomers. bMolar ratio of the 
regioisomers established by 1H NMR. cCombined yield of two regioisomers separated by column 
chromatography. dIsolated yield of a single compound 
 
3.3 Reactions with the Bridgehead Olefin in the Regioisomer Mixture 
 As previously stated, we did not foresee the isomer mixture to be a problem, but rather a 
challenging synthetic obstacle.  To resolve the isomer mixture we hypothesized taking the two 
isomers through a common intermediate ( allyl or resonance stabilized radical) via an allylic 
substitution reaction (scheme 3.13).  Selective nucleophilic addition to this common intermediate 
could then produce a single product.  As it turns out “challenging” is an understatement. 
Scheme 3.13 
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3.3.1 Acetoxylation 
 Transition metal catalysis is not only of major interest to modern organic chemistry but it 
is also of central interest to the Malinakova group.  For this reason, we chose to begin our 
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exploration of allylic functionalization with the palladium-catalyzed acetoxylation method with 
the intent of taking our two isomers through a common  allyl intermediate (Scheme 3.14).  This 
method was also attractive to us because, in spite of the relatively large amount of research 
towards the development of this method, little has been done in regard to acetoxylation of more 
complex sterically congested scaffolds. 
Scheme 3.14 
 
As a proof of concept we first decided to try Christina White’s conditions.139  A solution 
of the isomer mixture (1.0 equiv.) in DMSO (0.23M) was added to an open flask already 
containing the solid reagents Pd(OAc)2 (0.1 equiv.) and benzoquinone (2.0 equiv.).  Acetic acid 
(0.23 M) was then added, the flask was sealed and the resulting solutions stirred at 40 oC.  
Unfortunately, TLC monitoring continued to indicate the presence of starting material only.  
After 72 hours the reaction was quenched with ammonium chloride and purified by column 
chromatography affording an 88% recovery of starting material and no acetoxylated product 
(Entry 1, Table 3.4).  Initially we hypothesized that the reaction failed due to poor introduction 
of the air oxidant; however, when the reaction was run again, this time with air being bubbled 
through the solution just prior to sealing, the reaction failed once again (Entry 2, Table 3.4).  
Although attractive as an oxidant, our theory is that air is not an effective oxidant in our system.  
For this reason we choose to move on to alternative oxidants.  Changing the oxidant to one 
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atmophere of oxygen (Entry 3, Table 3.4) we were pleased to obtain a 12% yield of acetoxylated 
product 3.5 (86% recovery of starting material).  This result, although low yielding, proved to us 
that acetoxylation of the isomer mixture was indeed possible.  In addition, further analysis of the 
product revealed that a single regio- and stereoisomer was produced indicating that selective 
addition of the acetate anion into the  allyl intermediate was achieved.  Thinking that other 
oxidants may further improve the yield, we next tested Akermark conditions, which utilized 
hydrogen peroxide.141a  A flask was charged with the isomer mixture (1.0 equiv.) Pd(OAc)2 (0.05 
equiv.) and BQ (0.1 equiv.) followed by addition of acetic acid (0.2 M) and H2O2.  The yellow 
solution was then stirred at 50 oC under argon.  After two days, TLC monitoring indicated 
presence of starting material and a new spot.  Subsequent purification gave us an 18% yield of 
the same acetoxylated product, along with 45% recovery of starting material (Entry 4, Table 3.4).  
The yield was further improved to 30% by increasing the reaction temperature from 50 oC to 75 
oC (Entry 5, Table 3.4).  Unfortunately, this is where the success story ended.  Over the next 
several months various reactions conditions were tested with the yield never rising above 30%.   
Continuing with variations in the oxidant, I next tried TBHP141a and manganese 
dioxide,142 both resulting in a diminished yield (Entry 5-6, Table 3.4).  After identifying 
hydrogen peroxide as the best oxidant, I then moved on to investigate other variables.  Our next 
hypothesis was that our Pd(OAc)2 and BQ samples were old and recrystalization should improve 
the yield.  However, use of recrystalized Pd(OAc)2 resulted in a diminished yield (Entry 7-9, 
Table 3.4).  Addition of recrystalized bezoquinone also failed to improve product formation 
(Entry 10, Table 3.4).  Considering these results, we decided that perhaps it was not the quality 
of the catalyst, but rather the loading that was affecting yield.  Our theory was that the palladium 
catalyst was not achieving the proper number of turnovers in the catalytic cycle and addition of 
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excess catalyst should restart the reaction.  To test this we ran the synthesis with excess catalyst 
at the start (Entry 11, Table 3.4), addition of excess catalyst in three installments 4 hours apart 
(Entry 12, Table 3.4) and a stoichiometric amount of catalyst (Entry 13, Table 3.4).147c  
Unfortunately, this too failed to improve the yield.  Changing the solvent system148 (Entry 14-15, 
Table 3.4) and catalyst141a (Entry 16, Table 3.4) also proved unsuccessful in improving yield.  In 
spite of the low yield, we were pleased to observe formation of the desired acetoxylated product 
in all but two entries as a single diastereomer.   
Table 3.4 
 
Entry Pd(OAc)2  (%) 
BQ  
(equiv.) Solvent 
Time  
(h) 
Temp 
(oC) 
Oxidant 
(equiv.) 
3.5 
(%)a 
3.4 
(%)b 
1 10 2 DMSO/ AcOH 72 40 air 0 88 
2c 10 2 DMSO/ AcOH 44 40 air 0 69 
3 10d 1.9d DMSO/ AcOH 47 40 
O2  
(1 atm) 12 86 
4 5 10 AcOH 44 50 H2O2  (3.8) 18 45 
5 5 0.1 AcOH 43.5 75 H2O2  (4.1) 30 38 
6 5 0.1 AcOH 52 75 TBHP  (1.7) 14 31 
7 5d 0.2 AcOH 49 50 MnO2 (2.0) 14 66 
8 5d 0.1 AcOH 47 75 H2O2  (4.1) 21 40 
9 5d 0.1 AcOH 26 80 H2O2  25 38 
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(3.0) 
10 5d 0.1d AcOH 24 60 H2O2  (1.5) 20 56 
11 30 0.2 AcOH 21 75 H2O2  (16.5) 17 40 
12 15e 0.1 AcOH 23 40 H2O2  (3.7) 20 37 
13 100d 2 AcOH 27.5 80 H2O2  (3.0) 25 5 
14 10 0.2 DMSO/ AcOH 22 75 
H2O2  
(16.5) 12 30 
15f 10 2 AcOH/ dioxane 48 43 - 12 79 
16 5  Pd(OTFA)3 
0.1 DCM/ AcOH 21 80 
H2O2  
(3.0) 10 83 
aIsolated yield of a single compound. bCombined isolated yield of an inseparable mixture of two 
regioisomers. cRun in a sealed pressure tube after air bubbling for 2 minutes. dRecrystalized. 
eThree sequential additions of catalyst, 5% each four hours apart. fWith (vinylsulfinyl)benzene. 
 
 Using 1H NMR NOE analysis, the stereochemistry at the C-7 center was shown to 
possess an R configuration (Figure 3.3).  Irradiation of the allylic proton at 5.38 ppm caused an 
enhancement in the aromatic proton at 6.83 ppm. 
 
Figure 3.3 1H NMR NOE of acetate 3.5 
To rationalize the low yield observed in Table 3.4 we need to first consider the 
mechanism of acetoxylation.  For acetoxylation to be successful, the substrate must be able to 
orient itself in such a way that an allylic H can be removed to form a  allyl intermediate.  In our 
case, we believe that due to rigidity and ring strain in the bridged system, the substrate cannot 
assume the proper conformation and/or the resulting  allyl intermediate in too high in energy 
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(Figure 3.4).  Another possibility is that, if the substrate is truly unable to properly orient an 
allylic H, the reaction may be going through a Wacker type 2 intermediate.  However, this 
seems unlikely due to the recovered starting material having the same double bond isomer ratio.  
At this point we remain unsure as to why the reaction is so low yielding. 
 
Figure 3.4 Possible -allyl intermediates 
3.3.2 Tsuji-Trost and Organocuprate Substitution  
 While continuing to explore improvement of the acetoxylation results, we moved on to 
test Tsuji-Trost and organocuprate substitution of the acetoxylated product (Scheme 3.15).  
However, in both cases we failed to obtain the substituted product with both reactions resulting 
in starting material recovery.  Once again, we ascribe reaction failure to stereoconformational 
constraints, causing the  allyl intermediate to be too high in energy for the Tsuji-Trost and steric 
constraints hindering the cuprate addition (note: R2Cu would not require  allyl necessarily). 
Scheme 3.15 
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3.3.3 Selenium Dioxide Oxidation 
Although an attractive modern methodology, palladium-catalyzed allylic substitution of 
our bridged structure had proven ineffective.  Our next effort was to explore alternative allylic 
substitution pathways.  First we tried selenium dioxide mediated oxidation (with tetrabutyl 
hydgrogen peroxide and DCM) intending to form an alcohol product via a pericyclic process 
(Scheme 3.16).  Unfortunately, oxidation of our isomer mixture failed to give the desired product 
(starting material recovered).   
Scheme 3.16 
 
3.3.4 Allylic Bromination 
Next we tried allylic bromination using N-bromosuccinimide (NBS) and AIBN (radical 
initiator) in carbon tetrachloride (at 80 oC) (Scheme 3.17).  Once again we failed to observe 
product formation; however, this time a complex mixture rather than starting material was 
recovered.  Our theory is that the high energy strained radical intermediate is rearranging into a 
less strained (non-bridged) form.178 
Scheme 3.17 
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3.3.5 Ireland-Claisen Rearrangement 
To test the hypothesis of conformational restriction we next tried an Ireland-Claisen 
rearrangement on allyl acetate 3.5 (Scheme 3.18).  This reaction takes advantage of a base-
catalyzed enolate formation, followed by a Claisen-like rearrangement, to afford the chain 
extended product terminated by a carboxylic acid.  However, rather than obtaining the desired 
carboxylic acid product, the starting material was recovered, providing additional support to our 
conformational restriction hypothesis. 
Scheme 3.18 
 
Summary of Allylic Functionalization 
In summary, to our great disappointment, allylic substitution of our isomer mixture was 
not possible; acetoxylation alone afforded a low yield of the desired product.  These results 
demonstrated an important fundamental reality in organic synthesis.  In spite of our extensive 
understanding of a reaction, including mechanism, electronic and steric requirements, and ability 
to predict the outcome, when applied to a specific complex structure, nothing is certain.  Allylic 
functionalization of our complex, sterically congested and rigid bridged N-heterocyclic structure 
proved a far greater challenge than reactions with relatively simple and flexible substrates 
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reported in the literature.  Although the desired outcome was not achieved, this series of 
experiments has led us to an in-depth understanding of the chemical nature of our compound. 
3.3.6 Catalytic Hydrogenation 
 In addition to the previously described allylic functionalization methods we also 
endeavored to convert the mixture of regioisomers into a single diastereomer via stereoselective 
catalytic hydrogenation.  For our initial test we tried hydrogenation with H2 (g) and palladium on 
carbon catalyst (Scheme 3.19).  A solution of the isomeric mixture (1.0 equiv.) in methanol 
(0.03M) was injected into a flask containing palladium on carbon (10 mol%) and the resulting 
mixture was stirred overnight with H2 continuously bubbling through the solution.  After 
purification, we obtained an inseparable mixture of two diastereomers (3.6) in a 1.3:1 ratio 
(established by 1H NMR) in an 80% combined yield.  Although this did indicate a slight degree 
of selectivity, we were unable to obtain a single diasteromer.    
Scheme 3.19 
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 In order to improve selectivity the reaction was run again, this time exchanging the 
palladium on carbon catalyst for a chelation-controlled selective reducing agent (i.e. Crabtree’s 
catalyst) (Scheme 3.20).  Once again, we failed to observe a completely stereoselective 
reduction, affording a diastereomeric mixture of lactam 3.6; however, in this case the selectivity 
was inverted as would be expected.  We theorized that the selectivity was incomplete due to the 
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presence of chelating oxygens and nitrogens on both sides of the olefin. For this reason, we ran 
the reduction a third time, this time using alternative substrate mixture 3.4b and 3.4b’, affording 
a diastereomeric mixture of lactam 3.7, for which selectivity was slightly improved but still far 
from complete (Scheme 3.21).  We can speculate that, due to chelation with the amide carbonyl, 
the catalyst would preferentially approach from that side of the olefin; however, additional 
studies are needed to assign the relative stereochemistry for the major and minor isomers.  Due 
to the observed limited stereoselectivity, and our inability to separate the two distereomers, we 
move on to explore alternative strategies for conversion of the mixture to a single product. 
Scheme 3.20 
 
Scheme 3.21 
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3.3.7 Acid-Catalyzed Isomerization 
 Acid-catalyzed isomerization was also attempted on the mixture vide supra (Table 3.5).  
The theory here was that, although the exo isomer was major, under acidic conditions the exo 
olefin would isomerize into the more stable endo form.  With this is mind, a series of 
experiments were ran using either sulfuric acid or tosylic acid (Table 3.5).  Initially, we were 
pleased to see a promising shift in the regioisomer ratio when the reaction was ran with sulfuric 
acid at 25 oC for 19 hours (Entry 1, Table 3.5).  However, by 1H NMR analysis, we observed that 
we had not achieved complete conversion to the endo product.  We next tried the reaction at an 
elevated temperate (50 oC) for a comparable amount of time and were surprised to obtain the 
same product regioisomer ratio (Entry 2, Table 3.5).  Transitioning to tosylic acid we observed 
the same product ratio running the reaction at both 25 oC for four hours and 50 oC for 17.5 hours 
(Entry 3-4, Table 3.5).  From these results we can conclude that a thermodynamic equilibrium 
between the two regioisomers has been reached. 
Table 3.5 
 
Entry Acid Temp (oC) Time (h) SM Exo : Endo (%)a 
Pdt Exo : Endo 
(%)a 
1 H2SO4 25 19 60 : 40 33 : 67 
2 H2SO4 50 17.5 60 : 40 33 : 67 
3 TsOH 25 4 60 : 40 33 : 67 
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4 TsOH 50 17.5 60 : 40 33 : 67 
aMole ratio of the regioisomers established by 1H NMR. 
 In summary, diversification of the bridged N-heterocycle olefin isomer mixture has 
proven to be extremely challenging and largely unsuccessful.  Acetoxylation of the mixture 
afforded a modest 30% yield of 3.5 as a single diasteromer; however we were unable to improve 
that yield, or perform substitution on the acetoxylated product.  Other methods of allylic 
substitution also failed to produce the desired effect, namely selenium dioxide oxidation, allylic 
bromination and Ireland-Claisen rearrangement.  In addition, efforts to selectively reduce the 
olefin mixture or to isomerize the mixture into a single product also failed.  Although this would 
have been a powerful method of transforming the isomer mixture arising from the Heck reaction, 
we clearly needed to rethink our strategy. 
3.4 Return to Pd-Catalyzed Heck Cascade 
 Although conversion of the olefin isomer mixture would have represented an interesting 
contribution to organic synthesis, extensive investigation of potential methods and their 
subsequent failure has forced us to abandon this possibility.  For that reason, we next decided to 
return to the Heck cyclization conditions and endeavor to synthesize a single product.  We 
propose to achieve single isomer formation by either changing the conditions, or via trapping of 
the aryl-palladium intermediate just prior to -hydride elimination.  Trapping methods that we 
investigated include carbonylation,96 reductive Heck termination93 and Suzuki termination with a 
boronic acid.98  
3.4.1 Trapping Reactions 
 Reductive Heck termination was attempted on amide 3.2b using Jeffery’s ligandless 
Heck conditions (Scheme 3.22).67  We had expected to get a mixture of diasteromers, however 
the crude product was far more complex and we were unfortunately unable to clearly discern the 
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outcome.  Similar inconclusive results were obtained when I performed a reductive Heck 
cyclization on amide 3.2n, using either Jeffery’s ligandless Heck conditions (Entry 1-2, Table 
3.6)67 or standard reductive Heck conditions (Entry 3-4, Table 3.6).93b 
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Table 3.6 
 
Entry Conditions Outcome 
1 Pd(OAc)2, TBAC, Na2CO3, Et3N, HCOOH, DMF, 80 oC complex mixture 
2 Pd(OAc)2, TBAC, Na2CO3, HCOOH, DMF, 80 oC complex mixture 
3 Pd(OAc)2, PPh3, Et3N, HCOOH, DMF, 80 oC complex mixture 
4 Pd(OAc)2, PPh3, HCOONa, DMF, 110 oC complex mixture 
 
 We next tried terminating the Heck cascade via carbonylation, using the previously 
employed ligandless Heck conditions plus methanol and CO (1 atm.) (Scheme 3.23).96  
Unfortunately, rather than obtaining the desired product the unreacted starting material was 
recovered.  
Scheme 3.23 
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Boronic Acid Termination 
 A third trapping method tested was termination via Suzuki coupling with a boronic acid 
(Scheme 3.24).  This process, as described by Kim et al., was seen as an attractive alternative 
due to the demonstrated ability to suppress -hydride elimination and promote Suzuki 
termination.  THF was injected into a reaction vessel containing the solid reagents including 
amide 3.2b and tetrakis(triphenylphosphine)palladium, followed by (4-fluorophenyl)boronic acid 
in THF and Na2CO3 (aq.).  The resulting reaction mixture was stirred at 80 oC for 23 hours 
followed by purification via column chromatography to afford a white solid product.  Much to 
our dismay we did not observe formation of the desired boronic acid terminated product; 
however, after purification we did obtain an interesting result.  Analysis of the major product 
indicated that we had formed exclusively the exo isomer of bridged product 3.4b in a 69% yield 
(Scheme 3.24).  Based on this result, we determined that, although trapping prior to -hydride 
elimination did not seem possible, synthesis of a single isomer was, and that the choice of 
solvent plays a key role. 
Scheme 3.24 
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3.4.2 Heck Conditions for Single Isomer Formation 
 Over the course of this project we have explored various reaction conditions in an effort 
to achieve the single isomer formation (Table 3.7).  We theorized that introduction of a more 
reactive base would speed up reductive elimination of H-PdII-X, thereby diminishing the 
possibility for readdition of the catalyst.  With this in mind we tried alternative bases including 
KOAc (Entry 2, Table 3.7) and Et3N (Entry 3, Table 3.7).  However, in both cases we observed 
only a minimal change in the isomer ratio.  In our next attempt we explored classic Heck 
conditions, using a PPh3 ligand and Cs2CO3 base (Entry 4, Table 3.7).  Under these conditions 
we obtained a comparable mixture of isomers at a diminished yield of 54%.  Another strategy 
involved the introduction of a silver salt, which has been shown to suppress catalyst readdition.74  
The Heck cascade reaction was run under the same conditions as in entry 3, with the addition of 
silver triflate to yield a highly impure product mixture (Entry 5, Table 3.7).  Although analysis of 
the 1H NMR seemed to indicate single isomer formation, purification greatly diminished its 
yield.  Concurrently, we succeeded in single isomer formation via the previously mentioned 
boronic acid termination method.  Continuing with this promising result the reaction was ran 
again under the same conditions without the boronic acid affording a 61% yield of the single 
isomer product (Entry 6, Table 3.7).  In an effort to improve the yield the reaction was ran again, 
without the water and with an organic base (Et3N) and we were very pleased to observe a 90% 
yield of the desired product. (Entry 7, Table 3.7).  We believe that choice of solvent plays a 
central role in single isomer formation.  Via coordination, THF may not be stabilizing the H-
Pd(II)-X intermediate as well as DMF would, causing reductive elimination to be faster and 
thereby avoiding readdition of the palladium species. 
Table 3.7 
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Entry Catalyst Additive Base Solvent Lactam 3.4b:3.4b’ (%) 
3.4b : 3.4b’a 
(%) 
1 Pd(OAc)2 TBAC Na2CO3 DMF 90b 60 : 40 
2 Pd(OAc)2 TBAC KOAc DMF 93b 63 : 37 
3 Pd(OAc)2 TBAC Et3N DMF 90b 66 : 34 
4 Pd(OAc)2 PPh3 Cs2CO3 DMF 54b 67 : 33 
5 Pd(OAc)2 
TBAC/ 
AgOTf Et3N DMF 60
c 100 : 0 
6 Pd(PPh3)4 - Na2CO3 THF/H2O 61c 100 : 0 
7 Pd(PPh3)4 - Et3N THF 90c 100 : 0 
aMolar ratio of the regioisomers established by 1H NMR. bCombined isolated yield  
of an inseperable mixture of two regioisomers. cIsolated yield of a single compound. 
 
3.5 Reactions with the Bridgehead Olefin in the Single Regioisomer 
 Once we had successfully achieved single isomer formation we next endeavored to 
explore diversification of the bridgehead olefin.  A major advantage in this scenario was that 
because we were not trying to convert a mixture of products to a single product (through a 
common intermediate), we could utilize protocols for functionalization of terminal olefins.  With 
this in mind, we proposed diversification via either hydroboration or cross-metathesis.   
3.5.1 Hydroboration 
Initial attempts at hydroboration of lactam 3.4b afforded a 29% yield of what appeared to 
be alcohol 3.8 (Scheme 3.25).  However I was unable to clearly discern the outcome, leading me 
to abandon hydroboration for the more desirable cross-metathesis method. 
Scheme 3.25 
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3.5.2 Cross Metathesis 
 Cross metathesis was seen as an attractive possibility because it would coincide nicely 
with our goal of developing a transition metal-catalyzed sequence.  As demonstrated in the 
literature,127a, 127b, 128 cross metathesis is a powerful method for incorporating a flexible tether 
onto the substrate scaffold.  Considering this, we endeavored to explore cross metathesis of our 
single isomer product (3.4b) and a subsequent nucleophilic substitution in order to attach a 
second potentially biologically active fragment to our isoquinuclidine core, via a flexible tether.  
A solution of our single isomer lactam (3.4b) in DCM was added to a pressure tube containing 
Grubbs II catalyst, followed by the addition of neat 5-bromopent-1-ene.  The pressure tube was 
then flushed with argon, sealed and the mixture stirred at 40 oC over night (18 h).  Purification 
via column chromatography afforded a 66% yield of cross metathesis product 3.9 (Scheme 3.26). 
Scheme 3.26 
 
Selective irradiation NOE analysis of 3.9 was used to establish the relative 
stereochemistry of the olefin in an E configuration (Figure 3.5).  Irradiation of the vinylic proton 
at 5.13 ppm showed an enhancement of the methine proton at 4.46 ppm. 
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Figure 3.5 1H NMR NOE of alkyl bromide 3.9 
3.6 Nucleophilic Substitution 
Once we had successfully accessed cross metathesis product 3.9, our next goal was to 
explore substitution with a biologically relevant nucleophile.  For our first attempt we selected 
morpholine as the nucleophile because the desired product would nicely mimic existing drug 
scaffolds.171a  However, although the starting material was consumed, no substitution product 
was observed (Scheme 3.27).  Unfortunately, we were unable to determine what happened to the 
starting material, but we do believe that use of a stronger base (possible NaH)172 would facilitate 
nucleophilic substitution.  
Scheme 3.27 
 
In addition to morpholine, we also investigated the use of sulfonamide nucleophiles.  
Sulfonamide addition would not only attach a group with biological potential to the existing 
scaffold,171b but would also make additional diversification via N-functionalization possible.  The 
desired sulfonamides were obtained in a single step from tosyl chloride and the corresponding 
amine according to a literature precedent.98, 173  A solution of alkyl bromide 3.9 (1.0 equiv.) in 
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dry DMF (2 mL) was added dropwise, at room temperature, to a mixture of N-benzyl-4-
methylbenzenesulfonamide (1.5 equiv.) and anhydrous K2CO3 (2.6 equiv.) in dry DMF (1 mL).  
The reaction mixture was stirred at 60 oC for 21.5 h and the crude product purified by prep-TLC 
to afford bis amide 3.10a in a 94% yield.  Substitution with an alternative N-(but-3-en-1-yl)-4-
methylbenzenesulfonamide nucleophile afforded bis amide 3.10b in a 89% yield (Scheme 3.28).  
As observed, using cross methathesis and a subsequent nucleophilic substitution, we have been 
able to obtain a product with two potentially reactive functionalities linked together via a flexible 
alkyl tether.  This novel molecular scaffold seems well suited for further diversification or 
biological screening. 
Scheme 3.28 
 
Conclusion 
 In conclusion, I have developed a palladium-catalyzed method for obtaining a novel aryl-
fused azabicyclooctane ring system.  Initially, Heck cyclization afforded the desired product as a 
mixture of regioisomers, which we attempted to resolve via allylic substitution; however, this 
method proved impractical.  Returning to the Heck conditions, I was able to obtain the desired 
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product as a single exo regioisomer.  Cross metathesis, followed by nucleophilic substitution, 
allowed us to attach a sulfonamide functionality to the bridged core via a flexible tether, 
affording a novel alkaloid-type structure which we intend to submit for biological screening.  In 
addition, we hope to see this method applied to combinatorial library synthesis, in order to 
perform a more extensive diversification of the three-component coupling agents, cross 
metathesis partner and the substitution agent. 
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Chapter Four 
Synthesis of Functionalized Aryl-Fused Azabicyclo[2.2.2]octanes via Radical Cyclization 
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Another area of interest in the Malinakova group is use of the copper-catalyzed three-
component coupling method to construct amide tethered enynes which can then be cyclized 
through various annulation pathways.  Previous efforts in our lab have utilized sequential 
RCM/Heck annulations on amide tethered enyne 4.1 to achieve divergent synthesis of fused N-
heterocyclic scaffolds 4.2a and 4.2b (Scheme 4.1).179  As a continuation of our long-term goal to 
achieve divergent synthesis of polycyclic N-heterocyclic scaffolds, we were also seeking 
alternative reaction pathways.  
Scheme 4.1 
 
Just as with my first project, one promising annulation method that we hoped to apply 
was the Heck cascade method.  However, to achieve bridge formation via a Heck cascade 
process it was necessary to slightly redesign amide scaffold 4.1.  To avoid -hydride elimination 
after the first cyclization, we deemed it necessary to add a methyl substituent to the olefin.  With 
this in mind, I synthesized amide tethered enyne 4.3 under standard copper-catalyzed three-
component coupling conditions114 in a 50% yield (Scheme 4.2).  Amide 4.3 was then treated with 
Jeffery’s ligandless Heck conditions67 unfortunately affording a complex indiscernible reaction 
mixture.  Our current hypothesis is that reaction failure is due to two possible complications.  
Chelation of the aryl palladium to the alkyne could have quenched the cyclization; alternatively, 
following the first cyclization the alkyl palladium and alkyne may have been on opposite faces of 
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the amide, thereby disallowing the second cyclization (Figure 4.1).  More experimentation is 
needed to determine exactly what went wrong and how it might be corrected. 
Scheme 4.2 
 
 
Figure 4.1 Possible complications in Heck cyclization of amide 4.3 
4.1 Method Development, Mechanism 
While finalizing his results on the previously mentioned RCM/Heck sequence179 my 
colleague, Sandeep Raikar, serendipitously attempted radical cyclization of amide tethered enyne 
4.1a and was pleased to observe the formation of a bridged product (4.4a) in a 47% yield 
(Scheme 4.3).  He was also able to assign the relative Z stereochemistry of the olefin after 
obtaining an X-ray crystal structure of 4.4a (Figure 4.2).  Contrary to the Heck cascade reaction, 
amide 4.1a is well suited for a radical cyclization reaction because, under these conditions, -
hydride elimination is no longer a problem.  Observing the striking similarity of product 4.4a to 
the bridged scaffold constructed in my first project, I moved forward with optimization of this 
radical cascade method. 
Scheme 4.3 
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Figure 4.2 X-ray crystal structure of 4.4a 
 In order to optimize the radical cascade reaction, we first needed to consider the 
mechanism, including the stereoselectivity of cyclization.  For this we envisioned a conformation 
of the substrate very similar to that proposed for the Heck cascade reaction above.  Following 
radical initiation, an equilibrium would exist between two conformations of the pre-cyclization 
intermediate (V and VI), both having the alkyne and N-benzoyl protecting group in a low energy 
anti configuration (Scheme 4.4).  The aryl radical can then approach the olefin from one of two 
possible diastereotopic faces.  Although the steric interactions and therefore the presumed energy 
difference between V and VI is not as significant as was the case for the Heck cyclization, 
approach from the re face would lead to intermediate VIII with the alkyl radical and N-benzoyl 
on the same face.  This would also place the alkyl radical on the opposite face from the alkyne, 
thereby disallowing the second cyclization event.  Alternatively, approach from the si face would 
lead to intermediate VII with the alkyl radical and alkyne on the same face of the ring, allowing 
for a rapid second cyclization step to proceed.  Thus, just like with the Heck cascade, an 
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equilibrium between conformations V and VI would cause all the substrate to be converted to 
desired intermediate VIII.  
Scheme 4.4 
 
 Our proposed mechanism begins with radical initiation on 4.1a to generate an aryl radical 
intermediate (Scheme 4.5).  Sequential 6-exo-trig, 6-exo-dig cyclization would generate a vinyl 
radical intermediate, followed by termination to afford bridged product 4.4a.  It is important to 
note that vinyl radicals are not configurationally stable,180 therefore just as the catalyst readdition 
was an issue in the Heck reaction, interconversion between the Z and E stereoisomers of the 
vinyl radical proved to be a cause for the formation of stereoisomers.  
Scheme 4.5 
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4.2 Cu-Catalyzed Three-Component Coupling 
We next set out to synthesize a series of amide tethered enyne analogues, by varying the 
three reactants.  The desired amides (4.1a-e) were easily synthesized in a single step via copper-
catalyzed three-component coupling between an imine, benzoyl chloride and alkyne (Table 4.1). 
114  A solution of imine181 (1.0 equiv.), benzoyl chloride (1.2 equiv.) and alkyne (1.5 equiv.) in 
ACN (0.34 M) was stirred at room temperature for an average of 30 minutes, allowing time for 
acyl iminium formation.  Concurrently, a separate solution was prepared containing CuCl (20 
mol%) in ACN (0.67 M).  The resulting solution and neat DIPEA (1.5 equiv.) were added 
dropwise simultaneously to the CuCl solution.  This mixture was then allowed to stir at room 
temperature for two hours, followed by purification via column chromatography to afford enynes 
4.1a-e.  Using these standard conditions I synthesized a series of amide tethered enynes with 
various substituents on the aryl imines and aryl alkynes (Table 4.1).  Known compounds 4.1a 
and 4.1c (previously employed in our lab in an RCM/Heck sequence)179 were prepared in good 
yields to investigate their utility in the radical cascade process (Entry 1 and 3, Table 4.1).  
Original compound 4.1b was also prepared, in a 69% yield, to explore the effects of variation in 
the aryl bromide fragment (Entry 2, Table 4.1). In this project we sought to explore 
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functionalization of the bridgehead olefin by changing the initial alkyne substrate rather than 
diversification of a common core in the final step.  Considering this, I also prepared two new 
compounds, 4.1d and 4.1e, with alternative alkynes 4-ethynyl-N,N-dimethylaniline and 1-
ethynylnaphthalene respectively (Entry 4-5, Table 4.1). 
Table 4.1 
 
Entry Imine Alkyne Amide 4.1 Amide 4.1 (%)a 
1 
 
 
 
4.1a (81)b 
2 
 
 
 
4.1b (69)c 
3 
 
 
 
4.1c (74)b 
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4 
 
 
 
4.1d (81)c 
5 
 
 
 
4.1e (71)c 
aIsolated yield of a single compound. bKnown compound synthesized according to literature 
precedent.179 cOriginal compound synthesized according to literature precedent. 
 
4.3 Radical Cascade 
 As previously stated, my colleague had achieved a 47% yield of aryl-fused 
isoquinuclidine 4.4a, as a single stereoisomer (Entry 1, Table 4.2).  In an effort to improve the 
yield I moved forward to explore variations in time, temperature, reactant loading and 
concentration.   
4.3.1 Optimization of Conditions 
For my first trial I increased the reaction mixture concentration and obtained a much 
lower, 11% yield of azabicyclooctane 4.4a (Entry 2, Table 4.2).  This led us to believe that lower 
concentration facilitated the reaction; however we later discovered that purity of the amide 
starting material (4.1a) was the primary cause of the low yield.  After successive trials (not 
shown) and careful analysis of the starting material 1H NMR, we determined that even a slight 
amount of DIPEA left over from the three-component coupling reaction would hinder the radical 
process.  After resolving this issue we ran the reaction again with an increased loading of 
tributylstannane and AIBN and obtained a modest 55% yield of 4.4a (Entry 3, Table 4.2).  
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Lowering the reaction temperature to 80 oC afforded a slightly lower yield of 52% (Entry 4, 
Table 4.2).  After realizing that concentration was not the likely cause of the low yield in entry 2, 
I ran the reaction again, varying the equivalents and temperature, at a lower concentration 
affording a 50% yield of the product (Entry 5, Table 4.2).  Finally, decreased loading of the 
tributylstannane and AIBN was tested yielding bicyclooctane 4.4a in a comparable 50% yield 
(Entry 6, Table 4.2).  Clearly, this remains a work in progress with additional optimization 
needed.  The next reasonable course of action would be to lower the equivalents of the two 
reactants at a higher temperature. 
Table 4.2 
 
Entry Bu3SnH (equiv.) 
AIBN 
(equiv.) 
Toluene 
(mM) 
Temp 
(oC) 
Time 
(h) 
Yield 4.4aa 
(%) 
1 1.5 0.1 18 100 1 47 
2b 1.5 0.1 27 100 2 11 
3 2.0 0.5 16 100 3 55 
4 2.0 0.5 16 80 5.5 52 
5 2.0 0.5 37 80 5 50 
6 1.1 0.1 13 80 1.5 50 
aIsolated yield of a single compound. bImpure amide 4.1a starting material sample. 
4.3.2 Synthesis of Analogues 
While continuing to investigate optimization of the radical cascade process I moved 
forward with the synthesis of bicyclooctane 4.4 analogues.  We hypothesized that maybe an 
electron rich substrate would prove more conducive to the radical process, through stabilization 
of the radical intermediate.  All entries employed the conditions outlined in Table 4.3, Entry 3, 
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and the following standard procedure.  A solution of amide 4.1 in toluene was injected into a 
reaction flask charged with AIBN, followed by addition of neat tributylstannane.  The resulting 
solution was stirred at 100 oC for three hours then purified by column chromatography to afford 
bicyclooctane 4.4.  Radical cyclization of electron rich amide 4.1b afforded bicyclooctane 4.4b 
in an improved yield of 62%, when compared to unsubstituted analogue 4.4a (Entry 1-2, Table 
4.3).  As predicted, an electron rich substituent on the aryl bromide fragment stabilized the 
radical intermediate and thereby affording an improved yield.  This conclusion was further 
supported when radical cyclization of amide 4.1c afforded a 63% yield of the bicyclooctane 
product (Entry 3, Table 4.3).  However, in this instance the product was isolated as an 
inseparable mixture of Z and E isomers, 4.4c and 4.4c’ respectively.  The proposed rationale for 
the observed isomer formation is that the electron rich substituent on the aryl alkyne fragment 
stabilizes the vinylic radical, increasing its lifetime and thereby allowing an interconversion of 
the Z and E stereoisomers.  Running the reaction at a lower temperature may reduce the 
occurrence of isomerization, however this hypothesis remains to be investigated.  Radical 
cyclization of electron rich amide 4.1d also afforded the bicyclooctane product as an inseperable 
mixture of stereoisomers 4.4d and 4.4d’, in a diminished yield of 43% (Entry 4, Table 4.3).  
Finally, cyclization of naphthalene analogue 4.1e produced bicyclooctane 4.4e as a single 
stereoisomer, in a 56% yield (Entry 5, Table 4.3). 
Table 4.3 
N
AIBN (0.5 equiv.)
Bu3SnH (2.0 equiv.)
toluene (16 mM)
100 oC, 3h
N
Ph
Br
Ph
O
4.4a4.1a-e
Ph
Ph
O
N
4.4a'
Ph
O
Ph
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Entry Amide  4.1 Bicyclooctanes 4.4 
Bicyclooctanes 
4.4 (%) 
1 4.1a 
 
4.4a (55)a 
2 4.1b 
 
4.4b (62)a 
3 4.1c 
 
4.4c and 4.4c’ (63)b 
 
4 4.1d 
N
Ph
O
N
N
Ph
O
N
 
4.4d and 4.4d’ (43)b 
5 4.1e 
 
4.4e (56)a 
aIsolated yield of a single compound. bCombined isolated yield of an inseparable mixture  
of two regioisomers (70% and 30% repectively). 
 
Using 1H NMR NOE analysis, I confirmed the Z olefin stereochemistry of 4.4b, already 
assigned to by the X-ray crystallography of 4.4a (Figure 4.2).  Irradiation of the vinylic proton at 
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6.29 ppm caused an enhancement in the methylene protons at 2.78 and 2.46 ppm.  The relative 
stereochemistry of minor isomer 4.4d’ was also assigned as an E configuration using 1H NMR 
NOE analysis, performed on the mixture of isomers 4.4d and 4.4d’.  Irradiation of the methine 
proton at 5.11 ppm, assigned to the minor isomer, caused an enhancement of the vinylic proton 
at 6.12 ppm, assigned to the minor isomer. 
N
CH2Ph
Ph
O
H
N
H
Ph
O
N
H
NOE
4.4d'
5.11 ppm
6.12 ppm
6.29 ppm
2.78, 2.46 ppm
NOE
4.4b
O
O
 
Figure 4.3 1H NMR NOE of azabicyclooctanes 4.4b and 4.4d’ 
Conclusion 
 In conclusion, we have developed a radical cyclization method for obtaining an 
alternative bridged azabicyclooctane scaffold.  Future efforts will explore optimization of the 
conditions to improve yield as well as synthesis of additional analogues with biologically 
relevant substituents. 
A comparison of the two methods (Heck vs. radical cascade) provides insight into their 
distinct advantages and disadvantages (Figure 4.4).  To begin with, both methods achieve rapid 
formation of the bridged core in a single step via formation of two new C-C bonds.  Another key 
component is their ability to obtain the azabicyclooctane scaffold with transposition of the 
carbonyl component, a feat often difficult to achieve using functional group interconversion.  
Using the Heck cascade method I was able to obtain the bridged lactam scaffold in generally 
high yields, however the method was plagued by isomerization issues.  In addition, 
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diversification of the exocyclic olefin has thus far required an additional synthetic step (cross 
metathesis).  This issue may be resolved in the future during library synthesis by variation in the 
vinyl tin component.  In comparison, the radical cascade method affords the azabicyclooctane 
scaffold in a relatively low yield.  Here also, isomerization has been an issue, however only in 
select electron rich cases.  The radical method also allows for diversification of the olefin 
substituent via variation in the aryl alkyne starting material, thereby avoiding the need for 
addition synthetic steps.  Overall, we have provided two promising and complementary strategies 
for construction of the azabicyclooctane core, which would be well suited for combinatorial 
library synthesis. 
 
Figure 4.4 Azabicyclooctane products obtained via Heck and radical cascade method. 
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Chapter Five 
Attempts at Developing a Sequential Ru/Pd Protocol for the Synthesis of Bridged N-Heterocycles 
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For my third project we chose to shift gears and explore the formation of an alternative 
bridged N-heterocyclic scaffold.  Previously published work in the Malinakova group has 
accomplished efficient synthesis of fused N-heterocycles via a sequential RCM/Heck process.179  
Hoping to expand the potential application of this sequential method, my proposal was to run 
two sequential transition metal-catalyzed reactions (RCM/Heck) on a three-component coupling-
derived amide to obtain a novel bicyclobenzazepine ring system (Scheme 5.1).  Once the 
protocol had been sufficiently developed, we then intended to adapt the method to one-pot 
synthesis.182  Although similar methods have been employed by Grigg130-131 and Martin,44-45, 110b 
major advantages to this proposal include the presence of two easily diversifiable aryl 
substituents (R1 and R2) and the availability of a reactive Michael acceptor for further scaffold 
diversification (Scheme 5.1).  We were also aware that our proposed bicyclobenzazepine 
structure contained a twisted bridgehead amide.  Although this structural motif is highly strained 
and often challenging to construct, similar complexes have been made before.  What follows is a 
description of our preliminary efforts at developing this three-step transition metal-catalyzed 
process and the challenges faced therein. 
Scheme 5.1 
 
5.1 Cu-Catalyzed Three-Component Coupling 
For this project I once again needed to adapt the Arndtsen three-component process to my 
specific needs.  In this case, we were interested in nucleophilic addition of aryl-metal 
components (RM) to the acyl iminium intermediate (Table 5.1).  Initially, we attempted the 
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three-component coupling using an aryltin reagent; however, in spite of the literature 
precedent,113 we were unable to obtain the desired amide; presumably due to a slow 
transmetallation of the aryl tin reagent (Entry 1, Table 5.1).  Expanding on a recent publication 
by Arndtsen,116 we next attempted three-component coupling with an organoborane reagent and 
were pleased to observe formation of amides 5.1a-b (Table 5.1).  Copper-catalyzed three 
component coupling between imine 5.1a (n = 1), methacryloyl chloride and sodium 
tetraphenylborate afforded amide 5.2a in a modest 55% yield (Entry 2, Table 5.1).  Homoallyl 
adduct 5.2b was also obtained in a 53% yield, via three-component coupling with imine 5.1b 
(Entry 3, Table 5.1).  Currently, the use of aryl-metal components in the three-component 
coupling process is underdeveloped.  In the future we would like to see this method adapted and 
expanded to allow addition of aryl as well as heteroaryl boron reagents.   
Table 5.1 
 
Entry Imine 5.1 RM Solvent Amide 5.2 Amide 5.2 (%)a 
1 
 
SnPhBu3 ACN / DCM 
Br
N O
 
- 
2 
 
NaBPh4 pyridine / DCM 
Br
N O
 
5.2a (55) 
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3 
 
NaBPh4 pyridine / DCM 
 
5.2b (53) 
aIsolated yield of a single compound. 
5.2 Sequential RCM/Heck Annulations 
 My next goal was to explore sequential Ru/Pd catalysis on amides 5.2a-b.  Contrary to 
the literature precedent, ring-closing metathesis of amide 5.2a, using Grubbs I catalyst, easily 
afforded γ-lactam 5.3a in an 88% yield (Scheme 5.2).   
Scheme 5.2 
 
Unfortunately, palladium-catalyzed Heck cyclization of γ-lactam 5.3a failed to produce 
the desired bicyclobenzazepine scaffold, forming instead aryl-fused product 5.4 (Scheme 5.3).  
Assuming that aryl-fused product formation was due to the high temperature (140 oC), the 
reaction was run again at lower temperatures (100 oC and 80 oC); however, in both cases neither 
of the products were obtained.  Although this confirmed our concern about the high temperature, 
we were disappointed that we had not obtained the desired bridged product.  Our current working 
hypothesis is that conformational strain, imparted to the starting material (5.3a) by the presence 
of the lactam functionality, does not allow the aryl palladium and olefin to get in a close enough 
proximity for the cyclization to proceed.  We also proposed that the most likely solution to this 
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problem would be increasing the lactam ring size, thereby imparting greater flexibility to the 
molecule. 
Scheme 5.3 
 
 To investigate our ring size hypothesis, Grubbs I-catalyzed ring-closing metathesis was 
performed on N-homoallyl amide 5.2b affording δ-lactam 5.3b in a 80% yield (Scheme 5.4).  
Heck cyclization was then attempted on δ-lactam 5.3b with Na2CO3 at 80 oC and K2CO3 at 110 
oC.  Unfortunately, in spite of the larger lactam ring size, we once again failed to observe 
bicyclobenzazepine formation , and only recovered the starting material.   
Scheme 5.4 
 
Conclusion 
In conclusion, we have proposed a sequential transition metal-catalyzed RCM/Heck 
method of obtaining the bicyclobenzazepine scaffold.  However, although three-component 
coupling and ring-closing metatheses were both easily accomplished, we have thus far been 
unable to achieve Heck cyclization of the lactam intermediate.  Clearly, conformational issues 
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are a major problem for this method and greater exploration of Heck conditions should be 
undertaken.  One possibility I would like to see attempted is use of microwave Heck 
conditions.133  Another interesting avenue we have not yet explored would be radical cyclization 
conditions.  In spite of our inability to obtain the desired bridged product, we have successfully 
synthesized interesting γ- and δ-lactam products (5.3).  Formation of these lactams, followed by 
coupling of the aryl halide with an organometallic agent and addition of a biologically relevant 
nucleophile into the available Michael acceptor would constitute an excellent project for 
combinatorial library synthesis. 
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Chapter Six: 
Experimental 
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General Experimental 
Unless otherwise indicated, all NMR data were collected at room temperature in CDCl3 with 
internal CHCl3 as the reference (7.26 ppm for 1H and 77.16 ppm for 13C). IR spectra were 
measured in thin films on salt (NaCl) plates. MS were measured under fast atom bombardment 
(FAB) or electron impact (EI) conditions. Analytical thin-layer chromatography (TLC) was 
carried out on commercial Merck silica gel 60 plates, 0.25 mm thickness, with fluorescent 
indicator (F-254) or stained with aqueous KMnO4 solution. Column chromatography was 
performed with 40-63 mm silica gel (Sorbent). Dichloromethane (DCM), Acetonitrile (ACN) 
and dimethylformamide (DMF) was distilled from CaH and kept over 3Å (8-12 mesh) molecular 
sieves under an atmosphere of dry argon.  Tetrahydrofuran (THF) was freshly distilled from 
sodium/benzophenone. Triethyl amine was distilled from KOH and kept over 3Å (8-12 mesh) 
molecular sieves under an atmosphere of dry argon; other solvents were used as received.183 
Unless otherwise specified, all reactions were carried out under an atmosphere of dry argon in 
oven-dried (at least 6 h at 140 oC) glassware. All imines were prepared according to a modified 
literature procedure181 by condensation of a 1:1 mixture of aldehyde and amine in methylene 
chloride (25 °C) in the presence of activated 3 Å (8-12 mesh) molecular sieves for 4-6 h 
(monitored by 1H NMR) followed by filtration through celite and removal of solvent under 
vacuum to afford pure imines. All sulfonamides were prepared according to a modified literature 
procedure98 by stirring a solution of amine (1.0 equiv.), tosyl chloride (1.2 equiv.) and Et3N (2.3 
equiv.) in methylene chloride (25 oC) for 24 h, followed by column chromatography to afford 
pure sulfonamides.  Other materials were used as received from commercial suppliers. 
 
General protocol for the preparation of amides 3.2a-n. Neat acid chloride (1.3 equiv) was 
injected into a reaction vessel containing a solution of imine (1.0 equiv), CuCl (0.1 equiv) and 
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ACN (0.28 M).  The reaction was stirred at room temperature for 30 minutes then a solution of 
tributylvinyltin (1.2 equiv) in DCM (0.14 M) was added dropwise.  The reaction mixture was 
stirred at 45 oC for 6h, under argon, cooled, diluted with saturated aqueous KF (12 mL) and 
stirred for 16 h.  Water was added (10 mL) and the mixture was extracted with EA (3x30 mL).  
The combined organic phase was washed with water (2x40 mL) and brine (2x40 mL).  The 
organic phase was dried (MgSO4) and the solvents were removed under reduced pressure to 
afford a crude product that was purified by flash chromatography over silica eluting with 
EtOAc/Hexanes to yield pure amide 3.2a-n.  
 
 
N-benzyl-N-(1-(2-bromo-4,5-dimethoxyphenyl)allyl)methacrylamide (3.2a).  Treatment of 
imine 3.1a (335 mg, 1.00 mmol, 1.0 equiv), methacryloyl chloride (139 mg, 130 L, 1.30 mmol, 
1.3 equiv) and tributylvinyltin (386 mg, 1.20 mmol, 1.2 equiv) with CuCl (10 mg, 0.10 mmol, 
0.1 equiv) in ACN (4 mL) and DCM (8 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 4) afforded amide 
3.2a (355 mg, 83%) as a clear heavy oil: Rf = 0.40 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, 
CDCl3) δ 7.17-7.12 (m, 3H), 7.00 (d, J = 7.3 Hz, 2H), 6.84 (br s, 1H), 6.76 (s, 1H), 6.08 (dt, J = 
5.3 Hz, J = 1.5 Hz, 1H), 5.99 (ddd, J = 17.1 Hz, J = 10.4 Hz, J = 5.3 Hz, 1H), 5.36 (br s, 1H), 
5.26 (br s, 1H), 5.21 (s, 0.5H), 5.19 (s, 1H), 5.17 (s, 0.5H), 4.69 (br s, 1H), 4.43 (br s, 1H), 3.80 
(s, 3H), 3.75 (s, 3H), 2.02 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 21.3, 47.8, 56.2, 56.3, 63.0, 
113.5, 115.5, 115.7, 115.9, 118.2, 126.8, 127.3 (2C), 128.1 (2C), 129.6, 135.9, 138.0, 140.7, 
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148.3, 149.2, 173.7; IR (cm-1) 1647, 1620, 1252; Significant signal broadening of some signals 
in 1H and 13C NMR arises due to hindered rotation about the amide bond. See temperature 
dependent 1H NMR spectra for 3.2b; HRMS (ES+) calcd for C22H24BrNO3Na (M+Na)+ 
452.0837, found 452.0835. 
 
 
N-benzyl-N-(1-(6-bromobenzo[d][1,3]dioxol-5-yl)allyl)methacrylamide (3.2b).   Treatment of 
imine 3.1b (1.38 g, 4.33 mmol, 1.0 equiv), methacryloyl chloride (589 mg, 550 L, 5.66 mmol, 
1.3 equiv) and tributylvinyltin (1.66 g, 5.23 mmol, 1.2 equiv) with CuCl (44 mg, 0.44 mmol, 0.1 
equiv) in ACN (16 mL) and DCM (32 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 4) afforded amide 
3.2b (1.304 g, 73%) as a white solid: mp 100-110 oC; Rf = 0.57 (EtOAc/hexane 1 : 1); 1H NMR 
(500 MHz, CDCl3) δ 7.16 (br t, J = 7.1 Hz, 2H), 7.13 (br d, J = 6.7 Hz, 1H), 7.02 (d, J = 7.3 Hz, 
2H), 6.80 (s, 2H), 6.11 (d, J = 4.1 Hz, 1H), 5.99-5.96 (m, 0.7H), 5.94 (d, J = 1.4 Hz, 1H), 5.94-
5.93 (m, 0.3H), 5.91 (d, J = 1.4 Hz, 1H), 5.37 (br s, 1H), 5.26 (s, 1H), 5.18 (t, J = 8.2 Hz, 2H), 
4.77 (br s, 1H), 4.38 (br s, 1H), 2.01 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 21.4, 48.5, 62.7, 
102.0, 110.5, 113.0, 115.6, 116.5, 118.1, 126.7, 127.2 (2C), 128.1 (2C), 128.0, 128.9, 135.9, 
138.0, 147.5, 148.0, 173.7; Significant signal broadening of some signals in 1H and 13C NMR 
arises due to hindered rotation about the amide bond. See temperature dependent 1H NMR 
spectra for 3.2b; IR (cm-1) 1647, 1618, 1238; HRMS (ES+) calcd for C21H20BrNO3Na (M+Na)+ 
436.0524, found 436.0516. 
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N-benzyl-N-(1-(5-bromobenzo[d][1,3]dioxol-4-yl)allyl)methacrylamide (3.2c).  Treatment of 
imine 3.1c (504 mg, 1.58 mmol, 1.0 equiv), methacryloyl chloride (214 mg, 200 L, 2.06 mmol, 
1.3 equiv) and tributylvinyltin (602 mg, 1.90 mmol, 1.2 equiv) with CuCl (16 mg, 0.16 mmol, 
0.1 equiv) in ACN (6 mL) and DCM (12 mL) according to the general procedure described 
above, followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 4) afforded 
amide 3.2c (484 mg, 74%) as a light yellow heavy oil: Rf = 0.53 (EtOAc/hexane 1 : 1); 1H NMR 
(500 MHz, CDCl3) δ 7.16 (t, J = 7.2 Hz, 2H), 7.09 (t, J = 7.0 Hz, 1H), 7.03 (d, J = 7.4 Hz, 2H), 
6.93 (d, J = 8.0 Hz, 1H), 6.47 (d, J = 8.3 Hz, 1H), 6.31 (br s, 1H), 6.11 (ddd, J = 17.1 Hz, J = 
10.4 Hz, J = 5.6 Hz, 1H), 5.92 (d, J = 1.5 Hz, 1H), 5.86 (s, 1H), 5.27 (d, J = 10.0 Hz, 1H), 5.22 
(br s, 0.5H), 5.19 (q, J = 0.7 Hz, 1H), 5.16 (q, J = 0.7 Hz, 1H), 5.15 (br s, 0.5H), 4.84 (br d, J = 
13.5 Hz, 1H), 4.70 (br, J = 14.3 Hz, 1H), 1.93 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 21.3, 47.8, 
60.6, 101.5, 109.1, 115.5, 116.3, 117.6, 120.8, 126.0, 126.2 (2C), 126.6, 128.1 (2C), 134.3, 
138.7, 140.5, 147.2, 147.3, 173.5; Significant signal broadening of some signals in 1H and 13C 
NMR arises due to hindered rotation about the amide bond. See temperature dependent 1H NMR 
spectra for 3.2b; IR (cm-1) 1645, 1620, 933; HRMS (ES+) calcd for C21H21BrNO3 (M+H)+ 
414.0705, found 414.0706. 
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N-benzyl-N-(1-(2-bromo-5-methoxyphenyl)allyl)methacrylamide (3.2d).  Treatment of imine 
3.1d (482 mg, 1.58 mmol, 1.0 equiv), methacryloyl chloride (214 mg, 200 L, 2.06 mmol, 1.3 
equiv) and tributylvinyltin (603 mg, 1.90 mmol, 1.2 equiv) with CuCl (16 mg, 0.16 mmol, 0.1 
equiv) in ACN (6 mL) and DCM (12 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 4) afforded amide 
3.2d (399 mg, 63%) as a light yellow heavy oil: Rf = 0.58 (EtOAc/hexane 1 : 1); 1H NMR (500 
MHz, CDCl3) δ 7.33-7.27 (m, 1H), 7.16-7.12 (m, 3H), 7.02 (d, J = 7.2 Hz, 2H), 6.85 (d, J = 3.1 
Hz, 1H), 6.61 (dd, J = 8.7 Hz, J = 2.7 Hz, 1H), 6.13 (br s, 1H), 5.97 (ddd, J = 17.2 Hz, J = 10.4 
Hz, J = 5.4 Hz, 1H), 5.36 (br d, J = 8.1 Hz, 1H), 5.24 (s, 1H), 5.20 (q, J = 1.1 Hz, 0.5H), 5.18 (s, 
1H), 5.16 (q, J = 1.0 Hz, 0.5H), 4.69 (br s, 1H), 4.54 (br d, J = 13.0 Hz, 1H), 3.72 (s, 3H), 1.99 
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 21.3, 47.3, 55.6, 63.3, 114.8, 115.6, 115.7, 117.0, 118.6, 
126.8, 127.3 (2C), 128.1 (2C), 122.8, 135.4, 138.1, 138.9, 140.6, 159.0, 173.8; Significant signal 
broadening of some signals in 1H and 13C NMR arises due to hindered rotation about the amide 
bond. See temperature dependent 1H NMR spectra for 3.2b; IR (cm-1) 1647, 1624, 1281; HRMS 
(ES+) calcd for C21H22BrNO2Na (M+Na)+ 422.0732, found 422.0744. 
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N-benzyl-N-(1-(2-bromo-4-methylphenyl)allyl)methacrylamide (3.2e).  Treatment of imine 
3.1e (1.23 g, 4.27 mmol, 1.0 equiv), methacryloyl chloride (642 mg, 600 L, 6.17 mmol, 1.3 
equiv) and tributylvinyltin (1.64 g, 5.16 mmol, 1.2 equiv) with CuCl (44 mg, 0.44 mmol, 0.1 
equiv) in ACN (15 mL) and DCM (30 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 4) afforded amide 
3.2e (1.213 g, 74%) as a clear oil: Rf = 0.54 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 
7.21 (br s, 1H), 7.18 (d, J = 7.9 Hz, 1H), 7.13 (br t, J = 6.7 Hz, 3H), 7.03 (d, J = 7.9 Hz, 1H), 
6.98 (d, J = 6.9 Hz, 2H), 6.14 (br s, 1H), 5.98 (ddd, J = 17.2 Hz, J = 10.5 Hz, J = 5.3 Hz, 1H), 
5.34 (br d, J = 6.7 Hz, 1H), 5.25 (s, 1H), 5.18 (q, J = 1.1 Hz, 0.5H), 5.17 (br, 1H), 5.15 (q, J = 
1.1 Hz, 0.5H), 4.65 (br s, 1H), 4.46 (br d, J = 10.2 Hz, 1H), 2.24 (s, 3H), 1.99 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ 20.7, 21.3, 47.1, 63.0, 115.5, 118.1, 125.3, 126.6, 127.3 (2C), 128.0 (2C), 
128.3, 130.4, 133.7, 134.8, 135.8, 138.1, 139.9, 140.6, 173.8; Significant signal broadening of 
some signals in 1H and 13C NMR arises due to hindered rotation about the amide bond. See 
temperature dependent 1H NMR spectra for 3.2b; IR (cm-1) 1649, 1620; HRMS (ES+) calcd for 
C21H23BrNO (M+H)+ 384.0963, found 384.0963. 
 
 
N-benzyl-N-(1-(1-bromonaphthalen-2-yl)allyl)methacrylamide (3.2f).  Treatment of imine 
3.1f (324 mg, 1.00 mmol, 1.0 equiv), methacryloyl chloride (139 mg, 130 L, 1.30 mmol, 1.3 
equiv) and tributylvinyltin (381 mg, 1.20 mmol, 1.2 equiv) with CuCl (10 mg, 0.10 mmol, 0.1 
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equiv) in ACN (4 mL) and DCM (8 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 3) afforded amide 
3.2f (252 mg, 60%) as a light yellow oil: Rf = 0.32 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, 
CDCl3) δ 8.25 (d, J = 8.2 Hz, 1H), 7.77 (d, J = 8.0 Hz, 1H), 7.74 (d, J = 8.6 Hz, 1H), 7.56 (td, J 
= 8.2 Hz, J = 1.2 Hz, 1H), 7.51 (td, J = 8.1 Hz, J = 1.3 Hz, 1H), 7.44 (d, J = 8.5 Hz, 1H), 7.06 (br 
s, 2H), 7.01 (d, J = 7.3 Hz, 3H), 6.47 (d, J = 5.4 Hz, 1H), 6.12 (ddd, J = 16.8 Hz, J = 10.4 Hz, J 
= 5.4 Hz, 1H), 5.36 (d, J = 10.0 Hz, 1H), 5.23 (s, 1H), 5.18 (q, J = 1.0 Hz, 1.5H), 5.14 (q, J = 1.1 
Hz, 0.5H), 4.70 (d, J = 12.6 Hz, 1H), 4.63 (d, J = 15.7 Hz, 1H), 1.97 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ 21.2, 31.1, 64.0, 115.6, 118.5, 126.0, 126.8, 126.8, 127.1, 127.1 (2C), 127.7 
(2C), 127.7, 128.0, 128.0, 128.1, 132.4, 134.1, 135.6, 136.1, 138.1, 140.7, 173.8; Significant 
signal broadening of some signals in 1H and 13C NMR arises due to hindered rotation about the 
amide bond. See temperature dependent 1H NMR spectra for 3.2b; IR (cm-1) 1647, 1624; HRMS 
(ES+) calcd for C24H22BrNONa (M+Na)+ 442.0782, found 442.0784. 
 
 
N-benzyl-N-(1-(2-bromophenyl)allyl)methacrylamide (3.2g).  Treatment of imine 3.1g (837 
mg, 3.05 mmol, 1.0 equiv), methacryloyl chloride (417 mg, 390 L, 4.01 mmol, 1.3 equiv) and 
tributylvinyltin (1.159 g, 3.66 mmol, 1.2 equiv) with CuCl (31 mg, 0.31 mmol, 0.1 equiv) in 
ACN (12 mL) and DCM (24 mL) according to the general procedure described above, followed 
by flash chromatography over silica eluting with EtOAc/hexane (1 : 5) afforded amide 3.2g (809 
mg, 72%) as a yellow oil: Rf = 0.59 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.40 
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(br s, 1H), 7.32 (dd, J = 7.8 Hz, J = 1.7 Hz, 1H), 7.24 (dt, J = 7.5 Hz, J = 1.1 Hz, 1H), 7.15-7.09 
(m, 3H), 7.05 (t, J = 7.5 Hz, 1H), 6.98 (d, J = 7.0 Hz, 2H), 6.19 (br, 1H), 6.00 (ddd, J = 17.2 Hz, 
J = 10.4 Hz, J = 5.3 Hz, 1H), 5.36 (d, J = 8.2 Hz, 1H), 5.24 (s, 1H), 5.20 (q, J = 0.7 Hz, 0.5H), 
5.18 (s, 1H), 5.16 (q, J = 0.7 Hz, 0.5H), 4.60 (br, 1H), 4.50 (d, J = 12.3 Hz, 1H), 1.99 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δ 21.3, 47.8, 63.1, 115.5, 118.4, 125.5, 126.7, 127.2 (2C), 127.5, 128.1 
(2C), 129.6, 130.7, 133.6, 135.6, 138.0, 138.1, 140.6, 173.8; Significant signal broadening of 
some signals in 1H and 13C NMR arises due to hindered rotation about the amide bond. See 
temperature dependent 1H NMR spectra for 3.2b; IR (cm-1) 1647, 1622; HRMS (ES+) calcd for 
C20H21BrNO (M+H)+ 370.0807, found 370.0811. 
 
 
N-benzyl-N-(1-(2-bromo-5-fluorophenyl)allyl)methacrylamide (3.2h).  Treatment of imine 
3.1h (288 mg, 0.99 mmol, 1.0 equiv), methacryloyl chloride (134 mg, 125 L, 1.29 mmol, 1.3 
equiv) and tributylvinyltin (381 mg, 1.20 mmol, 1.2 equiv) with CuCl (10 mg, 0.10 mmol, 0.1 
equiv) in ACN (4 mL) and DCM (8 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 5) afforded amide 
3.2h (193 mg, 50%) as a yellow oil: Rf = 0.61 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, 
CDCl3) δ 7.34-7.27 (m, 1H), 7.09-7.23 (m, 3H), 7.04 (dd, J = 9.6 Hz, J = 3.0 Hz, 1H), 7.01 (d, J 
= 7.4 Hz, 2H), 6.78 (dt, J = 8.4 Hz, J = 2.9 Hz, 1H), 6.13 (d, J = 5.0 Hz, 1H), 5.96 (ddd, J = 17.2 
Hz, J = 10.4 Hz, J = 5.3 Hz, 1H), 5.39 (br d, J = 6.8 Hz, 1H), 5.24 (s, 1H), 5.21-5.17 (m, 2H), 
4.72 (br s, 1H), 4.48 (br s, 1H), 2.00 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 21.3, 48.2, 62.7, 
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115.7, 116.7 (d, J = 21.3 Hz), 118.0 (J = 23.8 Hz), 119.0, 119.4 (J = 2.5 Hz), 126.9, 127.2 (2C), 
128.0 (d, J = 82.5 Hz), 128.2 (2C), 134.4 (d, J = 8.8 Hz), 134.8, 137.8, 140.2, 162.0 (d, J = 246.3 
Hz), 173.7; Significant signal broadening of some signals in 1H and 13C NMR arises due to 
hindered rotation about the amide bond. See temperature dependent 1H NMR spectra for 3.2b; IR 
(cm-1) 1647, 1624; HRMS (ES+) calcd for C20H20BrFNO (M+H)+ 388.0712, found 388.0719. 
 
 
N-benzyl-N-(1-(2-bromo-6-fluorophenyl)allyl)methacrylamide (3.2i).  Treatment of imine 
3.1i (462 mg, 1.58 mmol, 1.0 equiv), methacryloyl chloride (214 mg, 200 L, 2.06 mmol, 1.3 
equiv) and tributylvinyltin (603 mg, 1.90 mmol, 1.2 equiv) with CuCl (16 mg, 0.16 mmol, 0.1 
equiv) in ACN (6 mL) and DCM (12 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 5) afforded amide 
3.2i (473 mg, 77%) as a yellow oil: Rf = 0.68 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) 
δ 7.29 (d, J = 7.8 Hz, 1H), 7.20 (t, J = 7.2 Hz, 2H), 7.12 (t, J = 7.1 Hz, 1H), 7.08 (d, J = 7.4 Hz, 
2H), 7.01 (dt, J = 8.2 Hz, J = 5.8 Hz, 1H), 6.90 (ddd, J = 11.0 Hz, J = 8.5 Hz, J = 0.8 Hz, 1H), 
6.41 (br s, 1H), 6.13-6.06 (m, 1H), 5.22 (d, J = 10.3 Hz, 1H), 5.13-5.09 (m, 3H), 4.88-4.80 (m, 
2H), 1.83 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 20.8, 49.2, 60.7, 115.5, 115.7 (d, J = 23.8 Hz), 
118.2, 125.8 (d, J = 6.3 Hz), 126.2 (2C), 126.7, 127.3, 128.3 (2C), 128.7, 129.2 (d, J = 3.8 Hz), 
130.0 (d, J = 8.8 Hz), 133.4, 139.7 (d, J = 196.3 Hz),  161.6 (d, J = 250.0 Hz), 173.7; Significant 
signal broadening of some signals in 1H and 13C NMR arises due to hindered rotation about the 
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amide bond. See temperature dependent 1H NMR spectra for 3.2b; IR (cm-1) 1649, 1624; HRMS 
(ES+) calcd for C20H20BrFNO (M+H)+ 388.0712, found 388.0704. 
 
 
N-benzyl-N-(1-(2-bromo-5-chlorophenyl)allyl)methacrylamide (3.2j).  Treatment of imine 
3.1j (1.285 g, 4.16 mmol, 1.0 equiv), methacryloyl chloride (567 mg, 530 L, 5.45 mmol, 1.3 
equiv) and tributylvinyltin (1.587 g, 5.01 mmol, 1.2 equiv) with CuCl (41 mg, 0.41 mmol, 0.1 
equiv) in ACN (16 mL) and DCM (32 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 5) afforded amide 
3.2j (959 mg, 57%) as a light yellow oil: Rf = 0.63 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, 
CDCl3) δ 7.33-7.28 (m, 1H), 7.25 (d, J = 2.5 Hz, 1H), 7.16 (d, J = 6.7 Hz, 2H), 7.12 (d, J = 6.0 
Hz, 1H), 6.99 (d, J = 6.9 Hz, 3H), 6.15 (br d, J = 4.0 Hz, 1H), 5.96 (ddd, J = 17.2 Hz, J = 10.5 
Hz, J = 5.3 Hz, 1H), 5.41 (br s, 1H), 5.25 (s, 1H), 5.23 (s, 0.5H), 5.19 (s, 1.5H), 4.75 (br s, 1H), 
4.44 (br s, 1H), 2.01 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 21.3, 48.2, 62.6, 115.7, 119.0, 
123.3, 126.9, 127.3 (2C), 128.2, 129.6, 130.8, 133.6, 134.2 (2C),134.7, 137.8, 139.8, 140.4, 
173.7; Significant signal broadening of some signals in 1H and 13C NMR arises due to hindered 
rotation about the amide bond. See temperature dependent 1H NMR spectra for 3.2b; IR (cm-1) 
1647, 1624; HRMS (ES+) calcd for C20H19BrClNONa (M+Na)+ 426.0236, found 426.0239. 
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N-benzyl-N-(1-(2-bromopyridin-3-yl)allyl)methacrylamide (3.2k).  Treatment of imine 3.1k 
(518 mg, 1.88 mmol, 1.0 equiv), methacryloyl chloride (257 mg, 240 L, 2.47 mmol, 1.3 equiv) 
and tributylvinyltin (716 mg, 2.26 mmol, 1.2 equiv) with CuCl (19 mg, 0.19 mmol, 0.1 equiv) in 
ACN (7 mL) and DCM (14 mL) according to the general procedure described above, followed 
by flash chromatography over silica eluting with EtOAc/hexane (1 : 3) afforded amide 3.2k (431 
mg, 62%) as a light yellow oil: Rf = 0.39 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 
8.17 (d, J = 3.0 Hz, 1H), 7.65 (d, J = 7.2 Hz, 1H), 7.17 (dd, J = 7.7 Hz, J = 4.7 Hz, 4H), 7.01 (d, 
J = 6.4 Hz, 2H), 6.05 – 5.99 (m, 2H), 5.38 (s, 1H), 5.23 (d, J = 16.9 Hz, 2H), 5.17 (d, J = 16.9 
Hz, 1H), 4.79 (s, 1H), 4.51 – 4.46 (m, 1H), 2.01 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 21.2, 
49.8, 62.2, 116.0 (2C), 119.2, 122.7 (2C), 127.2 (2C), 128.4, 134.4, 135.8, 137.4, 139.1, 140.4, 
144.8, 149.3, 173.7; Significant signal broadening of some signals in 1H and 13C NMR arises due 
to hindered rotation about the amide bond. See temperature dependent 1H NMR spectra for  
3.2b; IR (cm-1) 1655, 1618; HRMS (ES+) calcd for C19H19BrN2ONa (M+Na)+ 393.0578, found 
39.0539. 
 
 
N-benzyl-N-(1-(3-bromothiophen-2-yl)allyl)methacrylamide (3.2l).  Treatment of imine 3.1l 
(417 mg, 1.50 mmol, 1.0 equiv), methacryloyl chloride (203 mg, 190 L, 1.95 mmol, 1.3 equiv) 
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and tributylvinyltin (574 mg, 1.81 mmol, 1.2 equiv) with CuCl (15 mg, 0.16 mmol, 0.1 equiv) in 
ACN (6 mL) and DCM (12 mL) according to the general procedure described above, followed 
by flash chromatography over silica eluting with EtOAc/hexane (1 : 5) afforded amide 3.2l (443 
mg, 78%) as a light yellow oil: Rf = 0.61 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 
7.22-7.16 (m, 4H), 7.09 (t, J = 6.9 Hz, 2H), 6.79 (dd, J = 40.8 Hz, J = 4.5 Hz, 1H), 6.11-6.04 (m, 
2H), 5.30 (br s, 1H), 5.23-5.18 (m, 3H), 4.72 (t, J = 15.1 Hz, 1H), 4.54 (dd, J = 21.8 Hz, J = 16.1 
Hz, 1H), 2.01 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 20.9, 47.2, 58.6, 115.6, 115.8, 118.4, 
118.5, 125.2, 126.1, 127.1 (2C), 127.2 (2C), 128.3, 135.2, 135.3, 137.8, 173.5; Significant signal 
broadening of some signals in 1H and 13C NMR arises due to hindered rotation about the amide 
bond. See temperature dependent 1H NMR spectra for 3.2b; IR (cm-1) 1647, 1624; HRMS (ES+) 
calcd for C18H19BrNOS (M+H)+ 376.0371, found 376.0364. 
 
 
(E)-N-benzyl-N-(1-(2-bromo-4,5-dimethoxyphenyl)but-2-en-1-yl)methacrylamide (3.2m).  
Treatment of imine 3.1b (477 mg, 1.50 mmol, 1.0 equiv), methacryloyl chloride (203 mg, 190 
L, 1.30 mmol, 1.3 equiv) and (E)-tributyl(prop-1-en-1-yl)stannane (595 mg, 1.80 mmol, 1.2 
equiv) with CuCl (15 mg, 0.15 mmol, 0.1 equiv) in ACN (4 mL) and DCM (8 mL) according to 
the general procedure described above, followed by flash chromatography over silica eluting 
with EtOAc/hexane (1 : 4) afforded amide 3.2m (482 mg, 75%) as a clear heavy oil: Rf = 0.57 
(EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.22 (t, J = 7.0 Hz, 2H), 7.18 (d, J = 7.1 
Hz, 1H), 7.08 (d, J = 7.1 Hz, 2H), 6.90 (s, 1H), 6.82 (s, 1H), 6.19 (d, J = 5.5 Hz, 1H), 5.96 (q, J = 
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1.4 Hz, 2H), 5.62 (d, J = 5.9 Hz, 2H), 5.23 (s, 1H), 5.21 (s, 1H), 4.70 (d, J = 15.8 Hz, 1H), 4.36 
(d, J = 15.8 Hz, 1H), 1.98 (s, 3H), 1.49 (d, J = 4.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 13.6, 
21.0, 31.1, 43.2, 102.0, 110.3, 113.1, 115.7, 115.9, 126.9, 127.4, 127.5 (2C), 128.3 (2C), 128.5, 
128.8, 132.3, 138.5, 147.5, 147.9, 173.5; Significant signal broadening of some signals in 1H and 
13C NMR arises due to hindered rotation about the amide bond. See temperature dependent 1H 
NMR spectra for 3.2b; IR (cm-1) 1651, 1622; HRMS (ES+) calcd for C22H22BrNO3Na (M+Na)+ 
450.0681, found 450.0675. 
 
 
ethyl 2-((N-benzylmethacrylamido)(2-bromo-4,5-dimethoxyphenyl)methyl)acrylate (3.2n). 
Treatment of imine 3.1a (606 mg, 1.81 mmol, 1.0 equiv), methacryloyl chloride (230 L, 2.30 
mmol, 1.3 equiv) and ethyl 2-(tributylstannyl)acrylate (861 mg, 2.21 mmol, 1.2 equiv) with CuCl 
(21 mg, 0.21 mmol, 0.1 equiv) in ACN (8 mL) and DCM (16 mL) according to the general 
procedure described above, followed by flash chromatography over silica eluting with 
EtOAc/hexane (1 : 4) afforded amide 3.2n (655 mg, 72%) as a clear heavy oil: Rf = 0.40 
(EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.16 (t, J = 7.1 Hz, 2H), 7.10 (t, J = 6.5 Hz, 
1H), 7.04 (d, J = 6.7 Hz, 2H), 6.85 (s, 1H), 6.69 (s, 1H), 6.45 (d, J = 28.9 Hz, 2H), 5.45 (s, 1H), 
5.15 (s, 1H), 4.99 ( s, 1H), 4.70 (s, 2H), 4.06 – 3.90 (m, 2H), 3.79 (s, 3H), 3.66 (s, 3H), 2.05 (s, 
3H), 1.12 (dt, J = 7.0 Hz, J = 1.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 14.1, 20.9, 47.1, 56.1, 
56.2, 61.2, 62.7, 111.8, 114.5, 115.4, 116.0, 126.7, 127.7 (2C), 128.1 (2C), 128.8, 130.1, 137.7, 
140.1, 140.4, 148.6, 149.0, 165.3, 174.8; Significant signal broadening of some signals in 1H and 
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13C NMR arises due to hindered rotation about the amide bond. See temperature dependent 1H 
NMR spectra for 3.2b; IR (cm-1) 1718, 1649, 1628; HRMS (ES+) calcd for C25H28BrNO5Na 
(M+Na)+ 524.1049, found 524.1038. 
 
General protocol for the preparation of azabicyclooctanes 3.4a-m and 3.4a-m’.  A solution 
of amide 3.2a-m (1.0 equiv) in DMF (0.12 M) was injected into a reaction vessel containing the 
solid reagents including sodium carbonate (1.0 equiv), tetrabutylammonium chloride (1.0 equiv) 
and palladium acetate (0.1 equiv).  In situations when the imine was a solid, it was added along 
with the other solid reagents.  The reaction mixture was then stirred at 80 oC for 18-26 h.  After 
cooling to room temperature the solution was diluted with water (10 mL) and extracted with 
ethyl acetate (3x30 mL).  The combined organic phase was washed with water (2x40 mL) and 
brine (2x40 mL).  The organic phase was dried (MgSO4) and concentrated under reduced 
pressure to afford the crude product.  The crude product was purified by flash chromatography 
over silica eluting with ethyl EtOAc/hexane to yield an isomeric mixture of azabicyclooctanes 
3.4a-m and 3.4a-m’. 
 
 
(1S,4R)-10-benzyl-6,7-dimethoxy-4-methyl-2-methylene-1,2,3,4-tetrahydro-1,4-
(epiminomethano)naphthalen-9-one (3.4a) and (1S,4R)-10-benzyl-6,7-dimethoxy-2,4-
dimethyl-1,4-dihydro-1,4-(epiminomethano)naphthalen-9-one (3.4a’).  Treatment of amide 
3.2a (300 mg, 0.70 mmol, 1.0 equiv), sodium carbonate (74 mg, 0.70 mmol, 1.0 equiv) and 
tetrabutylammonium chloride (200 mg, 0.72 mmol, 1.0 equiv) with palladium acetate (18 mg, 
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0.082 mmol, 0.1 equiv) in DMF (8 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 4) afforded 
azabicyclooctanes 3.4a and 3.4a’ (166 mg, 68%) as a light yellow oil, as a 1.3 : 1.0 mixture of 
3.4a : 3.4a’ (by 1H NMR): Rf = 0.31 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.29-
7.23 (m, 3H), 7.10 (dd, J = 7.8 Hz, J = 2.2 Hz, 1H), 7.07 (dd, J = 7.6 Hz, J = 2.0 Hz, 1H), 6.87 
(s, 0.44H), 6.82 (s, 0.56H), 6.66 (s, 0.44H), 6.56 (s, 0.56H), 6.05 (p, J = 1.9 Hz, 0.44H), 4.88 (t, J 
= 2.2 Hz, 0.56H), 4.83 (d, J = 15.3 Hz, 0.56H), 4.73 (d, J = 15 Hz, 0.44H), 4.71 (t, J = 1.9 Hz, 
0.56H), 4.53 (s, 0.56H), 4.48 (d, J = 2.1 Hz, 0.44H), 4.38 (d, J = 15.3 Hz, 0.56H), 4.22 (d, J = 
15.1 Hz, 0.44H), 3.90 (s, 1.68H), 3.88 (s, 1.32H), 3.80 (s, 1.32H), 3.79 (s, 1.68H), 2.60 (dt, J = 
16.2 Hz, J = 2.2 Hz, 0.56H), 2.19 (dt, J = 16.2 Hz, J = 2.1 Hz, 0.56H), 1.84 (s, 1.32H), 1.71 (s, 
1.68H) 1.65 (d, J = 1.8 Hz, 1.32H); 13C  NMR  (125 MHz, CDCl3) δ [14.2], 16.1, [18.1], 38.8, 
47.1, 48.3, [49.2], [53.8], 56.3, 56.4, [56.4], [56.5], [63.7], 64.4, 106.3, 106.5, [106.6], [107.1], 
107.6, 127.5, [127.7], 128.1 (2C), [128.4 (2C)], 128.6 (2C), [128.7 (2C)], 131.9, [133.5], 134.8, 
[135.3], 136.9, [137.1], [137.4], 143.7, [146.3], [146.7], 147.2, [147.8], 148.6, 174.9, [175.0]; 
Values in brackets are for the minor isomer 3.4a’; IR (cm-1) 1668, 1607, 1290, 1059, 733; 
HRMS (ES+) calcd for C22H24NO3 (M+H)+ 350.1756, found 350.1758. 
 
 
(5S,8R)-11-benzyl-8-methyl-6-methylene-5,6,7,8-tetrahydro-5,8-
(epiminomethano)naphtho[2,3-d][1,3]dioxol-10-one (3.4b) and (5S,8R)-11-benzyl-6,8-
dimethyl-5,8-dihydro-5,8-(epiminomethano)naphtho[2,3-d][1,3]dioxol-10-one (3.4b’). 
Treatment of amide 3.2b (1.521 g, 3.67 mmol, 1.0 equiv), sodium carbonate (390 mg, 3.68 
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mmol, 1.0 equiv) and tetrabutylammonium chloride (1.012 g, 3.67 mmol, 1.0 equiv) with 
palladium acetate (83 mg, 0.37 mmol, 0.1 equiv) in DMF (30 mL) according to the general 
procedure described above, followed by flash chromatography over silica eluting with 
EtOAc/hexane (1 : 4) afforded 3.4b and 3.4b’ (1.103 g, 90%) as a clear oil, as a 1.5 : 1.0 mixture 
of 3.4b : 3.4b’ (by 1H NMR): Rf = 0.52 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 
7.33-7.24 (m, 3H), 7.13-7.08 (m, 2H), 6.83 (s, 0.4H), 6.80 (s, 0.6H), 6.63 (s, 0.4H), 6.52 (s, 
0.6H), 6.02 (p, J = 2.0 Hz, 0.4H), 5.95 (d, J = 2.0 Hz, 0.6H), 5.93 (d, J = 2.0 Hz, 0.4H), 5.91 (d, 
J = 1.0 Hz, 0.6H), 5.90 (d, J = 1.5 Hz, 0.4H), 4.87 (t, J = 2.0 Hz, 0.6H), 4.79 (d, J = 15.3 Hz, 
0.6H), 4.78 (d, J = 14.9 Hz, 0.4H), 4.70 (t, J = 2.0 Hz, 0.6H), 4.50 (s, 0.6H), 4.44 (d, J = 2.0 Hz, 
0.4H), 4.37 (d, J = 15.0 Hz, 0.6H), 4.13 (d, J = 15.0 Hz, 0.4H), 2.51 (dt, J =16.5 Hz, J = 2.0 Hz, 
0.6H), 2.18 (dt, J = 16.0 Hz, J = 2.0 Hz, 0.6H), 1.80 (s, 1.2H), 1.67 (s, 1.8H) 1.61 (d, J = 1.4 Hz 
1.2H); 13C NMR (125 MHz, CDCl3) δ [14.3], 16.2, [18.0], 38.7, 47.3, 48.3, [49.2], [54.0], [63.8], 
64.5, 101.2, [101.3], 103.8, [104.08], 104.12, [104.2], 107.8, 127.6, [127.7], 128.1 (2C), [128.3 
(2C)], 128.6 (2C), [128.7 (2C)], 133.0, [134.6], 135.2, [136.6], 136.8, [137.1], [139.3], 143.5, 
[144.8], [145.5], 146.2, [147.27], 147.29, 174.7, [174.9]; Values in brackets are for the minor 
isomer 3.4b’; IR (cm-1) 1740, 1682, 1242, 1047; HRMS (ES+) calcd for C21H19NO3Na (M+Na)+ 
356.1263, found 356.1253. 
Preparation of a single regioisomer of 3.4b: THF (4 mL) was injected into a reaction vessel 
containing the solid reagents including amide 3.2b (142 mg, 0.34 mmol, 1.0 equiv) and 
tetrakis(triphenylphosphine)palladium (20 mg, 0.02 mmol, 0.05 equiv), followed by neat 
triethylamine (138 mg, 190 L, 1.36 mmol, 4.0 equiv).  The reaction mixture was stirred at 80 oC 
for 23 h, cooled, diluted with 10 mL of water and extracted with ethyl acetate (3x30 mL).  The 
combined organic phase was washed with water (2x40 mL), brine (2x40 mL) and dilute HCl 
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(1x30 mL).  The organic phase was dried (MgSO4) and concentrated under reduced pressure to 
afford the crude product.  The crude product was purified by flash chromatography over silica 
eluting with EtOAc/hexane (1 : 4) to afford azabicyclooctanes 3.4b (102mg, 90%) as white solid, 
mp 120-124 oC; Rf = 0.52 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.29-7.23 (m, 
3H), 7.10 (d, J = 1.9, 1H), 7.08 (d, J = 1.3, 1H), 6.80 (s, 1H), 6.52 (s, 1H), 5.95 (d, J = 1.5 Hz, 
1H), 5.91 (d, J = 1.5 Hz, 1H), 4.87 (t, J = 2.3 Hz, 1H), 4.79 (d, J = 15.3 Hz, 1H), 4.70 (t, J = 1.9 
Hz, 1H), 4.50 (s, 1H), 4.38 (d, J = 15.3 Hz, 1H), 2.57 (dt, J = 16.1 Hz, J = 2.2 Hz, 1H), 2.16 (dt, 
J = 16.2 Hz, J = 2.2 Hz, 1H), 1.67 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 16.2, 38.7, 47.3, 48.3, 
64.5, 101.2, 103.8, 104.1, 107.8, 127.6, 128.1 (2C), 128.6 (2C), 133.0, 135.2, 136.8, 143.5, 
146.2, 147.3, 174.7; IR (cm-1) 1666, 1479, 910, 735; HRMS (ES+) calcd for C21H19NO3Na  
(M+Na)+ 356.1263, found 356.1262.  
 
 
(6R,9S)-10-benzyl-6-methyl-8-methylene-6,7,8,9-tetrahydro-9,6-
(epiminomethano)naphtho[1,2-d][1,3]dioxol-11-one (3.4c) and (6R,9S)-10-benzyl-6,8-
dimethyl-6,9-dihydro-9,6-(epiminomethano)naphtho[1,2-d][1,3]dioxol-11-one (3.4c’).  
Treatment of amide 3.2c (104 mg, 0.25 mmol, 1.0 equiv), sodium carbonate (27 mg, 0.25 mmol, 
1.0 equiv) and tetrabutylammonium chloride (69 mg, 0.25 mmol, 1.0 equiv) with palladium 
acetate (6 mg, 0.025 mmol, 0.1 equiv) in DMF (4 mL) according to the general procedure 
described above, followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 
4) afforded azabicyclooctanes 3.4c and 3.4c’ (67 mg, 80%) as a clear oil, as a 1.1 : 1.0 mixture of 
3.4c : 3.4c’ (by 1H NMR): Rf = 0.33 (EtOAc/hexane 1 : 2.3); 1H NMR (500 MHz, CDCl3) δ  
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7.29 (d, J = 1.7 Hz, 0.33H), 7.28 (d, J = 1.9 Hz, 0.67H), 7.25 (t, J = 1.9 Hz, 0.33H), 7.17 (t, J = 
7.2 Hz, 0.66H), 7.14 – 7.11 (m, J = 6.2, 4.5, 1.9 Hz, 2.01H), 7.03 (d, J = 7.4 Hz, 0.67H), 6.93 (d, 
J = 8.0 Hz, 0.33H), 6.73 – 6.68 (m, 1H), 6.51 (d, J = 7.7 Hz, 0.67H), 6.47 (d, J = 8.3 Hz, 0.33H), 
6.11 (ddd, J = 17.1 Hz, J = 10.3 Hz, J = 5.6 Hz, 0.66H), 6.03 (p, J = 1.8 Hz, 0.67H), 5.92 (d, J = 
1.4 Hz, 0.33H), 5.90 (d, J = 1.5 Hz, 0.33H), 5.88 (d, J = 1.5 Hz, 0.67H), 5.82 (d, J = 1.4 Hz, 
0.67H), 4.83 (s, 0.33H), 4.79 (s, 0.33H), 4.77 (d, J = 2.1 Hz, 0.67H), 4.76 (s, 0.34H), 4.74 (s, 
0.16H), 4.71 (s, 0.17H), 4.48 (d, J = 15.1 Hz, 0.33H), 4.20 (d, J = 14.9 Hz, 0.67H), 2.60 (dt, J = 
16.3 Hz, J = 2.2 Hz, 0.33H), 2.21 (dt, J = 16.0 Hz, J = 2.2 Hz, 0.33H), 1.80 (s, 2.01H), 1.67 (s, 
0.99H), 1.64 (d, J = 1.8 Hz, 2.01H); 14.5, [16.3], 18.1, 38.9, [47.4], [48.5], 49.2, [53.8], 57.9, 
[58.6], 101.3, [101.5], 104.4, [106.8], [108.4], [109.1], 114.1, 115.0, [115.5], 116.3, [122.6], 
[126.0], 126.2, [127.5], 127.7, [128.2 (2C)], 128.5 (2C), [128.6 (2C)], 128.7 (2C), 135.1, 137.0, 
[139.3], [140.8], [142.7], 145.8, 146.0, [173.5], 175.0; IR (cm-1) 1678, 1651, 1043; HRMS (ES+) 
calcd for C21H19NO3Na (M+Na)+ 356.1263, found 356.1253. 
 
 
(1S,4R)-10-benzyl-7-methoxy-4-methyl-2-methylene-1,2,3,4-tetrahydro-1,4-
(epiminomethano)naphthalen-9-one (3.4d) and (1S,4R)-10-benzyl-7-methoxy-2,4-dimethyl-
1,4-dihydro-1,4-(epiminomethano)naphthalen-9-one (3.4d’).  Treatment of amide 3.2d (103 
mg, 0.26 mmol, 1.0 equiv), sodium carbonate (28 mg, 0.26 mmol, 1.0 equiv) and 
tetrabutylammonium chloride (72 mg, 0.26 mmol, 1.0 equiv) with palladium acetate (6 mg, 
0.027 mmol, 0.1 equiv) in DMF (4 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 5) afforded 
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azabicyclooctanes 3.4d and 3.4d’ (54 mg, 65%) as a clear oil, as a 1.3 : 1.0 mixture of 3.4d : 
3.4d’ (by 1H NMR): Rf = 0.31 (EtOAc/hexane 1 : 2.3); 1H NMR (500 MHz, CDCl3) δ 7.32-7.23 
(m, 3H), 7.18 (d, J = 8.3 Hz, 0.56H), 7.15 (d, J = 8.2 Hz, 0.44H), 7.13 (dd, J = 8.1 Hz, J = 1.8 
Hz, 0.88H), 7.10 (dd, J = 7.8 Hz, J = 2.1 Hz, 1.12H), 6.79 (dd, J = 8.4 Hz, J = 2.6 Hz, 0.56H), 
6.69 (d, J = 2.5 Hz, 0.44H), 6.61 (d, J = 2.5 Hz, 0.22H), 6.59 (d, J = 2.5 Hz, 0.78H), 6.04 (p, J = 
1.9 Hz, 0.44H), 4.90 (t, J = 2.3 Hz, 0.56H), 4.82 (d, J = 15.1 Hz, 0.44H), 4.76 (d, J = 15.3 Hz, 
0.56H), 4.73 (t, J = 1.9 Hz, 0.56H), 4.56 (s, 0.56H), 4.48 (d, J = 2.1 Hz, 0.44H), 4.44 (d, J = 15.3 
Hz, 0.56H), 4.11 (d, J = 15.1 Hz, 0.44H), 3.76 (s, 1.32H), 3.75 (s, 1.68H), 2.60 (dt, J = 16.2 Hz, 
J = 2.2 Hz, 0.56H), 2.19 (dt, J = 16.3 Hz, J = 2.2 Hz, 0.56H), 1.83 (s, 1.32H), 1.70 (s, 1.68H) 
1.62 (d, J = 1.8 Hz, 1.32H) ; 13C  NMR  (125 MHz, CDCl3) δ [14.1], 15.9, [18.0], 38.9, 46.7, 
48.3, [49.1], [53.3], 55.5, [56.6], [63.9], 64.8, 108.4, 108.6, [109.1], [109.7], 112.3, [121.8], 
123.1, 127.5, [127.7], 128.1 (2C), [128.4 (2C)], 128.6 (2C), [128.7 (2C)], [133.4], 135.0, 136.7, 
[136.9], [137.2], 140.6, 143.5, [144.0], [146.4], [157.6], 158.7, [175.0], 175.1; Values in brackets 
are for the minor isomer 3.4d’; IR (cm-1) 1612, 1612, 1240, 1028; HRMS (ES+) calcd for 
C21H21NO2Na (M+H)+ 342.1470, found 342.1466. 
 
 
(1S,4R)-10-benzyl-4,6-dimethyl-2-methylene-1,2,3,4-tetrahydro-1,4-
(epiminomethano)naphthalen-9-one (3.4e) and (1S,4R)-10-benzyl-2,4,6-trimethyl-1,4-
dihydro-1,4-(epiminomethano)naphthalen-9-one (3.4e’).  Treatment of amide 3.2e (239 mg, 
0.62 mmol, 1.0 equiv), sodium carbonate (69 mg, 0.65 mmol, 1.0 equiv) and 
tetrabutylammonium chloride (175 mg, 0.63 mmol, 1.0 equiv) with palladium acetate (16 mg, 
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0.069 mmol, 0.1 equiv) in DMF (7 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 9) afforded 
azabicyclooctanes 3.4e and 3.4e’ (146 mg, 77%) as a light yellow oil, as a 1.1 : 1.0 mixture of 
3.4e : 3.4e’ (by 1H NMR): Rf = 0.53 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.32-
7.23 (m, 3H), 7.14 (s, 0.53H), 7.12 (s, 0.47), 7.11-7.08 (m, 2H), 6.98 (s, 0.47), 6.97 (s, 0.53), 
6.91 (d, J = 7.5 Hz, 0.53H), 6.85 (d, J = 7.3, 0.47H), 6.02 (p, J = 1.7 Hz, 0.47H), 4.89 (t, J = 2.3 
Hz, 0.53H), 4.83 (d, J = 15.1 Hz, 0.47H), 4.76 (d, J = 15.3 Hz, 0.53H), 4.70 (t, J = 1.8 Hz, 
0.53H), 4.58 (s, 0.53H), 4.51 (d, J = 2.1 Hz, 0.47H), 4.44 (d, J = 15.3 Hz, 0.53H), 4.08 (d, J = 
15.1 Hz, 0.47H), 2.60 (dt, J = 16.2 Hz, J = 2.2 Hz, 0.53H), 2.37 (s, 1.59H), 2.33 (s, 1.41H), 2.19 
(dt, J = 16.2 Hz, J = 2.2 Hz, 0.53H), 1.84 (s, 1.41H), 1.71 (s, 1.59H) 1.61 (d, J = 1.8 Hz, 1.41H); 
13C  NMR  (125 MHz, CDCl3) δ [14.0], 15.8, [18.0], 21.6, [21.7], 38.7, [47.3], 48.3, 49.1, [54.0], 
[63.6], 64.4, 107.9, [121.3], 121.8, [122.4], 123.0, [125.4], 127.3, 127.5, [127.7], 128.1 (2C), 
[128.3 (2C)], 128.6 (2C), [128.7 (2C)], [134.4], 135.7, 136.5, 136.9, [137.2], [137.6], 139.8, 
141.2, [143.7], [144.8], [147.0], [174.7], 174.8; Values in brackets are for the minor isomer 
3.4e’; IR (cm-1) 1672, 1495, 700; HRMS (ES+) calcd for C21H22NO  (M+H)+ 304.1701, found 
304.1698. 
 
 
(1S,4R)-12-benzyl-4-methyl-2-methylene-1,2,3,4-tetrahydro-1,4-
(epiminomethano)phenanthren-11-one (3.4f) and (1S,4R)-12-benzyl-2,4-dimethyl-1,4-
dihydro-1,4-(epiminomethano)phenanthren-11-one (3.4f’).  Treatment of amide 3.2f (235 mg, 
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0.56 mmol, 1.0 equiv), sodium carbonate (62 mg, 0.58 mmol, 1.0 equiv) and 
tetrabutylammonium chloride (160 mg, 0.57 mmol, 1.0 equiv) with palladium acetate (13 mg, 
0.057 mmol, 0.1 equiv) in DMF (7 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 9) afforded 
azabicyclooctanes 3.4f and 3.4f’ (123 mg, 65%) as a yellow solid, as a 2.3 : 1.0 mixture of 3.4f : 
3.4f’ (by 1H NMR): mp 110-120 oC; Rf = 0.52 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, 
CDCl3) δ 8.69 (d, J = 8.8 Hz, 0.7H), 8.65 (d, J = 8.9 Hz, 0.3H), 7.84 (d, J = 8.2 Hz, 0.7H), 7.82 
(d, J = 7.7 Hz, 0.3H), 7.68 (d, J = 8.1 Hz, 0.7H), 7.59 (d, J = 8.0 Hz, 0.3H), 7.50 (ddd, J = 8.5 
Hz, J = 6.8 Hz, J = 1.6 Hz, 0.7H), 7.48-7.42 (m, 1H), 7.37 (ddd, J = 8.0 Hz, J = 6.8 Hz, J = 0.9 
Hz, 0.3H), 7.30-7.28 (m, 1H), 7.25-7.22 (m, 2.4H), 7.14-7.12 (m, 1H), 7.11 (s, 0.3H), 7.09-7.07 
(m, 1.3), 6.16 (p, J = 2.0 Hz, 0.3H), 4.97 (t, J = 2.3 Hz, 0.7H), 4.90 (d, J = 15.3 Hz, 0.7H), 4.79 
(d, J = 15.1 Hz, 0.3H), 4.75 (t, J = 1.9 Hz, 0.7H), 4.69 (s, 0.7H), 4.64 (d, J = 2.3 Hz, 0.3H), 4.41 
(d, J = 15.3 Hz, 0.7H), 4.23 (d, J = 15.1 Hz, 0.3H), 2.62 (dt, J = 16.4 Hz, J = 2.2 Hz, 0.7H), 2.48 
(dt, J = 16.4 Hz, J = 2.2 Hz, 0.7H), 2.44 (s, 0.9H), 2.32 (s, 2.1H), 1.67 (d, J = 1.8 Hz, 0.9H); 13C  
NMR  (125 MHz, CDCl3) δ [18.0], [20.1], 21.9, 40.4, 48.3, [49.4], 51.1, [57.8], [64.8], 65.4, 
108.1, [121.0], 121.3, [124.0], 124.4, [124.7], 125.1, [126.3], 126.4, [126.9], 127.6, 127.7, 128.1 
(2C), [128.4 (2C)], [128.5], 128.6 (2C), [128.8 (2C)], [129.5], 129.7, 130.9, [130.9], [133.2], 
134.3, 135.0, 136.8, [137.0], 138.8, [139.6], [142.8], 143.0, 146.8, 174.9, [175.0]; Values in 
brackets are for the minor isomer 3.4f’; IR (cm-1) 1668, 1607, 735; HRMS (ES+) calcd for 
C24H21NONa (M+Na)+ 362.1521, found 362.1521. 
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(1S,4R)-10-benzyl-4-methyl-2-methylene-1,2,3,4-tetrahydro-1,4-
(epiminomethano)naphthalen-9-one (3.4g) and (1S,4R)-10-benzyl-2,4-dimethyl-1,4-
dihydro-1,4-(epiminomethano)naphthalen-9-one (3.4g’).  Treatment of amide 3.2g (206 mg, 
0.56 mmol, 1.0 equiv), sodium carbonate (60 mg, 0.57 mmol, 1.0 equiv) and 
tetrabutylammonium chloride (155 mg, 0.56 mmol, 1.0 equiv) with palladium acetate (13 mg, 
0.056 mmol, 0.1 equiv) in DMF (7 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 9) afforded 
azabicyclooctanes 3.4g and 3.4g’ (145 mg, 90%) as a yellow oil, as a 1.0 : 1.0 mixture of 3.4g : 
3.4g’ (by 1H NMR): Rf = 0.57 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.32-7.28 
(m, 3H), 7.26-7.24 (m, 1.5H), 7.18-7.15 (m, 0.5H), 7.14-7.11 (m, 1.5H), 7.09-7.08 (m, 1.5H), 
7.06 (dd, J = 7.2 Hz, J = 1.0 Hz, 0.5H) 7.02 (d, J = 7.3, 0.5H), 6.04 (p, J = 1.9 Hz, 0.5H), 4.91 (t, 
J = 2.3 Hz, 0.5H), 4.83 (d, J = 15.1 Hz, 0.5H), 4.77 (d, J = 15.3 Hz, 0.5H), 4.73 (t, J = 1.8 Hz, 
0.5H), 4.62 (s, 0.5H), 4.54 (d, J = 2 Hz, 0.5H), 4.45 (d, J = 15.3 Hz, 0.5H), 4.11 (d, J = 15.1 Hz, 
0.5H), 2.62 (dt, J = 16.3 Hz, J = 2.1 Hz, 0.5H), 2.21 (dt, J = 15.7 Hz, J = 2.2 Hz, 0.5H), 1.86 (s, 
1.5H), 1.73 (s, 1.5H) 1.62 (d, J = 1.8 Hz, 1.5H); 13C NMR (125 MHz, CDCl3) δ [14.0], 15.8, 
[18.0], 38.6, 47.4, 48.3, [49.1], [54.1], [63.9], 64.7, 108.3, 121.3, [121.5], 122.0, [122.2], 125.2, 
[125.9], 126.9, [127.5], 127.7, [127.8], 128.1 (2C), [128.3 (2C)], 128.6 (2C), [128.7 (2C)], 
[134.5], 136.8, [137.1], [139.3], 141.3, [142.5], [143.5], 144.7, 146.7, 174.6, [174.7]; Values in 
brackets are for the endo isomer 3.4g’; IR (cm-1) 1672, 1605, 748, 733; HRMS (ES+) calcd for 
C20H20NO (M+H)+ 290.1545, found 290.1531. 
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(1S,4R)-10-benzyl-7-fluoro-4-methyl-2-methylene-1,2,3,4-tetrahydro-1,4-
(epiminomethano)naphthalen-9-one (3.4h) and (1S,4R)-10-benzyl-7-fluoro-2,4-dimethyl-
1,4-dihydro-1,4-(epiminomethano)naphthalen-9-one (3.4h’).  Treatment of amide 3.2h (245 
mg, 0.63 mmol, 1.0 equiv), sodium carbonate (67 mg, 0.63 mmol, 1.0 equiv) and 
tetrabutylammonium chloride (176 mg, 0.63 mmol, 1.0 equiv) with palladium acetate (14 mg, 
0.062 mmol, 0.1 equiv) in DMF (8 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 9) afforded 
azabicyclooctanes 3.4h and 3.4h’ (129 mg, 66%) as an orange oil, as a 1.2 : 1.0 mixture of 3.4g : 
3.4h’ (by 1H NMR): Rf = 0.50 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.30-7.27 
(m, 2H), 7.26 (d, J = 1.8 Hz, 1H), 7.23 (dd, J = 8.4 Hz, J = 5.0 Hz, 0.53H), 7.18 (dd, J = 9.0 Hz, 
J = 5.0 Hz, 0.47H), 7.11 (dd, J = 7.8 Hz, J = 2.1 Hz, 0.94H), 7.07 (dd, J = 7.7 Hz, J = 2.8 Hz, 
1.06H), 6.96 (ddd, J = 9.2 Hz, J = 8.4 Hz, J = 2.6 Hz, 0.53H), 6.81-6.77 (m, 0.94H), 6.73 (dd, J 
= 8.0 Hz, J = 2.5 Hz, 0.53H), 6.05 (p, J = 1.8 Hz, 0.47H), 4.93 (t, J = 2.4 Hz, 0.53H), 4.81 (d, J = 
2.7 Hz, 0.47H), 4.77 (d, J = 2.4 Hz, 0.53H), 4.76 (t, J = 2.0 Hz, 0.53H), 4.57 (s, 0.53H), 4.50 (d, 
J = 2.1 Hz, 0.47H), 4.41 (d, J = 15.2 Hz, 0.53H), 4.15 (d, J = 15.1 Hz, 0.47H), 2.61 (dt, J = 16.3 
Hz, J = 2.2 Hz, 0.53H), 2.19 (dt, J = 16.2 Hz, J = 2.2 Hz, 0.53H), 1.84 (s, 1.41H), 1.71 (s, 1.59H) 
1.63 (d, J = 1.8 Hz, 1.41H); 13C NMR (125 MHz, CDCl3) δ [14.1], 16.0, [18.0], 38.5, 47.1, 48.3, 
[49.2], [53.7], [63.5], 64.3, 109.0, [109.8 (d, J = 22.5 Hz)], 110.0 (d, J = 23.8 Hz), [111.6 (d, J = 
21.3 Hz)], 111.1 (d, J = 21.3 Hz), [122.2 (d, J = 8.8 Hz)], 123.7 (d, J = 7.5 Hz), 127.7, [127.85], 
128.1 (2C), [128.4 (2C)], 128.7 (2C), [128.8 (2C)], 136.6, [136.88], 136.9 (d, J = 2.5 Hz), [140.3 
(d, J = 2.5 Hz)], [141.1 (d, J = 7.5 Hz)], 142.9, 144.6 (d, J = 7.5 Hz), [146.4], 160.3 (d, J = 113.8 
Hz), [162.3 (d, J = 113.8 Hz)], 174.4; Values in brackets are for the minor isomer 3.4h’; IR (cm-
1) 1672, 1603, 733, 700; HRMS (ES+) calcd for C20H19FNO (M+H)+ 308.1451, found 308.1446. 
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(1S,4R)-10-benzyl-8-fluoro-4-methyl-2-methylene-1,2,3,4-tetrahydro-1,4-
(epiminomethano)naphthalen-9-one (3.4i) and (1S,4R)-10-benzyl-8-fluoro-2,4-dimethyl-1,4-
dihydro-1,4-(epiminomethano)naphthalen-9-one (3.4i’).  Treatment of amide 3.2i (96 mg, 
0.25 mmol, 1.0 equiv), sodium carbonate (27 mg, 0.26 mmol, 1.0 equiv) and 
tetrabutylammonium chloride (70 mg, 0.25 mmol, 1.0 equiv) with palladium acetate (6 mg, 
0.024 mmol, 0.1 equiv) in DMF (4 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 9) afforded pure 
azabicyclooctanes 3.4i (30 mg, 38%) as a light yellow oil, and pure azabicyclooctanes 3.4i’ (41.8 
mg, 54%) as a clear oil. 
Analytical data for 3.4i: mp 65-67 oC; Rf = 0.5 (EtOAc/hexane 1 : 2.3); 1H NMR (500 MHz, 
CDCl3) δ 7.29-7.26 (m, 1H), 7.26-7.21 (m, 3H), 7.12-7.10 (m, 2H), 7.07 (d, J = 7.6 Hz, 1H), 
6.89 (dt, J = 8.5 Hz, J = 0.8 Hz, 1H), 5.02 (s, 1H), 4.96 (t, J = 2.4 Hz, 1H), 4.75 (t, J = 2.0 Hz, 
1H), 4.72 (d, J = 15.1 Hz, 1H), 4.49 (d, J = 15.1 Hz, 1H), 2.62 (dt, J = 16.3 Hz, J = 2.2 Hz, 1H), 
2.21 (dt, J = 16.3 Hz, J = 2.2 Hz, 1H), 1.72 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 16.0, 38.3, 
47.8, 48.6, 57.9, 108.9, 113.9 (d, J = 20 Hz), 118.0 (d, J = 3.8 Hz), 125.8 (d, J = 18.8 Hz), 127.6, 
128.1 (2C), 128.7 (2C), 129.1 (d, J = 7.5 Hz), 136.5, 142.2, 144.4 (d, J = 5 Hz), 155.8 (d, J = 
246.3 Hz), 174.3; IR (cm-1) 1676, 1622, 700; HRMS (ES+) calcd for C20H19FNO (M+H)+ 
308.1451, found 308.1450. 
Analytical data for 3.4i’: Rf = 0.55 (EtOAc/hexane 1 : 2.3); 1H NMR (500 MHz, CDCl3) δ 7.33-
7.28 (m, 3H), 7.14 (dd, J = 7.9 Hz, J = 2.0 Hz, 2H), 7.08-7.06 (m, 2H), 6.81-6.77 (m, 1H), 6.05 
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(p, J = 1.9 Hz, 1H), 4.96 (d, J = 2.1 Hz, 1H), 4.83 (d, J = 15.0 Hz, 1H), 4.12 (d, J = 15.0 Hz, 1H), 
1.86 (s, 3H), 1.62 (d, J = 1.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 14.2, 17.9, 49.3, 54.5, 
57.2, 113.0 (d, J = 21.3 Hz), 117.2 (d, J = 2.5 Hz), 127.4 (d, J = 7.5 Hz), 127.8, 128.4 (2C), 128.5 
(d, J = 20 Hz), 128.8 (2C), 134.8, 136.8, 146.4, 148.4 (d, J = 5 Hz), 156.0 (d, J = 243.8 Hz), 
174.5; IR (cm-1) 1682, 1622, 700; HRMS (ES+) calcd for C20H19FNO (M+H)+ 308.1451, found 
308.1442. 
 
 
(1S,4R)-10-benzyl-7-chloro-4-methyl-2-methylene-1,2,3,4-tetrahydro-1,4-
(epiminomethano)naphthalen-9-one (3.4j) and (1S,4R)-10-benzyl-7-chloro-2,4-dimethyl-
1,4-dihydro-1,4-(epiminomethano)naphthalen-9-one (3.4j’).  Treatment of amide 3.2j (225 
mg, 0.56 mmol, 1.0 equiv), sodium carbonate (60 mg, 0.57 mmol, 1.0 equiv) and 
tetrabutylammonium chloride (154 mg, 0.55 mmol, 1.0 equiv) with palladium acetate (13 mg, 
0.056 mmol, 0.1 equiv) in DMF (7 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/hexane (1 : 9) afforded 
azabicyclooctanes 3.4j and 3.4j’ (145 mg, 80%) as a yellow oil, as a 1.1 : 1.0 mixture of 3.4j : 
3.4j’ (by 1H NMR): Rf = 0.58 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.33-7.27 
(m, 3H), 7.24 (d, J = 2.1 Hz, 0.48H), 7.21 (d, J = 8.1 Hz, 0.52H), 7.17 (d, J = 7.9 Hz, 0.52H), 
7.12-7.07 (m, 2.52H), 7.04 (d, J = 2.0 Hz, 0.48H), 7.00 (d, J = 2.0 Hz, 0.48H), 6.03 (p, J = 1.9 
Hz, 0.48H), 4.92 (t, J = 2.4 Hz, 0.52H), 4.81 (d, J = 15 Hz, 0.48H), 4.76-4.75 (m, 0.74H), 4.73, 
(s, 0.30H), 4.57 (s, 0.52H), 4.49 (d, J = 2.0 Hz, 0.48H), 4.44 (d, J = 15.2 Hz, 0.48H), 4.11 (d, J = 
14.8 Hz, 0.52H), 2.61 (dt, J = 16.3 Hz, J = 2.2 Hz, 0.52H), 2.18 (dt, J = 16.3 Hz, J = 2.2 Hz, 
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0.52H), 1.83 (s, 1.44H), 1.71 (s, 1.56H) 1.61 (d, J = 1.8 Hz 1.44H); 13C NMR (125 MHz, CDCl3) 
δ [13.9], 15.8, [18.0], 38.3, 47.2, 48.4, [49.2], [53.9], [63.3], 64.1, 109.0, [122.1], [122.3], 
[122.4], 123.6, [125.6], 127.71, [127.72], 127.9, 128.1 (2C), [128.4 (2C)], 128.7 (2C), [128.8 
(2C)], 133.1, [132.6], 134.5, [136.5], 136.8, [139.8], 140.9, 142.7, [143.3], [144.3], 146.4, 
174.19, [174.22]; Values in brackets are for the minor isomer 3.4j’; IR (cm-1) 1672, 1404, 737, 
700; HRMS (ES+) calcd for C20H19ClNO (M+H)+ 324.1155, found 324.1144. 
 
 
(4R,7S)-8-benzyl-4-methyl-6-methylene-4,5,6,7-tetrahydro-7,4-
(epiminomethano)benzo[b]thiophen-9-one (3.4l).  Treatment of amide 3.2l (300 mg, 0.80 
mmol, 1.0 equiv), sodium carbonate (85 mg, 0.80 mmol, 1.0 equiv) and tetrabutylammonium 
chloride (223 mg, 0.80 mmol, 1.0 equiv) with palladium acetate (18 mg, 0.080 mmol, 0.1 equiv) 
in DMF (8 mL) according to the general procedure described above, followed by flash 
chromatography over silica eluting with EtOAc/hexane (1 : 9) afforded pure azabicyclooctanes 
3.4l (28 mg, 12%) as a light yellow oil: Rf = 0.40 (EtOAc/hexane 1 : 1.5); 1H NMR (500 MHz, 
CDCl3) δ 7.33 – 7.31 (d, J = 7.5 Hz, 0.5H), 7.29 – 7.28 (m, 0.5H), 7.28 – 7.27 (m, 1H), 7.24 (t, J 
= 1.0 Hz, 1H), 7.11 (d, J = 1.9 Hz, 1H), 7.09 (d, J = 4.9 Hz, 2H), 6.92 (d, J = 4.9 Hz, 1H), 4.86 
(t, J = 2.2 Hz, 1H), 4.81 (s, 0.5H), 4.79 (s, 1H), 4.78 (s, 0.5H), 4.71 (t, J = 1.8 Hz, 1H), 4.39 (d, J 
= 15.3 Hz, 1H), 2.56 (dt, J = 15.9 Hz, J = 2.0 Hz, 1H), 2.22 (dt, J = 15.9 Hz, J = 2.1 Hz, 1H), 
1.74 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 16.5, 38.7, 47.4, 48.4, 61.0, 107.5, 122.1, 124.2, 
127.6, 128.0 (2C), 128.7 (2C), 136.8, 137.0, 143.6, 145.8, 175.3; IR (cm-1) 1674, 1452, 729, 698; 
HRMS (ES+) calcd for C18H17NOSNa (M+Na)+ 318.0929, found 318.0919. 
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(5S,8R)-11-benzyl-8-methyl-6-vinyl-5,6,7,8-tetrahydro-5,8-(epiminomethano)naphtho[2,3-
d][1,3]dioxol-10-one (3.4m). Treatment of amide 3.2m (112 mg, 0.26 mmol, 1.0 equiv), sodium 
carbonate (28 mg, 0.26 mmol, 1.0 equiv) and tetrabutylammonium chloride (72 mg, 0.26 mmol, 
1.0 equiv) with palladium acetate (6 mg, 0.027 mmol, 0.1 equiv) in DMF (3 mL) according to 
the general procedure described above, followed by flash chromatography over silica eluting 
with EtOAc/hexane (1 : 9) afforded pure azabicyclooctane 3.4m (20 mg, 22%) as a clear oil and 
a complex mixture of 3.4m’ and 3.4m” (41 mg, 45%) as a clear oil. 
Analytical data for 3.4m: Rf = 0.49 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 
1H NMR (500 MHz, CDCl3) δ 7.30 (d, J = 2.7 Hz, 0.5H), 7.28 (s, 1H), 7.27 (t, J = 1.4 Hz, 1H), 
7.25 (d, J = 0.5 Hz, 0.5H), 7.13 (d, J = 1.9 Hz, 1H), 7.12 (d, J = 1.9 Hz, 1H), 6.79 (s, 1H), 6.47 
(s, 1H), 5.94 (dd, J = 6.0 Hz, J = 1.5Hz, 2H), 4.97 (ddd, J = 17.2 Hz, J = 9.9 Hz, J = 8.4 Hz, 1H), 
4.87 (dd, J = 2.0 Hz, 0.5 Hz, 0.5H), 4.83 (t, J = 2.1 Hz, 1H), 4.81 (dd, J = 2.0 Hz, J = 0.5 Hz, 
0.5H), 4.65 (d, J = 15.0 Hz, 1H), 4.50 (d, J = 15.0 Hz, 1H), 4.12 (d, J = 3.3 Hz, 1H), 2.79 (sept, J 
= 5.0 Hz, 1H), 2.13 (dd, J = 12.9 Hz, J = 9.8 Hz, 1H), 1.64 (s, 3H), 1.17 (dd, J = 12.9 Hz, J = 4.7 
Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 16.5, 38.9, 44.6, 46.7, 48.5, 62.0, 101.1, 103.6, 105.3, 
115.9, 127.6, 128.2 (2C), 128.7 (2C), 131.2, 135.9, 137.1, 140.0, 145.8, 147.2, 174.9; IR (cm-1) 
1668, 1622, 1040; HRMS (ES+) calcd for C22H22NO3 (M+H)+ 348.1600, found 348.1591. 
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(5R,7S,8S)-11-benzyl-8-methyl-6-methylene-10-oxo-5,6,7,8-tetrahydro-5,8-
(epiminomethano)naphtho[2,3-d][1,3]dioxol-7-yl acetate (3.5). A solution of azabicyclooctane 
3.4b and 3.4b’ (207 mg, 0.62 mmol, 1.0 equiv) in acetic acid (3 mL) was injected into a reaction 
vessel containing the solid reagents including benzoquinone (7 mg, 0.065 mmol, 0.1 equiv) and 
palladium acetate (7 mg, 0.033 mmol, 0.05 equiv).  30% hydrogen peroxide (78 L, 2.55 mmol, 
4.1 equiv) was added by syringe and the resulting mixture was stirred at 75 oC for 43.5h, cooled 
to room temperature, diluted with water (10 mL) and extracted with ethyl acetate (3x30 mL).  
The combined organic phase was washed with water (2x40 mL) and brine (2x40 mL).  The 
organic phase was dried (MgSO4) and concentrated under reduced pressure to afford the crude 
product.  The crude product was purified by flash chromatography over silica eluting with 
EtOAc/hexane (1:4) to afford azabicyclooctane 3.5 (73 mg, 30%) as yellow heavy oil and 
recovered starting material 3.4b and 3.4b’ (38%) with isomer ratio retained: 
Analytical data for 3.5: Rf = 0.40 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.26-
7.27 (m, 3H), 7.13-7.15 (m, 2H), 6.83 (s, 1H), 6.49 (s, 1H), 5.96 (d, J = 1.4, 1H), 5.93 (d, J = 1.5, 
1H), 5.37 (s, 1H), 5.01 (d, J = 1.5 Hz, 1H), 4.94 (d, J = 1.8 Hz, 1H), 4.72 (d, J = 15.2 Hz, 1H), 
4.58 (d, J = 15.3 Hz, 1H), 4.51 (s, 1H), 2.15 (s, 3H), 1.61 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
12.9, 21.3, 48.6, 51.5, 63.0, 73.9, 101.5, 103.6, 105.4, 112.0, 127.7, 128.3 (2C), 128.6 (2C), 
131.4, 133.8, 136.5, 143.9, 147.0, 147.6, 171.2, 171.7; IR (cm-1) 1740, 1672, 700; HRMS (ES+) 
calcd for C23H21NO5Na (M+Na)+ 414.1317, found 414.1319. 
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(5S,8R)-11-benzyl-6,8-dimethyl-5,6,7,8-tetrahydro-5,8-(epiminomethano)naphtho[2,3-
d][1,3]dioxol-10-one (3.6).  
Preparation of azabicyclooctane 3.6 via reduction with Pd on carbon. A solution of 
azabicyclooctane 3.4b and 3.4b’ (193 mg, 0.58 mmol, 1.0 equiv) in MeOH (6 mL) was injected 
into a reaction vessel containing Pd/C (7.1 mg, 0.067 mmol, 0.1 equiv) in MeOH (14 mL).  The 
flask was flushed with argon, H2 then stirred overnight at room temperature unger H2 (1 atm).  
The resulting solution was filtered through celite to afford a diastereomeric mixture of 
azabicyclooctane 3.6 (156 mg, 80%) as a light yellow oil. 
Preparation of azabicyclooctane 3.6 via reduction with Crabtree’s Ir catalyst. A solution of 
azabicyclooctane 3.4b and 3.4b’ (18 mg, 0.055 mmol, 1.0 equiv) in DCM (2 mL) was injected 
into a reaction vessel containing Crabtree’s Ir catalyst (3.9 mg, 0.0048 mmol, 0.09 equiv) in 
DCM (2 mL).  The flask was flushed with argon, H2 then stirred overnight at room temperature 
unger H2 (1 atm).  The resulting solution was filtered through celite to afford a diastereomeric 
mixture of azabicyclooctane 3.6 (17 mg, 94%) as a light yellow oil. 
Analytical data for 3.6 obtained via reduction with Pd on carbon. Rf = 0.50 (EtOAc/hexane 1 
: 1); 1H NMR (500 MHz, CDCl3) δ 7.27 (d, J = 2.6 Hz, 0.57H), 7.25 (d, J = 1.7 Hz, 0.43H), 7.24 
(d, J = 2.1 Hz, 0.86H), 7.23 (d, J = 1.8 Hz, 1.14H), 7.11 (dd, J = 7.8 Hz, J = 1.6 Hz, 1.14H), 7.06 
– 7.03 (m, 0.86H), 6.78 (s, 0.57H), 6.77 (s, 0.43H), 6.51 (s, 0.57H), 6.40 (s, 0.43H), 5.94 (d, J = 
1.5 Hz, 0.57H), 5.93 (dd, J = 1.5 Hz, J = 0.6 Hz, 1H), 5.90 (d, J = 1.5 Hz, 0.43H), 5.04 (d, J = 
14.9 Hz, 0.43H), 4.63 (d, J = 15.1 Hz, 0.57H), 4.48 (d, J = 15.1 Hz, 0.57H), 4.18 (d, J = 14.9 Hz, 
0.43H), 4.03 (d, J = 1.6 Hz, 0.43H), 4.00 (d, J = 3.2 Hz, 0.57H), 2.29 – 2.23 (m, 0.57H), 2.10 
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(dd, J = 12.5 Hz, J = 9.7 Hz, 0.43H), 1.90 – 1.85 (m, 0.43H), 1.71 (dd, J = 12.6 Hz, J = 9.8 Hz, 
0.43H), 1.64 (s, 1.29H), 1.61 (s, 1.71H), 1.29 (dd, J = 13 Hz, J = 4.5 Hz, 0.57H), 1.00 (d, J = 6.9 
Hz, 1.29H), 0.85 (dd, J = 12.5 Hz, J = 4.7 Hz, 0.57H), 0.57 (d, J = 6.9 Hz, 1.71H); 13C NMR 
(125 MHz, CDCl3) δ [16.5], 16.6, [19.7], 20.2, 34.2, [35.1], [39.9], 40.5, [46.7], 46.8, 48.4, 
[50.2], 62.7, [63.0], [101.05], 101.08, [103.4], 103.6, [104.0], 105.5, 127.5, [127.6], 128.1 (2C), 
[128.5 (2C)], [128.6 (2C)], 128.7 (2C), 131.4, [134.8], 135.5, [135.7], [136.9], 137.2, 145.7 (2C), 
[146.7], [147.0], 175.0, [175.2] Values in brackets are for the minor isomer; IR (cm-1) 1666, 
1589, 737; HRMS (ES+) calcd for C21H21NO3Na (M+Na)+ 358.1419, found 358.1426. 
Analytical data for 3.6 obtained via reduction with Crabtree’s Ir catalyst. Rf = 0.50 
(EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.27 (d, J = 2.6 Hz, 0.40H), 7.25 (d, J = 1.7 
Hz, 0.60H), 7.24 (d, J = 2.1 Hz, 1.2H), 7.23 (d, J = 1.8 Hz, 0.8H), 7.11 (dd, J = 7.8 Hz, J = 1.6 
Hz, 0.8H), 7.06 – 7.03 (m, 1.2 H), 6.78 (s, 0.4H), 6.77 (s, 0.6H), 6.51 (s, 0.4H), 6.40 (s, 0.6H), 
5.94 (d, J = 1.5 Hz, 0.4H), 5.93 (dd, J = 1.5 Hz, J = 0.6 Hz, 1H), 5.90 (d, J = 1.5 Hz, 0.6H), 5.04 
(d, J = 14.9 Hz, 0.6H), 4.63 (d, J = 15.1 Hz, 0.4H), 4.48 (d, J = 15.1 Hz, 0.4H), 4.18 (d, J = 14.9 
Hz, 0.6H), 4.03 (d, J = 1.6 Hz, 0.6H), 4.00 (d, J = 3.2 Hz, 0.4H), 2.29 – 2.23 (m, 0.4H), 2.10 (dd, 
J = 12.5 Hz, J = 9.7 Hz, 0.6H), 1.90 – 1.85 (m, 0.6H), 1.71 (dd, J = 12.6 Hz, J = 9.8 Hz, 0.6H), 
1.64 (s, 1.8H), 1.61 (s, 1.2H), 1.29 (dd, J = 13.0 Hz, J = 4.5 Hz, 0.4H), 1.00 (d, J = 6.9 Hz, 
1.8H), 0.85 (dd, J = 12.5 Hz, J = 4.7 Hz, 0.4H), 0.57 (d, J = 6.9 Hz, 1.2H); 13C NMR (125 MHz, 
CDCl3) δ 16.5, [16.6], 19.7, [20.2], [34.2], 35.1, 39.9, [40.5], 46.7, [46.8], [48.4], 50.2, [62.7], 
63.0, 101.05, [101.08], 103.4, [103.6], 104.0, [105.5], [127.5], 127.6, [128.1 (2C)], 128.5 (2C), 
128.6 (2C), [128.7 (2C)], [131.4], 134.8, [135.5], 135.7, 136.9, [137.2], [145.7 (2C)], 146.7, 
147.0, [175.0], 175.2 Values in brackets are for the minor isomer; IR (cm-1) 1666, 1479, 737; 
HRMS (ES+) calcd for C21H21NO3Na (M+Na)+ 358.1419, found 358.1426. 
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(1S,4R)-10-benzyl-2,4-dimethyl-1,2,3,4-tetrahydro-1,4-(epiminomethano)naphthalen-9-one 
(3.7).  A solution of azabicyclooctane 3.4e and 3.4e’ (24 mg, 0.080 mmol, 1.0 equiv) in DCM (2 
mL) was injected into a reaction vessel containing Crabtree’s Ir catalyst (7.0 mg, 0.0087 mmol, 
0.11 equiv) in DCM (2 mL).  The flask was flushed with argon, H2 then stirred overnight at room 
temperature unger H2 (1 atm).  The resulting solution was filtered through celite to afford a 
diastereomeric mixture of azabicyclooctane 3.7 (24 mg, 99%) as a light yellow oil: Rf = 0.51 
(EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.26 (s, 0.34H), 7.25 (t, J = 1.9 Hz, 0.68H), 
7.22 – 7.21 (m, 2.28H), 7.12 (dd, J = 8.0 Hz, J = 2.0 Hz, 0.68H), 7.07 (s, 1H), 7.03 (dd, J = 6.5 
Hz, J = 2.9 Hz, 1.52H), 6.96 (d, J = 7.2 Hz, 0.34H), 6.91 (d, J = 7.4 Hz, 0.76H), 6.88 (d, J = 7.4 
Hz, 0.34H), 6.78 (d, J = 7.4 Hz, 0.76H), 5.00 (d, J = 14.9 Hz, 0.76H), 4.57 (q, J = 15.1 Hz, 
0.68H), 4.24 (d, J = 14.9 Hz, 0.76H), 4.11 (d, J = 1.4 Hz, 0.76H), 4.06 (d, J = 3.1 Hz, 0.34H), 
2.37 (s, 1.02H), 2.35 (s, 2.28H), 2.30-2.24 (m, 0.34H), 2.14 (dd, J = 12.5 Hz, J = 9.8 Hz, 0.34H), 
1.91-1.86 (m, 0.76H), 1.74 (dd, J = 12.6 Hz, J = 9.9 Hz, 0.76H), 1.66 (s, 2.28H), 1.65 (s, 1.02H), 
1.32 (dd, J = 12.6 Hz, J = 4.5 Hz, 0.76H), 1.00 (d, J = 6.9 Hz, 2.28H), 0.88 (dd, J = 12.5 Hz, J = 
4.8 Hz, 0.34H), 0.55 (d, J = 6.9 Hz, 0.34H); 13C NMR (125 MHz, CDCl3) δ 16.17, [16.24], 19.8, 
[20.2], 21.67, [21.72], [34.1], 35.0, 39.9, [40.6], 46.7, [46.8], [48.5], 50.2, [62.5], 62.8, 121.3, 
[122.4], 122.9, [123.7], [126.5 (2C)], 126.6, 127.5, [128.2 (2C)], 128.5 (2C), 128.57 (2C), 
[128.60 (2C)], [134.9], 136.9, 137.0, [137.2], [137.4], 138.9, 141.0, [141.9], [175.1], 175.2 
Values in brackets are for the minor isomer; IR (cm-1) 1664, 1454, 733; HRMS (ES+) calcd for 
C21H24NO (M+H)+ 306.1858, found 306.1857. 
152 
 
 
 
(5S,8R,E)-11-benzyl-6-(4-bromobutylidene)-8-methyl-5,6,7,8-tetrahydro-5,8-
(epiminomethano)naphtho[2,3-d][1,3]dioxol-10-one (3.9) . A solution of azabicyclooctane 
3.4b (39 mg, 0.12 mmol, 1.0 equiv) in dichloromethane (5 mL) was injected into a pressure tube 
containing the Ru catalyst (Grubbs Catalyst, 2nd Generation) (5 mg, 0.0059 mmol, 0.05 equiv), 
followed by injecting neat 5-bromo-1-pentene (21 L, 0.18 mmol, 1.5 equiv).  The pressure tube 
was flushed with argon, sealed and the resulting mixture stirred at 40 oC for 19h.  The crude 
product was purified by prep-TLC to afford 3.9 (35 mg, 66%) as a clear colorless oil: Rf = 0.41 
(EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.29-7.27 (m, 2H), 7.26-7.25 (m, 1H), 7.11 
(dd, J = 8.0 Hz, J = 1.9 Hz, 2H), 6.81 (s, 1H), 6.53 (s, 1H), 5.94 (d, J = 1.5 Hz, 1H), 5.91 (d, J = 
1.5 Hz, 1H), 5.14 (dt, J = 7.1 Hz, J = 2.1 Hz, 1H), 4.62 (d, J = 15.2 Hz, 1H), 4.51 (d, J = 15.2 
Hz, 1H), 4.45 (s, 1H), 3.25 (dd, J = 6.6 Hz, J = 2.3 Hz, 2H), 2.46 (d, J = 16.1 Hz, 1H), 2.10 (d, J 
= 16.1 Hz, 1H), 2.02-1.93 (m, 2H), 1.79 (p, J = 6.9 Hz, 2H), 1.70 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 16.5, 27.1, 32.0, 33.2, 36.7, 47.3, 48.3, 64.7, 101.2, 103.6, 104.1, 121.2, 127.6, 128.2 
(2C), 128.6 (2C), 133.2, 135.2, 136.5, 136.9, 146.1, 147.1, 174.7; IR (cm-1) 1666, 1494, 1037; 
HRMS (ES+) calcd for C24H24BrNO3Na (M+Na)+ 476.0837, found 476.0847. 
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Preparation of N-benzyl-N-((E)-4-((5S,8R)-11-benzyl-8-methyl-10-oxo-7,8-dihydro-5,8-
(epiminomethano)naphtho[2,3-d][1,3]dioxol-6(5H)-ylidene)butyl)-4-
methylbenzenesulfonamide (3.10a). A solution of alkyl bromide 3.9 (35 mg, 0.077 mmol, 1.0 
equiv) in dry DMF (2 mL) was added dropwise at room temperature under nitrogen to a mixture 
of N-benzyl-4-methylbenzenesulfonamide (30 mg, 0.12 mmol, 1.0 equiv) and anhydrous K2CO3 
(28 mg, 0.20 mmol, 2.6 equiv) in dry DMF (1 ml).  The reaction mixture was stirred at 60 oC for 
21.5 h and the crude product purified by preparative TLC to afford 3.10a (46 mg, 94%) as a clear 
oil: Rf = 0.41 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.68 (d, J = 6.6 Hz, 1H), 7.30 
(d, J = 6.4 Hz, 2H), 7.29 (s, 1H), 7.28 (s, 2H), 7.24 (d, J = 2.0 Hz, 1H), 7.23 (d, J = 1.0 Hz, 2H), 
7.22 (d, J = 1.6 Hz, 2H), 7.05 (d, J = 2.8 Hz, 1H), 7.03 (d, J = 1.4 Hz, 1H), 6.79 (s, 1H), 6.47 (s, 
1H), 5.92 (dd, J = 12.8 Hz, J = 1.2 Hz, 2H), 4.98 (dt, J = 5.6 Hz, J = 1.6 Hz, 2H), 4.71 (d, J = 
5.6, 1H), 4.35 (s, 1.5H), 4.31 (s, 0.5H), 4.23 (q, J = 9.6 Hz, 2H), 2.97 (t, J = 6.0, 2H) 3.44 (s, 
3H), 2.24 (d, J = 12.8, 1H), 1.90 (d, J = 12.8, 1H), 1.67 (s, 3H), 1.64-1.58 (m, 2H), 1.30-1.23 (m, 
2H); 13C NMR δ 16.5, 21.7, 25.8, 27.8, 36.6, 47.3, 48.12, 48.13, 52.5, 64.6, 101.2, 103.6, 104.1, 
122.0, 127.3 (2C), 127.5, 128.0, 128.1 (2C), 128.4 (2C), 128.6 (2C), 128.7 (2C), 129.9 (2C), 
133.3, 135.3, 135.5, 136.6, 136.8, 136.9, 143.4, 146.1, 147.0, 174.7; IR (cm-1) 1664, 1479, 1159; 
HRMS (ES+) calcd for C38H38N2O5SNa (M+Na)+ 657.2399, found 657.2401. 
 
 
N-((E)-4-((5S,8R)-11-benzyl-8-methyl-10-oxo-7,8-dihydro-5,8-
(epiminomethano)naphtho[2,3-d][1,3]dioxol-6(5H)-ylidene)butyl)-N-(but-3-en-1-yl)-4-
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methylbenzenesulfonamide (3.10b). A solution of alkyl bromide 3.9 (37 mg, 0.081 mmol, 1.0 
equiv) in dry DMF (2 mL) was added dropwise at room temperature under nitrogen to a mixture 
of N-(but-3-en-1-yl)-4-methylbenzenesulfonamide (27 mg, 0.12 mmol, 1.5 equiv) and anhydrous 
K2CO3 (29 mg, 0.21 mmol, 2.6 equiv) in dry DMF (1 ml).  The reaction mixture was stirred at 60 
oC for 19 h and the crude product purified by preparative TLC to afford 3.10b (43 mg, 89%) as a 
cloudy colorless oil: Rf = 0.40 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.63 (d, J = 
8.2 Hz, 2H), 7.27 (d, J = 8.3 Hz, 2H), 7.25 (s, 1H), 7.23 (s, 2H), 7.08 (dd, J = 7.5 Hz, J = 2.0 Hz, 
2H), 6.80 (s, 1H), 6.50 (s, 1H), 5.92 (dd, J = 18.9 Hz, J = 1.3 Hz, 2H), 5.71 – 5.63 (m, 1H), 5.19 
(tt, J = 7.1 Hz, J = 2.0 Hz, 1H), 5.03 (dq, J = 7.5 Hz, J = 1.5 Hz, 1H), 5.00 (t, J = 1.0 Hz, 1H), 
4.74 (d, J = 15.2 Hz, 1H), 4.44 (s, 1H), 4.38 (d, J = 15.2 Hz, 1H), 3.10 (hept, J = 7.5 Hz, 2H), 
3.00 (td, J = 6.9 Hz, J = 1.8 Hz, 2H), 2.41 (s, 3H), 2.38 (d, J = 16.9 Hz, 1H), 2.22 (q, J = 7.6 Hz, 
2H), 2.03 (d, J = 16.5 Hz, 1H), 1.81 (hept, J = 7.4 Hz, 2H), 1.70 (s, 3H), 1.49 (p, J = 7.4 Hz, 
2H); 13C NMR δ 16.5, 21.6, 25.9, 28.3, 33.4, 36.7, 47.3, 47.9, 48.1, 48.2, 64.6, 101.2, 103.6, 
104.1, 117.2, 122.0, 127.2 (2C), 127.5, 128.1 (2C), 128.6 (2C), 129.8 (2C), 133.3, 134.7, 135.3., 
135.7, 136.88, 136.91, 143.3, 146.1, 147.1, 174.7; IR (cm-1) 1663, 1479, 1157; HRMS (ES+) 
calcd for C35H39N2O5S (M+H)+ 599.2580, found 599.2573. 
 
General protocol for the preparation of amides 4.1a-e and 4.3. A solution of imine (1.0 
equiv.), acid chloride (1.0-1.2 equiv.) and alkyne (1.5-2.0 equiv.) in ACN (6-10 mL) was stirred 
at room temperature for 5-30 minutes.  A separate solution was prepared containing CuCl (20 
mol%) in ACN (2-5 mL).  The resulting solution and neat DIPEA (1.5 equiv.) were added 
dropwise simultaneously to the CuCl.  The mixture was then allowed to stir at room temperature 
155 
 
for two hours followed by purification via column chromatography to afford enynes 4.1a-e and 
4.3. 
 
 
N-allyl-N-(1-(6-bromobenzo[d][1,3]dioxol-5-yl)-3-phenylprop-2-yn-1-yl)benzamide (4.1b). 
Treatment of (E)-N-((6-bromobenzo[d][1,3]dioxol-5-yl)methylene)-1-phenylmethanamine (467 
mg, 1.74 mmol, 1.0 equiv), benzoyl chloride (200 μL, 1.72 mmol, 1.0 equiv) and 
phenylacetylene (382 μL, 3.48 mmol, 2.0 equiv) with DIPEA (450 μL, 2.29 mmol, 1.5 equiv) 
and CuCl (34 mg, 0.35 mmol, 0.2 equiv) in ACN (8 mL) according to the general procedure 
described above, followed by flash chromatography over silica eluting with EtOAc/Hexane (1:4) 
afforded enyne 4.1b (571 mg, 69%) as a yellow oil: Rf = 0.30 (EtOAc/hexane 1 : 1); 1H NMR 
(500 MHz, CDCl3) δ 7.32 (p, J = 4.5 Hz, 6H), 7.18 (p, J = 6.5 Hz, 5H), 6.91 (br s, 1H), 6.69 (br 
s, 1H), 5.98 (q, J = 2.5 Hz, 2H), 5.52 (br s, 1H), 5.33 (br s, 1H), 4.64 (d, J = 15.5 Hz, 1H), 4.39 
(d, J = 14.5 Hz, 1H), 2.02 (br s, 3H); 13C NMR (125 MHz, CDCl3) δ 20.8, 47.5, 55.1, 86.4, 87.4, 
102.2 (2C), 111.7 (2C), 113.3, 115.5, 117.0, 122.2, 126.8, 127.7 (2C), 128.1, 128.4, 128.7, 128.8, 
131.8 (2C), 138.0, 140.4, 147.4, 148.6, 173.0; Significant signal broadening of some signals in 
1H and 13C NMR arises due to hindered rotation about the amide bond. See temperature 
dependent 1H NMR spectra for 3.2b; IR (cm-1) 3057, 1643, 1256; HRMS (ES+) calcd for 
C27H26BrN2O (M+H)+ 473.1228, found 473.1234. 
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N-allyl-N-(1-(2-bromophenyl)-3-(4-(dimethylamino)phenyl)prop-2-yn-1-yl)benzamide 
(4.1d) Treatment of (E)-N-(2-bromobenzylidene)prop-2-en-1-amine (645 mg, 2.88 mmol, 1.0 
equiv), benzoyl chloride (335 μL, 2.88 mmol, 1.0 equiv) and 4-ethynyl-N,N-dimethylaniline 
(838 mg, 5.77 mmol, 2.0 equiv) with DIPEA (751 μL, 4.32 mmol, 1.5 equiv) and CuCl (57 mg, 
0.58 mmol, 0.2 equiv) in ACN (8 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluting with EtOAc/Hexane (1:4) afforded enyne 
4.1d (1.102 g, 81%) as a clear red oil: Rf = 0.48 (EtOAc/hexane 1 : 2.3); 1H NMR (500 MHz, 
CDCl3) δ 8.02 (d, J = 7.0 Hz, 1H), 7.85 (br s, 1H), 7.52 (br s, 2H), 7.42 (d, J = 8.5 Hz, 4H), 7.36 
(t, J = 7.5 Hz, 2H), 7.21 (t, J = 6.5 Hz, 1H), 6.68 (d, J = 8.0 Hz, 2H), 6.02 (br s, 1H), 5.61 (br d, J 
= 47.5 Hz, 1H), 4.81 (d, J = 10.0 Hz, 1H), 4.67 (br s, 1H), 3.98 (br s, 1H), 3.63 (br s, 1H), 3.00 
(s, 6H); 13C NMR (125 MHz, CDCl3) δ 40.4, (46.1), 49.2, (50.9), 56.6, 83.8, (87.7), 89.2, 109.0, 
111.9, 116.2, 124.7, 127.4 (2C), 127.8, 128.2 (2C), 129.9, 130.2, 132.0 (2C), 132.9 (2C), 133.4, 
134.0, 134.6, 135.9, 136.5, 150.5, 171.8; Significant signal broadening of some signals in 1H and 
13C NMR arises due to hindered rotation about the amide bond. See temperature dependent 1H 
NMR spectra for 3.2b; IR (cm-1) 3057, 2218, 1643, 1394; HRMS (ES+) calcd for C27H26BrN2O 
(M+H)+ 473.1228, found 473.1220. 
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N-allyl-N-(1-(2-bromophenyl)-3-(naphthalen-1-yl)prop-2-yn-1-yl)benzamide (4.1e). 
Treatment of (E)-N-(2-bromobenzylidene)prop-2-en-1-amine (389 mg, 1.74 mmol, 1.0 equiv), 
benzoyl chloride (200 μL, 1.72 mmol, 1.0 equiv) and 1-ethynylnaphthalene (525 mg, 3.45 mmol, 
2.0 equiv) with DIPEA (450 μL, 2.59 mmol, 1.5 equiv) and CuCl (35 mg, 0.35 mmol, 0.2 equiv) 
in ACN (8 mL)  according to the general procedure described above, followed by flash 
chromatography over silica eluting with EtOAc/Hexane (1:4) afforded enyne 4.1e (596 mg, 
71%) as a clear red oil: Rf = 0.60 (EtOAc/hexane 1 : 2.3); 1H NMR (500 MHz, CDCl3) δ 8.38 (d, 
J = 8.0 Hz, 1H), 8.11 (d, J = 7.5 Hz, 1H), 7.90 (d, J = 8.0 Hz, 2H), 7.79 (d, J = 7.0 Hz, 1H), 7.61 
(t, J = 7.0 Hz, 2H), 7.56 (t, J = 7.0 Hz, 2H), 7.50-7.38 (m, 6H), 7.26 (t, J = 7.5 Hz, 1H), 6.23 (br 
s, 1H), 5.69 (br s, 1H), 4.87 (d, J = 10.0 Hz, 1H), 4.81 (br s, 1H), 4.09 (br s, 1H), 3.76 (br s, 1H); 
13C NMR (125 MHz, CDCl3) δ (46.3), 49.5, (51.1), 56.7, 60.5, 91.0, 116.8, 120.1, 124.8, 125.3, 
126.1, 126.7, 127.2, 127.4, 127.6 (2C), 128.4 (2C), 128.6, 129.4, 130.1, 130.4, 131.0, 131.9, 
133.3, 133.5, 133.6, 134.1, 135.6, 136.3, 171.9; Signals for the minor rotamer are given in the 
parentheses. Significant signal broadening of some signals in 1H and 13C NMR arises due to 
hindered rotation about the amide bond. See temperature dependent 1H NMR spectra for 3.2b; IR 
(cm-1) 3059, 2210, 1643, 1396; HRMS (ES+) calcd for C29H22BrNONa (M+Na)+ 502.0782, 
found 502.0792. 
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N-benzyl-N-(1-(6-bromobenzo[d][1,3]dioxol-5-yl)-3-phenylprop-2-yn-1-yl)methacrylamide 
(4.3). 
Treatment of imine 3.1b (527 mg, 1.66 mmol, 1.0 equiv), methacryloyl chloride (200 μL, 2.06 
mmol, 1.2 equiv) and phenyl acetylene (250 μL, 2.28 mmol, 1.4 equiv) with DIPEA (430 μL, 
2.47 mmol, 1.5 equiv) and CuCl (38 mg, 0.38 mmol, 0.2 equiv) in ACN (15 mL)  according to 
the general procedure described above, followed by flash chromatography over silica eluting 
with EtOAc/Hexane (1:4) afforded enyne 4.1e (398 mg, 50%) as a white solid: mp 98-105 oC; Rf 
= 0.40 (EtOAc/hexane 1 : 2.3); 
1H NMR (500 MHz, CDCl3) δ  7.32 (q, J = 6.6 Hz, 5H), 7.17 (q, J = 10.0 Hz, 5H), 6.91 (s, 1H), 
6.69 (s, 1H), 5.98 (q, J = 2.0 Hz, 2H), 5.54 (s, 1H), 5.33 (s, 2H), 4.64 (d, J = 15.9 Hz, 1H), 4.39 
(d, J = 14.4 Hz, 1H), 2.02 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 20.8, 47.5, 55.1, 86.4, 87.4, 
102.2, 111.7, 113.3, 115.5, 117.0, 122.2, 126.8, 127.7 (2C), 128.1 (2C), 128.4 (2C), 128.7, 128.8, 
131.8 (2C), 138.0, 140.4, 147.4, 148.6, 173.0; Signals for the minor rotamer are given in the 
parentheses. Significant signal broadening of some signals in 1H and 13C NMR arises due to 
hindered rotation about the amide bond. See temperature dependent 1H NMR spectra for 3.2b; IR 
(cm-1) 3053, 1647, 1622, 1477, 1265, 737; HRMS (ES+) calcd for C27H22BrNO3Na (M+Na)+ 
510.0681, found 510.0691.  
 
General protocol for the preparation of azabicyclooctanes 4.4a-e and 4.4c-d’. A solution of 
amide 4.1a-e (1.0 equiv) in toluene (16 mM) was injected into a reaction flask charged with 
159 
 
AIBN (0.5 equiv), followed by addition of neat tributylstannane (1.5 equiv).  The resulting 
solution was stirred at 100 oC for three hours then purified by column chromatography to afford 
bicyclooctanes 4.4a-e and 4.4c-d’. 
 
 
((1S,4R,Z)-2-benzylidene-1,2,3,4-tetrahydro-1,4-(epiminomethano)naphthalen-10-
yl)(phenyl)methanone (4.4a). Treatment of amide 4.1a (221 mg, 0.51 mmol, 1.0 equiv) with 
Bu3SnH (298 mg, 1.02 mmol, 2.0 equiv) and AIBN (41.8 mg, 0.25 mmol, 0.5 equiv) in toluene 
(32 mL) according to the general procedure described above, followed by flash chromatography 
over silica eluted with EtOAc/Hexane (1:2) afforded azabicyclooctane 4.4a (99 mg, 55%) as a 
whit solid: mp 110-115 oC; Rf = 0.16 (EtOAc/hexane 1 : 2.3); 1H NMR (500 MHz, CDCl3) δ 
7.52-7.48 (m, 5H), 7.35 (d, J = 7.5 Hz, 1H), 7.32 (d, J = 4.3 Hz, 2H), 7.29 (d, J = 7.0 Hz, 3H), 
7.23 – 7.17 (m, 2H), 7.09 (d, J = 7.2 Hz, 1H), 6.23 (t, J = 2.0 Hz, 1H), 5.16 (s, 1H), 3.83 (dd, J = 
11.9 Hz, J = 2.1 Hz, 1H), 3.61 (t, J = 2.0 Hz, 1H), 3.50 (dt, J = 11.9 Hz, J = 2.5 Hz, 1H), 2.96 
(dt, J = 16.8 Hz, J = 2.4 Hz, 1H), 2.64 (dq, J = 16.8 Hz, J = 2.6 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 33.0, 35.5, 48.3, 63.0, 122.7, 124.3, 124.8, 127.1 (2C), 127.2, 127.3, 128.3, 128.47 
(2C), 128.53 (2C), 128.8 (2C), 129.9, 136.7, 136.8, 137.2, 138.4, 140.9, 170.0; IR (cm-1) 1636, 
1418, 744; HRMS (ES+) calcd for C25H21NONa (M+Na)+ 374.1521, found 374.1516. 
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((5S,8R,Z)-6-benzylidene-5,6,7,8-tetrahydro-5,8-(epiminomethano)naphtho[2,3-
d][1,3]dioxol-11-yl)(phenyl)methanone (4.4b). Treatment of amide 4.1b (66 mg, 0.14 mmol, 
1.0 equiv) with Bu3SnH (74 μL, 0.28 mmol, 2.0 equiv) and AIBN (12 mg, 0.070 mmol, 0.5 
equiv) in toluene (9 mL) according to the general procedure described above, followed by flash 
chromatography over silica eluted with EtOAc/Hexane (1:2) afforded azabicyclooctane 4.4b (34 
mg, 62%) as a white solid: mp 120-126 oC; Rf = 0.29 (EtOAc/hexane 1 : 1); 1H NMR (500 MHz, 
CDCl3) δ 7.23 (dt, J = 7.5 Hz, J = 1.0 Hz, 1H), 7.17 (dd, J = 5.0 Hz, J =2.0 Hz, 3H), 7.11 (dd, J 
= 8.0 Hz, J = 1.0 Hz, 2H), 7.04 (t, J = 7.5 Hz, 2H), 6.94 (dd, J = 7.0 Hz, J = 2.0 Hz, 2H), 6.87 (s, 
1H), 6.61 (s, 1H), 6.29 (s, 1H), 5.95 (dd, J = 7.5 Hz, J = 1.5 Hz, 2H), 5.67 (s, 1H), 3.75 (dd, J = 
12.0 Hz, J = 2.5 Hz, 1H), 3.467-3.43 (m, 2H), 2.78 (dt, J = 16.5 Hz, J =  2.0 Hz, 1H), 2.46 (dq, J 
= 16.0 Hz, J = 3.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 33.3, 35.5, 48.9, 55.1, 101.1, 104.3, 
106.3, 124.1, 126.9 (2C), 128.2 (4C), 128.5 (2C), 128.8, 129.5, 131.3, 135.2, 135.6, 136.7, 137.4, 
146.4, 147.3, 169.8; IR (cm-1) 1624, 1479, 1038, 700; HRMS (ES+) calcd for C26H22NO3 
(M+H)+ 396.1600, found 396.1604. 
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((1S,4R,E)-2-(4-methoxybenzylidene)-1,2,3,4-tetrahydro-1,4-(epiminomethano)naphthalen-
10-yl)(phenyl)methanone (4.4c) and ((1S,4R,Z)-2-(4-methoxybenzylidene)-1,2,3,4-
tetrahydro-1,4-(epiminomethano)naphthalen-10-yl)(phenyl)methanone (4.4c’). Treatment of 
amide 4.1c (105 mg, 0.23 mmol, 1.0 equiv) with Bu3SnH (138 mg, 0.47 mmol, 2.0 equiv) and 
AIBN (19 mg, 0.16 mmol, 0.5 equiv) in toluene (14 mL) according to the general procedure 
described above, followed by flash chromatography over silica eluted with EtOAc/Hexane (1:2) 
afforded a diastereomeric mixture of azabicyclooctanes 4.4c and 4.4c’ (55 mg, 63%) as a cloudy 
colorless oil: Rf = 0.27 (EtOAc/hexane 1 : 2.3); 1H NMR (500 MHz, CDCl3) δ 7.49 (q, J = 5.5 
Hz, 2.1H), 7.35 (t, J = 6.5 Hz, 1.4H), 7.31 (d, J = 7.6 Hz, 0.6H), 7.29 (d, J = 7.4 Hz, 0.9H), 7.24 
(dd, J = 3.4 Hz, J =  1.3 Hz, 0.6H), 7.20 (d, J = 8.8 Hz, 0.6H), 7.16 (dd, J = 8.5 Hz, J = 1.5 Hz, 
1.4H), 7.10 (d, J = 7.5 Hz, 1.4H), 7.08 (d, J = 1.9 Hz, 0.6H), 6.88 (d, J = 8.6 Hz, 1.4H), 6.83 (d, 
J = 8.7 Hz, 0.6H), 6.70 (d, J = 8.6 Hz, 1.4H), 6.25 (s, 0.7H), 6.17 (t, J = 5.2 Hz, 0.3H), 5.77 (s, 
0.7H), 5.13 (s, 0.3H), 3.83 – 3.82 (m, 0.7H), 3.81 (s, 2.1H), 3.80 (d, J = 2.2 Hz, 0.3H), 3.79 (s, 
0.9H), 3.60 (t, J = 2.5 Hz, 0.3H), 3.51 (dt, J = 10.8 Hz, J = 2.6 Hz, 1.4H), 3.47 (t, J = 2.6 Hz, 
0.3H), 2.92 (dt, J = 16.7 Hz, J = 2.3 Hz, 0.3H), 2.80 (dt, J = 16.4 Hz, J = 2.2 Hz, 0.7H), 2.61 (dq, 
J = 16.5 Hz, J = 2.5 Hz, 0.3H), 2.47 (dq, J = 16.4, 2.7 Hz, 0.7H); 13C NMR (125 MHz, CDCl3) δ 
(33.0), 33.2, 35.4, (35.6), (48.3), 48.8, 55.2, (55.4), 55.5, (63.0), (113.91 (2C)), 113.94 (2C), 
(122.5), 122.6, 124.29, (124.31), 124.6, 127.0 (2C), (127.1 (2C)), 127.2, (128.1), (128.23 (2C)), 
128.24 (2C), (128.4), 128.7, (129.3), 129.42 (2C), (129.43 (2C)), (129.6), 129.7, 129.9, (130.1), 
(134.8), 135.8, 136.0, (136.7), 138.1, (138.6), (140.9), 141.6, 158.6, (158.7), 169.8, (169.9); IR 
(cm-1) 1626, 1509, 1250, 728; HRMS (ES+) calcd for C26H24NO2 (M+H)+ 382.1807, found 
382.1800. 
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((1S,4R,E)-2-(4-(dimethylamino)benzylidene)-1,2,3,4-tetrahydro-1,4-
(epiminomethano)naphthalen-10-yl)(phenyl)methanone (4.4d) and ((1S,4R,Z)-2-(4-
(dimethylamino)benzylidene)-1,2,3,4-tetrahydro-1,4-(epiminomethano)naphthalen-10-
yl)(phenyl)methanone (4.4d’). Treatment of amide 4.1d (133 mg, 0.28 mmol, 1.0 equiv) with 
Bu3SnH (150 μL, 0.57 mmol, 2.0 equiv) and AIBN (23 mg, 0.14 mmol, 0.5 equiv) in toluene (18 
mL) according to the general procedure described above, followed by flash chromatography over 
silica eluted with EtOAc/Hexane (1:2) afforded a diastereomeric mixture of azabicyclooctanes 
4.4d and 4.4d’ (48 mg, 43%) as a yellow oil: Rf = 0.27 (EtOAc/hexane 1 : 1); 1H NMR (500 
MHz, CDCl3) δ 7.49 (s, 1.4H), 7.34 (t, J = 7.0 Hz, 1.2H), 7.31 (t, J = 7.5 Hz, 1.2H), 7.23 (d, J = 
8.0 Hz, 0.9H), 7.17 (dd, J = 7.5 Hz, J = 1.5 Hz, 2.1H), 7.13-7-06 (m, 2.8H),  6.84 (d, J = 9.0 Hz, 
1.4H), 6.64 (d, J = 8.5 Hz, 0.6H), 6.53 (d, J = 8.5, 1.4H), 6.24 (s, 0.7H), 6.12 (s, 0.3H), 5.83 (s, 
0.7H), 5.11 (s, 0.3H), 3.80 (dd, J = 13.5 Hz, J = 4.0 Hz, 0.7H), 3.70 (d, J = 6.5 Hz, 0.6H), 3.59 (t, 
J = 2.5 Hz, 0.3H), 5.51 (s, 1.4H), 3.48 (d, J = 2.5 Hz, 0.3H), 2.96 (s, 4.2H), 2.94 (s, 1.8H), 2.80 
(dt, J = 16.5 Hz, J = 2.0 Hz, 0.7H), 2.62 (dq, J = 17.0 Hz, J = 3.0 Hz, 0.3H), 2.64 (dq, J =16.5 
Hz, J = 3.0 Hz, 0.7H); 13C NMR (125 MHz, CDCl3) δ (33.1), 33.2, 35.5, (35.7), (40.5), 40.8, 
(48.3), 48.8, 55.3, (63.2), (112.3 (2C)), 112.6 (2C), (122.4), 122.6, (124.3), 124.5, (124.8), 124.9, 
125.2, (125.3), (127.0), 127.05 (3C), (127.11 (2C)), (128.0), (128.1 (2C)), 128.2 (2C), (128.7 
(2C)), 129.1 (2C), 129.3, 129.5, (129.8), (132.5), 134.4, 135.9, (136.8), 138.3, (138.9), (141.0), 
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141.7, (149.5), 149.6, 169.8, (169.9); IR (cm-1) 1628, 1520, 1418, 729; HRMS (ES+) calcd for 
C27H27N2O (M+H)+ 395.2123, found 395.2116. 
 
 
((1S,4R,Z)-2-(naphthalen-1-ylmethylene)-1,2,3,4-tetrahydro-1,4-
(epiminomethano)naphthalen-10-yl)(phenyl)methanone (4.4e). Treatment of amide 4.1b (58 
mg, 0.12 mmol, 1.0 equiv) with Bu3SnH (64 μL, 0.24 mmol, 2.0 equiv) and AIBN (10 mg, 0.060 
mmol, 0.5 equiv) in toluene (6 mL) according to the general procedure described above, 
followed by flash chromatography over silica eluted with EtOAc/Hexane (1:2) afforded 
azabicyclooctane 4.4b (27 mg, 56%) as a white solid: mp 121-124 oC; Rf = 0.22 (EtOAc/hexane 
1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.94 (dd, J = 6.5 Hz, J = 2.0 Hz, 1H), 7.89 (dd, J = 6.6 Hz, 
J = 2.5 Hz, 1H), 7.72 (d, J = 8.2 Hz, 1H), 7.56 – 7.53 (m, 2H), 7.39 (d, J = 6.9 Hz, 1H), 7.35 (td, 
J = 7.4 Hz, J = 1.1 Hz, 1H), 7.2t (td, J = 7.4 Hz, J = 1.3 Hz, 1H), 7.20 (t, J = 7.5 Hz, 1H), 7.06 
(d, J = 7.4 Hz, 1H), 6.98 (dt, J = 7.5 Hz, J = 1.0 Hz, 1H), 6.95 (d, J = 6.8 Hz, 1H), 6.84 (dd, J = 
8.0 Hz, J = 1.0 Hz, 2H), 6.76 (s, 1H), 6.49 (t, J = 7.7 Hz, 2H), 5.53 (s, 1H), 3.86 (dd, J = 11.9 
Hz, J = 2.3 Hz, 1H), 3.58 (p, J = 2.4 Hz, 1H), 3.49 (dt, J = 11.9 Hz, J = 2.6 Hz, 1H), 2.99 (dt, J = 
16.5 Hz, J = 2.2 Hz, 1H), 2.65 (dq, J = 16.5 Hz, J = 2.8 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 
33.0, 35.5, 48.9, 55.9, 122.6, 123.0, 124.6, 125.1, 125.3, 126.2, 126.3, 126.59, 126.61 (2C), 
127.3, 127.7 (2C), 128.3, 128.5, 129.2, 132.1, 133.8, 133.9, 135.4, 138.0, 139.0, 141.7, 170.0; IR 
(cm-1) 1628, 1418, 743; HRMS (ES+) calcd for C29H24NO (M+H)+ 402.1858, found 402.1852. 
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N-allyl-N-((2-bromophenyl)(phenyl)methyl)methacrylamide (5.2a). Imine 5.1a (266 mg, 1.19 
mmol, 1.0 equiv) and methacryloyl chloride (130 μL, 1.34 mmol, 1.1 equiv) were dissolved in 
DCM (6 mL), after 30 min pyridine (93 mg, 1.18 mmol, 1.0 equiv) was added and the solution 
was transferred to a vial with NaBPh4 (407 mg, 1.19 mmol, 1.0 equiv).  CuCl (12 mg, 0.12, 
0.010 equiv) in DCM (3 mL) was added, and the reaction solution was stirred at room 
temperature for 24 h.  Purification by flash chromatography over silica, eluted with 
EtOAc/Hexane (1:4) afforded amide 5.2a (242 mg, 55%) as a clear oil: Rf = 0.57 (EtOAc/hexane 
1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 7.9 Hz, 1H), 7.34 (t, J = 7.3 Hz, 2H), 7.30 (d, J 
= 7.0 Hz, 1H), 7.25 (t, J = 7.5 Hz, 1H), 7.17 (td, J = 7.7 Hz, J = 1.5 Hz, 1H), 7.12 (d, J = 7.3 Hz, 
2H), 7.05 (dd, J = 7.7 Hz, J = 1.4 Hz, 1H), 6.80 (br s, 1H), 5.42 (br s, 1H), 5.12 (s, 1H), 4.90 (br 
s, 1H), 4.72 (d, J = 10.1 Hz, 1H), 4.59 (d, J = 16.7 Hz, 1H), 4.15 (d, J = 12.6 Hz, 1H), 3.90 (dd, J 
= 15.2 Hz, J = 6.1 Hz, 1H), 1.99 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 21.1, 47.9, 65.8, 115.5, 
115.8, 116.4, 125.8, 127.5, 127.8, 128.4 (2C), 128.8, 129.6, 131.4, 133.3 (2C), 139.4, 139.6, 
140.5, 173.4; Significant signal broadening of some signals in 1H and 13C NMR arises due to 
hindered rotation about the amide bond. See temperature dependent 1H NMR spectra for 3.2b; IR 
(cm-1) 1647, 1626, 1437, 700; HRMS (ES+) calcd for C20H21BrNO (M+H)+ 370.0807, found 
370.0807.  
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N-((2-bromophenyl)(phenyl)methyl)-N-(but-3-en-1-yl)methacrylamide (5.2b). Imine 5.1b 
(552 mg, 2.32 mmol, 1.0 equiv) and methacryloyl chloride (250 μL, 2.57 mmol, 1.1 equiv) were 
dissolved in DCM (6 mL), after 30 min pyridine (190 μL, 2.36 mmol, 1.0 equiv) was added and 
the solution was transferred to a vial with NaBPh4 (796 mg, 2.33 mmol, 1.0 equiv).  CuCl (23 
mg, 0.23, 0.010 equiv) in DCM (3 mL) was added, and the reaction solution was stirred at room 
temperature for 24 h.  Purification by flash chromatography over silica, eluted with 
EtOAc/Hexane (1:4) afforded amide 5.2b (473 mg, 53%) as a clear oil: Rf = 0.51 (EtOAc/hexane 
1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 7.9 Hz, 1H), 7.36-7.26 (m, 5H), 7.19 (t, J = 7.6 
Hz, 1H), 7.13 (d, J = 7.3 Hz, 2H), 7.08 (dd, J = 7.5 Hz, J = 1.0 Hz, 1H), 6.72 (s, 1H), 5.41 (s, 
1H), 5.10 (s, 1H), 4.80 (d, J = 9.8 Hz, 1H), 4.65 (dd, J = 17.0 Hz, J = 1.5 Hz,1H), 3.52 (s, 1H), 
3.38 (td, J = 11.0 Hz, J = 5.0 Hz, 1H), 1.98 (s, 3H), 1.90-1.83 (m, 1H), 1.54-1.46 (m, 1H); 13C 
NMR (125 MHz, CDCl3) δ 21.1, 32.2, 45.0, 65.7, 115.3, 116.4, 125.3, 127.6, 127.8, 128.4, 128.8 
(2C), 129.6, 131.0, 133.4 (2C), 135.1, 139.3, 139.7, 140.5, 173.2; Significant signal broadening 
of some signals in 1H and 13C NMR arises due to hindered rotation about the amide bond. See 
temperature dependent 1H NMR spectra for 3.2b; IR (cm-1) 1647, 1624, 1414, 700; HRMS (ES+) 
calcd for C21H23BrNO (M+H)+ 384.0963, found 384.0956.  
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1-((2-bromophenyl)(phenyl)methyl)-3-methyl-1H-pyrrol-2(5H)-one (5.3a). A solution of 
amide 5.2a (164 mg, 0.44 mmol, 1.0 equiv) in toluene (15 mL) was added to a reaction vessel 
containing Grubbs I catalyst (35 mg, 0.042 mmol, 0.1 equiv) and the reaction solution was 
stirred at 45 oC for 2 h. Purification by flash chromatography over silica, eluted with 
EtOAc/Hexane (1:4) afforded lactam 5.3a (133 mg, 88%) as a red oil: Rf = 0.57 (EtOAc/hexane 
1 : 2.3); 1H NMR (500 MHz, CDCl3) δ 7.60 (dd, J = 8.0 Hz, J = 1.5 Hz, 1H), 7.34 (t, J = 1.5 Hz, 
0.5 H), 7.32 (s, 1H), 7.31 (s, 0.5H), 7.29 (t, J = 2.0 Hz, 0.5H), 7.28 (s, 0.5H), 7.25 (d, J = 1.0 Hz, 
0.5H), 7.23 (d, J = 1.0 Hz, 0.5H), 7.16 (dt, J = 8.0 Hz, J = 1.5 Hz, 1H), 7.06 (s, 1H), 7.05 (s, 1H), 
6.98 (dd, J = 7.5 Hz, J = 1.5 Hz, 1H), 6.78 (s, 1H), 6.69 (q, J = 2.0 Hz, 1H), 3.67 (dt, J = 20.0 
Hz, J = 2.0 Hz, 1H), 3.52 (dt, J = 20.0 Hz, J = 2.0 Hz, 1H), 1.95 (q, J = 1.5 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 11.5, 49.7, 59.4, 125.1, 127.4, 127.6, 128.0 (2C), 128.7 (2C), 129.4, 130.1, 
133.5, 135.7, 136.0, 139.2, 139.6, 171.8; IR (cm-1) 1681, 1649, 1236, 700; HRMS (ES+) calcd 
for C18H16BrNONa (M+Na)+ 364.0313, found 364.0328. 
 
 
1-((2-bromophenyl)(phenyl)methyl)-3-methyl-5,6-dihydropyridin-2(1H)-one (5.3b). A 
solution of amide 5.2b (333 mg, 0.87 mmol, 1.0 equiv) in toluene (20 mL) was added to a 
reaction vessel containing Grubbs I catalyst (72 mg, 0.087 mmol, 0.1 equiv) and the reaction 
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solution was stirred at 45 oC for 2 h. Purification by flash chromatography over silica, eluted 
with EtOAc/Hexane (1:4) afforded lactam 5.3b (247 mg, 80%) as a pail yellow oil: Rf = 0.34 
(EtOAc/hexane 1 : 1); 1H NMR (500 MHz, CDCl3) δ 7.60 (dd, J = 7.9 Hz, J = 1.2 Hz, 1H), 7.33 
(t, J = 7.3 Hz, 2H), 7.29 (d, J = 7.3 Hz, 1H), 7.24 (dd, J = 7.5 Hz, J = 1.0 Hz, 1H), 7.17 (d, J = 
7.8 Hz, 3H), 7.12 (s, 1H), 7.06 (dd, J = 7.7 Hz, J = 1.3 Hz, 1H), 6.35 – 6.29 (q, J = 1.5 Hz, 1H), 
3.19 – 3.02 (m, 2H), 2.34-2.29 (m, 2H), 1.93 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 17.5, 24.3, 
43.4, 61.4, 125.3, 127.3, 127.5, 128.4 (2C), 128.7 (2C), 129.2, 130.6, 132.3, 133.59, 133.61, 
138.9, 139.4, 165.7; IR (cm-1) 1668, 1628, 1205, 700; HRMS (ES+) calcd for C19H19BrNO 
(M+H)+ 356.0650, found 356.0646. 
 
 
1-(9H-fluoren-9-yl)-3-methyl-1H-pyrrol-2(5H)-one (5.4). A pressure tube charged with lactam 
5.3a (342 mg, 0.15 mmol, 1.0 equiv),  palladium acetate (3 mg, 0.015 mmol, 0.1 equiv), cesium 
carbonate (95 mg, 0.29 mmol, 2.0 equiv) and tetrabutylammonium chloride (38 mg, 0.14 mmol, 
1.0 equiv) in DMF (2 mL) was flushed and stirred at 140 oC for 5h. Purification by flash 
chromatography over silica, eluted with EtOAc/Hexane (1:5) afforded lactam 5.4 (37 mg, 88%) 
as a red oil: Rf = 0.4 (EtOAc/hexane 1 : 2.3); 1H NMR (500 MHz, CDCl3) δ 7.73 (dt, J = 7.3 Hz, 
J = 1.1 Hz, 2H), 7.42 (s, 1.5H), 7.41 (t, J = 0.8 Hz, 2H), 7.39 (t, J = 1.0 Hz, 1H), 7.30 (d, J = 1.1 
Hz, 0.5H), 7.29 (d, J = 0.9 Hz, 1H), 7.27 (d, J = 1.1 Hz, 0.5H), 6.59 (q, J = 1.6 Hz, 1H), 6.47 (s, 
1H), 3.27 (p, J = 1.9 Hz, 2H), 2.02 (q, J = 2.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 11.7, 
46.6, 57.0, 120.3 (2C), 125.2 (2C), 127.8 (2C), 128.8 (2C), 135.4, 136.1, 140.9, 143.2, 173.2; IR 
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(cm-1) 3065, 1684, 1452, 739; HRMS (ES+) calcd for C18H16NO (M+H)+ 262.1232, found 
262.1238.  
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GCMS purity analysis for compounds 4.4a-e 
 
The Gas Chromatography-Mass Spectrometric data were collected on an Agilent 6890N gas 
chromatograph eluting into a Quattro Micro GC mass spectrometer (Micromass Ltd, Manchester 
UK). An HP-5MS, 15 meter column with a 0.25” ID was used. The carrier gas was Helium using 
constant flow control set to 1.5 mL per minute. 1.0 μL of sample was injected into the column 
with a 20:1 split ratio. The injector port temperature was 240 oC. The chromatographic 
conditions were as follows: The initial column temperature was 50 oC with a 1 minute hold after 
which the temperature was increased 25 oC/min to a final temperature of 300 oC and held for 2 
minutes. EI ionization was used with ion energy of 70V. The mass range was 45 to 400 m/z with 
a 0.3 scan time and an inter scan delay time of 0.07 seconds.  
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X-Ray Crystal Structure Report for Lactam 4.4a 
 
Acknowledgment  
This x-ray analysis was performed by Victor Day. 
 
Table 1.  Crystal data and structure refinement for C25H21NO. 
Identification code  q94a 
Empirical formula  C25 H21 N O 
Formula weight  351.43 
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Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  Cc 
Unit cell dimensions a = 12.0461(4) Å = 90°. 
 b = 17.2429(6) Å = 93.888(2)°. 
 c = 8.6644(3) Å  = 90°. 
Volume 1795.54(11) Å3 
Z 4 
Density (calculated) 1.300 Mg/m3 
Absorption coefficient 0.610 mm-1 
F(000) 744 
Crystal size 0.21 x 0.19 x 0.09 mm3 
Theta range for data collection 4.48 to 68.47°. 
Index ranges -12<=h<=14, -18<=k<=20, -10<=l<=10 
Reflections collected 8386 
Independent reflections 2622 [R(int) = 0.0237] 
Completeness to theta = 68.47° 95.1 %  
Absorption correction Multi-scan 
Max. and min. transmission 1.000 and 0.888 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2622 / 2 / 327 
Goodness-of-fit on F2 1.037 
Final R indices [I>2sigma(I)] R1 = 0.0301, wR2 = 0.0799 
R indices (all data) R1 = 0.0304, wR2 = 0.0802 
Absolute structure parameter 0.0(3) 
Largest diff. peak and hole 0.466 and -0.157 e.Å-3 
 
Table 2.  Atomic coordinates ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) for C25H21NO.  
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
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________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O 5448(1) 4050(1) 1412(2) 35(1) 
N 4753(1) 3552(1) 3538(2) 22(1) 
C(1) 5358(2) 4137(1) 4528(2) 23(1) 
C(2) 4979(2) 4053(1) 6172(2) 22(1) 
C(3) 3732(2) 4146(1) 6089(2) 21(1) 
C(4) 3127(2) 4704(1) 6820(2) 23(1) 
C(5) 1973(2) 4726(1) 6554(2) 27(1) 
C(6) 1426(2) 4188(1) 5574(2) 26(1) 
C(7) 2033(2) 3622(1) 4844(2) 23(1) 
C(8) 3177(1) 3606(1) 5102(2) 20(1) 
C(9) 3967(1) 3058(1) 4376(2) 20(1) 
C(10) 4674(1) 2649(1) 5650(2) 19(1) 
C(11) 5291(2) 3223(1) 6729(2) 23(1) 
C(12) 4784(1) 1885(1) 5780(2) 22(1) 
C(13) 4134(1) 1303(1) 4830(2) 21(1) 
C(14) 4668(2) 734(1) 4003(2) 24(1) 
C(15) 4053(2) 192(1) 3122(2) 27(1) 
C(16) 2900(2) 195(1) 3081(2) 26(1) 
C(17) 2366(2) 744(1) 3935(2) 24(1) 
C(18) 2975(2) 1299(1) 4791(2) 23(1) 
C(19) 4825(2) 3580(1) 1996(2) 22(1) 
C(20) 4107(1) 3051(1) 981(2) 22(1) 
C(21) 4230(2) 2246(1) 1015(2) 26(1) 
C(22) 3570(2) 1784(1) 4(2) 29(1) 
C(23) 2786(2) 2118(1) -1030(2) 28(1) 
C(24) 2652(2) 2918(1) -1063(2) 29(1) 
C(25) 3319(2) 3382(1) -71(2) 26(1) 
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________________________________________________________________________________   
 
Table 3.  Bond lengths [Å] and angles [°] for  C25H21NO. 
_____________________________________________________  
O-C(19)  1.236(2) 
N-C(19)  1.345(2) 
N-C(1)  1.484(2) 
N-C(9)  1.497(2) 
C(1)-C(2)  1.532(3) 
C(1)-H(1A)  0.97(2) 
C(1)-H(1B)  0.99(2) 
C(2)-C(3)  1.507(2) 
C(2)-C(11)  1.549(2) 
C(2)-H(2)  0.989(19) 
C(3)-C(4)  1.387(2) 
C(3)-C(8)  1.403(2) 
C(4)-C(5)  1.394(3) 
C(4)-H(4)  0.95(2) 
C(5)-C(6)  1.393(3) 
C(5)-H(5)  0.97(2) 
C(6)-C(7)  1.396(3) 
C(6)-H(6)  1.00(2) 
C(7)-C(8)  1.381(2) 
C(7)-H(7)  0.98(2) 
C(8)-C(9)  1.508(2) 
C(9)-C(10)  1.521(2) 
C(9)-H(9)  0.95(2) 
C(10)-C(12)  1.328(2) 
C(10)-C(11)  1.521(2) 
C(11)-H(11A)  0.98(2) 
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C(11)-H(11B)  1.02(2) 
C(12)-C(13)  1.487(2) 
C(12)-H(12)  1.17(2) 
C(13)-C(18)  1.394(3) 
C(13)-C(14)  1.397(3) 
C(14)-C(15)  1.388(3) 
C(14)-H(14)  0.95(2) 
C(15)-C(16)  1.388(3) 
C(15)-H(15)  0.97(2) 
C(16)-C(17)  1.386(3) 
C(16)-H(16)  0.93(2) 
C(17)-C(18)  1.389(2) 
C(17)-H(17)  0.97(2) 
C(18)-H(18)  0.94(2) 
C(19)-C(20)  1.500(2) 
C(20)-C(25)  1.393(2) 
C(20)-C(21)  1.396(3) 
C(21)-C(22)  1.392(3) 
C(21)-H(21)  1.01(2) 
C(22)-C(23)  1.383(3) 
C(22)-H(22)  0.97(2) 
C(23)-C(24)  1.389(3) 
C(23)-H(23)  0.95(2) 
C(24)-C(25)  1.390(3) 
C(24)-H(24)  0.95(2) 
C(25)-H(25)  0.95(2) 
C(19)-N-C(1) 119.17(14) 
C(19)-N-C(9) 125.99(14) 
C(1)-N-C(9) 114.09(13) 
N-C(1)-C(2) 107.93(14) 
264 
 
N-C(1)-H(1A) 108.5(12) 
C(2)-C(1)-H(1A) 110.9(12) 
N-C(1)-H(1B) 110.1(12) 
C(2)-C(1)-H(1B) 110.5(12) 
H(1A)-C(1)-H(1B) 108.9(18) 
C(3)-C(2)-C(1) 107.71(13) 
C(3)-C(2)-C(11) 109.46(14) 
C(1)-C(2)-C(11) 107.21(14) 
C(3)-C(2)-H(2) 112.2(11) 
C(1)-C(2)-H(2) 106.7(11) 
C(11)-C(2)-H(2) 113.3(10) 
C(4)-C(3)-C(8) 119.71(15) 
C(4)-C(3)-C(2) 127.24(15) 
C(8)-C(3)-C(2) 113.01(14) 
C(3)-C(4)-C(5) 119.47(16) 
C(3)-C(4)-H(4) 116.9(14) 
C(5)-C(4)-H(4) 123.6(14) 
C(6)-C(5)-C(4) 120.58(17) 
C(6)-C(5)-H(5) 117.9(12) 
C(4)-C(5)-H(5) 121.5(12) 
C(5)-C(6)-C(7) 120.03(17) 
C(5)-C(6)-H(6) 121.3(12) 
C(7)-C(6)-H(6) 118.6(12) 
C(8)-C(7)-C(6) 119.27(16) 
C(8)-C(7)-H(7) 122.2(13) 
C(6)-C(7)-H(7) 118.5(13) 
C(7)-C(8)-C(3) 120.94(15) 
C(7)-C(8)-C(9) 126.58(15) 
C(3)-C(8)-C(9) 112.45(14) 
N-C(9)-C(8) 106.51(13) 
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N-C(9)-C(10) 105.94(13) 
C(8)-C(9)-C(10) 109.03(13) 
N-C(9)-H(9) 110.0(13) 
C(8)-C(9)-H(9) 111.2(13) 
C(10)-C(9)-H(9) 113.8(12) 
C(12)-C(10)-C(11) 123.48(15) 
C(12)-C(10)-C(9) 124.75(15) 
C(11)-C(10)-C(9) 111.71(13) 
C(10)-C(11)-C(2) 108.17(13) 
C(10)-C(11)-H(11A) 110.0(12) 
C(2)-C(11)-H(11A) 108.1(12) 
C(10)-C(11)-H(11B) 108.4(11) 
C(2)-C(11)-H(11B) 110.2(12) 
H(11A)-C(11)-H(11B) 111.9(17) 
C(10)-C(12)-C(13) 125.23(15) 
C(10)-C(12)-H(12) 119.3(10) 
C(13)-C(12)-H(12) 115.5(10) 
C(18)-C(13)-C(14) 118.61(16) 
C(18)-C(13)-C(12) 120.34(15) 
C(14)-C(13)-C(12) 121.02(16) 
C(15)-C(14)-C(13) 120.54(18) 
C(15)-C(14)-H(14) 119.3(12) 
C(13)-C(14)-H(14) 120.1(12) 
C(16)-C(15)-C(14) 120.51(17) 
C(16)-C(15)-H(15) 122.2(13) 
C(14)-C(15)-H(15) 117.3(13) 
C(17)-C(16)-C(15) 119.22(16) 
C(17)-C(16)-H(16) 120.5(15) 
C(15)-C(16)-H(16) 120.2(15) 
C(16)-C(17)-C(18) 120.55(17) 
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C(16)-C(17)-H(17) 122.1(12) 
C(18)-C(17)-H(17) 117.3(12) 
C(17)-C(18)-C(13) 120.53(16) 
C(17)-C(18)-H(18) 120.3(12) 
C(13)-C(18)-H(18) 119.2(12) 
O-C(19)-N 120.82(15) 
O-C(19)-C(20) 120.01(15) 
N-C(19)-C(20) 119.14(14) 
C(25)-C(20)-C(21) 119.24(16) 
C(25)-C(20)-C(19) 118.31(15) 
C(21)-C(20)-C(19) 122.40(15) 
C(22)-C(21)-C(20) 120.00(16) 
C(22)-C(21)-H(21) 120.9(12) 
C(20)-C(21)-H(21) 119.1(12) 
C(23)-C(22)-C(21) 120.33(16) 
C(23)-C(22)-H(22) 122.4(12) 
C(21)-C(22)-H(22) 117.2(12) 
C(22)-C(23)-C(24) 120.07(17) 
C(22)-C(23)-H(23) 120.2(12) 
C(24)-C(23)-H(23) 119.8(12) 
C(23)-C(24)-C(25) 119.80(17) 
C(23)-C(24)-H(24) 123.6(12) 
C(25)-C(24)-H(24) 116.6(12) 
C(24)-C(25)-C(20) 120.55(15) 
C(24)-C(25)-H(25) 119.1(12) 
C(20)-C(25)-H(25) 120.4(12) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table 4.  Anisotropic displacement parameters  (Å2x 103) for C25H21NO.  The anisotropic displacement factor 
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exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O 36(1)  32(1) 38(1)  3(1) 7(1)  -7(1) 
N 19(1)  20(1) 25(1)  1(1) 1(1)  -3(1) 
C(1) 17(1)  21(1) 30(1)  -1(1) 0(1)  -3(1) 
C(2) 20(1)  20(1) 25(1)  -2(1) -1(1)  0(1) 
C(3) 22(1)  20(1) 21(1)  4(1) 1(1)  -2(1) 
C(4) 26(1)  18(1) 25(1)  2(1) 1(1)  0(1) 
C(5) 27(1)  22(1) 32(1)  4(1) 6(1)  3(1) 
C(6) 19(1)  26(1) 33(1)  7(1) -1(1)  0(1) 
C(7) 23(1)  22(1) 23(1)  4(1) -1(1)  -1(1) 
C(8) 21(1)  19(1) 20(1)  4(1) 1(1)  -1(1) 
C(9) 19(1)  19(1) 20(1)  0(1) 1(1)  -3(1) 
C(10) 16(1)  23(1) 20(1)  -2(1) 2(1)  0(1) 
C(11) 22(1)  22(1) 24(1)  -1(1) -2(1)  0(1) 
C(12) 18(1)  24(1) 23(1)  2(1) 0(1)  1(1) 
C(13) 23(1)  18(1) 20(1)  4(1) -1(1)  1(1) 
C(14) 25(1)  21(1) 28(1)  4(1) 2(1)  1(1) 
C(15) 32(1)  21(1) 27(1)  -2(1) 3(1)  2(1) 
C(16) 32(1)  20(1) 24(1)  0(1) -3(1)  -6(1) 
C(17) 23(1)  25(1) 25(1)  6(1) -3(1)  -3(1) 
C(18) 28(1)  20(1) 21(1)  3(1) 1(1)  2(1) 
C(19) 23(1)  17(1) 26(1)  2(1) 5(1)  3(1) 
C(20) 22(1)  24(1) 20(1)  -1(1) 8(1)  0(1) 
C(21) 27(1)  24(1) 28(1)  -1(1) 3(1)  2(1) 
C(22) 35(1)  21(1) 31(1)  -4(1) 7(1)  0(1) 
C(23) 30(1)  31(1) 22(1)  -4(1) 5(1)  -6(1) 
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C(24) 30(1)  35(1) 23(1)  4(1) 0(1)  0(1) 
C(25) 32(1)  23(1) 23(1)  3(1) 5(1)  2(1) 
______________________________________________________________________________  
 
Table 5.  Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) for C25H21NO. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1A) 6150(20) 4040(12) 4510(20) 23(5) 
H(1B) 5194(18) 4667(13) 4120(20) 24(5) 
H(2) 5363(16) 4464(11) 6800(20) 14(4) 
H(4) 3536(19) 5061(13) 7470(30) 27(5) 
H(5) 1524(18) 5104(12) 7060(20) 21(5) 
H(6) 600(20) 4198(11) 5370(20) 24(5) 
H(7) 1627(19) 3240(12) 4180(30) 26(5) 
H(9) 3579(19) 2715(12) 3670(20) 21(5) 
H(11A) 5056(18) 3162(12) 7780(30) 24(5) 
H(11B) 6130(20) 3133(12) 6680(20) 25(5) 
H(12) 5419(18) 1630(12) 6730(20) 26 
H(14) 5454(19) 703(11) 4070(20) 16(4) 
H(15) 4460(20) -170(13) 2520(30) 28(5) 
H(16) 2490(20) -174(13) 2500(30) 30(6) 
H(17) 1570(20) 742(11) 4010(20) 22(5) 
H(18) 2609(18) 1677(11) 5350(20) 16(4) 
H(21) 4810(19) 2006(12) 1770(20) 27(5) 
H(22) 3708(18) 1231(12) 30(20) 23(5) 
H(23) 2350(18) 1804(12) -1730(20) 22(5) 
H(24) 2110(18) 3176(11) -1720(20) 21(5) 
H(25) 3230(18) 3931(13) -120(20) 25(5) 
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________________________________________________________________________________   
 
Table 6.  Torsion angles [°] for C25H21NO. 
________________________________________________________________  
C(19)-N-C(1)-C(2) 170.79(14) 
C(9)-N-C(1)-C(2) 0.09(19) 
N-C(1)-C(2)-C(3) -56.69(17) 
N-C(1)-C(2)-C(11) 61.03(17) 
C(1)-C(2)-C(3)-C(4) -119.59(17) 
C(11)-C(2)-C(3)-C(4) 124.16(18) 
C(1)-C(2)-C(3)-C(8) 58.13(17) 
C(11)-C(2)-C(3)-C(8) -58.12(18) 
C(8)-C(3)-C(4)-C(5) -0.6(2) 
C(2)-C(3)-C(4)-C(5) 176.97(16) 
C(3)-C(4)-C(5)-C(6) 0.6(2) 
C(4)-C(5)-C(6)-C(7) -0.2(3) 
C(5)-C(6)-C(7)-C(8) -0.2(2) 
C(6)-C(7)-C(8)-C(3) 0.3(2) 
C(6)-C(7)-C(8)-C(9) -177.75(15) 
C(4)-C(3)-C(8)-C(7) 0.2(2) 
C(2)-C(3)-C(8)-C(7) -177.75(15) 
C(4)-C(3)-C(8)-C(9) 178.44(14) 
C(2)-C(3)-C(8)-C(9) 0.53(18) 
C(19)-N-C(9)-C(8) -113.55(17) 
C(1)-N-C(9)-C(8) 56.41(17) 
C(19)-N-C(9)-C(10) 130.46(16) 
C(1)-N-C(9)-C(10) -59.58(16) 
C(7)-C(8)-C(9)-N 121.06(17) 
C(3)-C(8)-C(9)-N -57.10(16) 
C(7)-C(8)-C(9)-C(10) -125.04(17) 
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C(3)-C(8)-C(9)-C(10) 56.80(16) 
N-C(9)-C(10)-C(12) -119.22(19) 
C(8)-C(9)-C(10)-C(12) 126.51(19) 
N-C(9)-C(10)-C(11) 58.08(17) 
C(8)-C(9)-C(10)-C(11) -56.19(18) 
C(12)-C(10)-C(11)-C(2) 177.95(18) 
C(9)-C(10)-C(11)-C(2) 0.6(2) 
C(3)-C(2)-C(11)-C(10) 55.44(18) 
C(1)-C(2)-C(11)-C(10) -61.13(18) 
C(11)-C(10)-C(12)-C(13) 175.07(16) 
C(9)-C(10)-C(12)-C(13) -7.9(3) 
C(10)-C(12)-C(13)-C(18) -57.1(3) 
C(10)-C(12)-C(13)-C(14) 125.1(2) 
C(18)-C(13)-C(14)-C(15) 2.0(2) 
C(12)-C(13)-C(14)-C(15) 179.88(15) 
C(13)-C(14)-C(15)-C(16) -1.7(3) 
C(14)-C(15)-C(16)-C(17) -0.1(3) 
C(15)-C(16)-C(17)-C(18) 1.7(2) 
C(16)-C(17)-C(18)-C(13) -1.3(2) 
C(14)-C(13)-C(18)-C(17) -0.5(2) 
C(12)-C(13)-C(18)-C(17) -178.38(15) 
C(1)-N-C(19)-O 5.1(2) 
C(9)-N-C(19)-O 174.64(16) 
C(1)-N-C(19)-C(20) -172.64(15) 
C(9)-N-C(19)-C(20) -3.1(2) 
O-C(19)-C(20)-C(25) -61.0(2) 
N-C(19)-C(20)-C(25) 116.77(18) 
O-C(19)-C(20)-C(21) 116.5(2) 
N-C(19)-C(20)-C(21) -65.7(2) 
C(25)-C(20)-C(21)-C(22) 0.0(3) 
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C(19)-C(20)-C(21)-C(22) -177.48(17) 
C(20)-C(21)-C(22)-C(23) -0.3(3) 
C(21)-C(22)-C(23)-C(24) -0.2(3) 
C(22)-C(23)-C(24)-C(25) 1.0(3) 
C(23)-C(24)-C(25)-C(20) -1.4(3) 
C(21)-C(20)-C(25)-C(24) 0.9(3) 
C(19)-C(20)-C(25)-C(24) 178.44(17) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
 
  
 
